var title_f36_5_36944="Anserine bursa injection";
var content_f36_5_36944=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51695&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51695&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anserine bursa injection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient lies on the back with the leg extended and externally rotated. The tibial tubercle, medial joint line, and midline of the medial lower leg are identified and marked. Ethyl chloride is sprayed on the skin. A 22-gauge needle is inserted perpendicular to the skin and is directed slightly upward toward the concavity of the medial tibial plateau. It is passed through the subcutaneous fat until the subtle resistance of the conjoined tendon is felt. Local anesthetic (1/2 mL) is injected for comfort. Then the needle is gently passed an additional 3/8\" to the firm periosteum of the tibia and immediately withdrawn 1/8\" to avoid injection into the medial collateral ligament. The bursa is located between the MCL and the tendon, and 1/2 mL local anesthetic plus 1/2 mL methylprednisolone (80 mg/mL, Depo Medrol) is injected. Injection should be free flowing with little resistance; pressure on injection usually suggests improper position (too deep).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD. Femur Tibia",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36944=[""].join("\n");
var outline_f36_5_36944=null;
var title_f36_5_36945="Drug packet layers";
var content_f36_5_36945=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Drug packet: Cut-away view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph shows a cut-away view of a drug packet revealing a hard wax exterior shell, latex wrapping beneath the wax, and a core of compact drug.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Hoffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36945=[""].join("\n");
var outline_f36_5_36945=null;
var title_f36_5_36946="Patient information: Syncope (fainting) (The Basics)";
var content_f36_5_36946=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15704\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/7/39039\">",
"         Holter monitor",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/22/18799\">",
"          Cardiac event recorder",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/49/14097\">",
"           Tilt table test",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?8/46/8931\">",
"         Patient information: Bradycardia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/17/33042\">",
"         Patient information: Vagal maneuvers and their responses (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/9/4245\">",
"         Patient information: Syncope (fainting) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Syncope (fainting) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/syncope-fainting-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H630594272\">",
"      <span class=\"h1\">",
"       What is syncope?",
"      </span>",
"      &nbsp;&mdash;&nbsp;&ldquo;Syncope&rdquo; is the medical term for fainting. It describes what happens when you pass out. After fainting, a person quickly &ldquo;comes to&rdquo; and is OK again. Syncope is very common. About 1 out of every 3 people has it at some point in life.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594279\">",
"      <span class=\"h1\">",
"       What causes syncope?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Syncope happens when the brain temporarily doesn&rsquo;t get enough blood. This could happen to you if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Your body has a reaction in which your heart starts beating too slowly or your blood vessels expand. This is called &ldquo;vasovagal syncope.&rdquo; Causes can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Extreme emotion or fear",
"       </li>",
"       <li>",
"        Severe pain",
"       </li>",
"       <li>",
"        An abnormal response to urinating, coughing, or other body functions",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Your heart starts to beat too quickly or too slowly (for reasons other than vasovagal syncope). Causes can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Heart disease",
"       </li>",
"       <li>",
"        Problems with the heart&rsquo;s electrical system",
"       </li>",
"       <li>",
"        Side effects from some medicines",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Your heart cannot pump out enough blood, because something is blocking the flow of blood. This can happen in people who have conditions called &ldquo;aortic stenosis&rdquo; (a valve disease) or &ldquo;hypertrophic cardiomyopathy&rdquo; (a heart muscle disease).",
"       </li>",
"       <li>",
"        Your blood pressure drops when you stand or sit up. Causes can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Blood loss (for example, if you get hurt and bleed a lot)",
"       </li>",
"       <li>",
"        Not drinking enough water",
"       </li>",
"       <li>",
"        Side effects from some medicines",
"       </li>",
"       <li>",
"        Drinking alcohol",
"       </li>",
"       <li>",
"        Diseases that affect blood pressure",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594286\">",
"      <span class=\"h1\">",
"       What other symptoms should I watch for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Tell your doctor about these symptoms if you have any of them and have also fainted:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Dizziness",
"       </li>",
"       <li>",
"        Feeling like you are going to throw up",
"       </li>",
"       <li>",
"        Pale skin",
"       </li>",
"       <li>",
"        Heavy sweating",
"       </li>",
"       <li>",
"        Feeling like you are looking through a tunnel",
"       </li>",
"       <li>",
"        Strange body movements while passed out",
"       </li>",
"       <li>",
"        Staying passed out for a long time",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594293\">",
"      <span class=\"h1\">",
"       Is syncope dangerous?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It can be dangerous if you fall and hurt yourself when you faint. It can also be dangerous if you faint while driving. To be safe, you should check with your doctor or nurse before you start driving again after passing out.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594300\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Anyone who faints should see a doctor or nurse. Most cases of syncope are not serious. But injuries are a common result of fainting. Knowing what causes you to faint can help you prevent it from happening again.",
"     </p>",
"     <p>",
"      A doctor or nurse will ask you questions and do an exam. During the exam, the doctor or nurse might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Check your blood pressure and heart rate when you are lying down, sitting, or standing",
"       </li>",
"       <li>",
"        Listen to your heart. This can show if something is wrong with the heart valves or heart muscle.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594307\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will want to know how you feel before, during, and after you faint. He or she will also want to know what medicines you are taking. Here are some of the tests doctors use to find the cause of syncope:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Electrocardiogram (ECG or EKG) &ndash; For this test, your doctor will put sticky pads on your chest, belly, arms, and legs. Long, thin wires connect the pads to a machine. The device records the electrical activity in your heart. This can show if the pattern of your heartbeats is abnormal.",
"       </li>",
"       <li>",
"        Tests for blood in your bowel movements &ndash; This can show if you are bleeding on the inside.",
"       </li>",
"       <li>",
"        Home heart monitor &ndash; You might wear or carry a device around at home. You will keep doing normal activities. One type of monitor records all your heart beats for a day or two (",
"        <a class=\"graphic graphic_figure graphicRef76605 \" href=\"mobipreview.htm?38/7/39039\">",
"         figure 1",
"        </a>",
"        ). With others, you push a button to record heart beats when you feel symptoms (",
"        <a class=\"graphic graphic_figure graphicRef75670 \" href=\"mobipreview.htm?18/22/18799\">",
"         figure 2",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Tilt table test &ndash; For this test, you will lie flat on a table. Your doctor will monitor your heartbeats and blood pressure while your body is tilted with your head up (",
"        <a class=\"graphic graphic_figure graphicRef57312 \" href=\"mobipreview.htm?13/49/14097\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Exercise test &ndash; Your doctor will record ECGs while you are exercising on a treadmill or bike.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594314\">",
"      <span class=\"h1\">",
"       Can syncope be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You might be able to reduce your chances of fainting again by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Learning what causes your syncope. Then, you can avoid those activities or find better ways to deal with them.",
"       </li>",
"       <li>",
"        Laying down with your feet up when you feel like you might faint",
"       </li>",
"       <li>",
"        Learning how to keep your blood pressure from dropping when you are standing up. Ways to do this include:",
"       </li>",
"       <li>",
"        Wearing elastic compression stockings &ndash; These are tight socks that go up to your knees. They keep blood from pooling in your legs.",
"       </li>",
"       <li>",
"        Clenching your leg muscles before standing up and while standing",
"       </li>",
"       <li>",
"        Standing or sitting up slowly",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594321\">",
"      <span class=\"h1\">",
"       How is syncope treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on what is causing your",
"      <strong>",
"      </strong>",
"      syncope. You might not need treatment. If you do, treatments might include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines that help the heart beat at a normal speed or in a normal pattern",
"       </li>",
"       <li>",
"        A pacemaker or implantable cardioverter-defibrillator (ICD) &ndash; These are devices that are put under your skin. Thin wires attach them to your heart. They help the heart beat at a normal speed or in a regular pattern.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594328\">",
"      <span class=\"h1\">",
"       What if my child faints?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child faints, you should take him or her to see a doctor. Most cases of syncope in kids are not serious. But your child might have a heart condition that is causing syncope. Other causes of syncope in children include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Holding their breath",
"       </li>",
"       <li>",
"        Poisoning from carbon monoxide",
"       </li>",
"       <li>",
"        Swallowing medicines, drugs or alcohol",
"       </li>",
"       <li>",
"        Low levels of sugar in the blood",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630594335\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/46/8931?source=see_link\">",
"       Patient information: Bradycardia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/17/33042?source=see_link\">",
"       Patient information: Vagal maneuvers and their responses (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?4/9/4245?source=see_link\">",
"       Patient information: Syncope (fainting) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/5/36946?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15704 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36946=[""].join("\n");
var outline_f36_5_36946=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594272\">",
"      What is syncope?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594279\">",
"      What causes syncope?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594286\">",
"      What other symptoms should I watch for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594293\">",
"      Is syncope dangerous?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594300\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594307\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594314\">",
"      Can syncope be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594321\">",
"      How is syncope treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594328\">",
"      What if my child faints?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630594335\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15704\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/7/39039\">",
"      Holter monitor",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/22/18799\">",
"       Cardiac event recorder",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/49/14097\">",
"        Tilt table test",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/46/8931?source=related_link\">",
"      Patient information: Bradycardia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?4/9/4245?source=related_link\">",
"      Patient information: Syncope (fainting) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/17/33042?source=related_link\">",
"      Patient information: Vagal maneuvers and their responses (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_5_36947="Atrial tachycardia with AV block";
var content_f36_5_36947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Atrial tachycardia with AV block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 206px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADOAcUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6poorzm3/ALc1zxz4mtU8UapptjY3SwQwWcNmQo+y2snWWF2JLTOevp0oA9Gorjx4Y1sLGH8feIA27n/RtP8AmHPA/wBG4P504eGdYG7d498RYB4/cacMfX/RaAOuorjf+Ec1r7Z5X/CdeI9nl7s+Rp2c5x/z604+GdbzFjx74hwfvf6Pp/PHb/RaAOworj/+EY1so23x74gLbuD9n0/AGeh/0XrTF8O6211PEPHXiIBEVlPkaf1Oev8AovtQB2dFcgPDGt7owfHniHp837jT+fp/otIvhfXdg3ePfEBbcckW+n425/69euKAOworh4dC1ya6v4E8ceIgYCoRmg0/BJXPP+i+9Wl8Ma3lc+O/EWNvOINP+9/4C9KAOuorjB4Y8Q7YM+OteLZ/e4hsMY/2f9E69OtQjQNfkW4EPjrXi8cm1cwWGMcZz/ovWgDuaK4//hGtbLkDx14jwUyMwaf19/8ARaU+GNc8yP8A4rrxD5eDv/c6fnPbH+idOtAHX0VxFnoOuXVqssfjrxCSZGU5t7ADAYj/AJ9M54qQ+GdfIl2+OteJx+6zDp/P1/0T+VAHZ0VyA8Ma75q58deIfK2/MfJ0/O72/wBE6dap6ZoXiC8sLac+NvEKF2O8Nb2C4UEgEA2nsOtAHd0Vxw8M69tf/iufEG7d8v7nT+V9/wDROvWmz+HNdiW4f/hOvEPlJHuQ+Rp5bIBzkfZOnSgDs6K4m08O6/NBaSnxx4g2yRhpP3GnggkA8D7J/M07/hGvERhU/wDCba+Jd+CPL0/GzPXP2TrigDtKK4jUvD2vW1jdzReOfERaOMtGPs2ntkgdx9lH86nTwzrhKZ8c+ItpTJPkaeDu+n2TpQB2FFcYnhnxDsh3+N9e3lv3m2LT8Ac9P9E5PSo9S8P69bWFzNH458Q+YgzGDBp7A9MZH2UUAdvRXI/8IxrfmH/iufEWzHB8nT85/wDASj/hGdbzHnxx4iwfv/utP447f6Jz+lAHXUVxV/4e12C33xeOPEZfzEXHkaeeCwB/5dR61Y/4RjWdxH/Cc+I9uOD5Oncn/wABKAOtorkP+EZ1zzEH/Cb+I9hB3N5Wn/Kfp9k5qGbw9rsUO5/GviMsZQgVItOPylgM82o7UAdrRXIf8Izrm6Qf8Jv4iwMbD5WnfN/5KcU4eGNZyufHPiTBHP7nTuD/AOAtAHW0Vw1/omt2scDf8Jt4j3S3Cw48rTuAWxn/AI9fTmrR8Na3tkI8beJMr90eVp3zcf8AXpxQB19FcgPDWt+YAfG/iTZtzu8rTuvpj7L+tV7rQtagmsk/4TfxJ+/kMbfudPO35Sf+fX2oA7eiuPPhrWwGx428SHDYA8rTuR6/8etPPhnWRu/4rjxKcDIxDp3P/krQB1tFcRNoGuJf2UK+OfEQSVXL7rfTyRgDGCLXHerCeG9aK5bxt4mU7iMeTpvTPX/j1oA6+iuOPh3Wh5uPGnig7OFHk6b8/wBP9F/nUX/CP63/AGobf/hOfEnlCDzM/ZtPzndjr9lx+FAHbUVyB8N6zmMf8Jr4n+fqfI035Pr/AKL/ACzSf8I7rWx2/wCE08UZVsBfJ03LD1H+jdPrQB2FFcONC1v+0rm3/wCE38SMkUKSLtt9OySS3Gfs3sPSpx4d1otED408UjeuSTBpv7s8cN/o3XntnpQB2NFcd/wjutbFb/hM/FOS+0r5Gm5Azjd/x7dO/rUMWg6417exHxx4kZIVQoFt9O3MSCSP+Pb6elAHb0VyQ8NawWUf8Jv4mGRnPkadx7f8etRnw9rIVD/wmnirLPsx9n03K8/eP+i9KAOxoriLfQtZkvL6E+OfEhFuVAC2+nZOVz/z7f4Vc8CT6gbvxPYalqdzqf8AZ2prbwT3McSSeW1pbS7T5SIpw0r87c4xQB1dFFFABXCeD2b/AIWF45XAKf2gh685+w2Xau7rzTw7qcNj8SvHKzR3jlr6LHkwSSj/AI8bP+6CAePrQB6GFJFuWt1yGzjI/d8Hkfy49aY6kRTYtUYl8hdw+fp8x4/zisoa3YqYV8vWAYzkZsrg7uCOfl5696bLrenhHVl1cCV92RZ3AIPHAO3gcdPrQBs4Vr5geT5Q49Rk1y9h488L33ik+G7WS8OtW4ybVtKukMK9NxYxhVQ5GGJCnIweRW5puqW2oX8q2/nhkiBYSwPHjk/3lFeKeE9d0iX9rHxQ8WqWDpcaTHawstwhEkymHMa88uNrZUc8H0oA9O0rx34W1TxLceHLF7xtXiYPPavpV1H5XAYNIWjCqDwQzEA5GCciuhjVhql8cl1MUeIyeP4vXjmvEPh/rukT/tSePXg1SwkS8tLaG2ZLhCJ3WKLcqYPzEbWyBkjafSvWbvxDZW+s6naXT3ERRI0DxQu55BOcgHHWgDfCjzIP3A+VDhsj9304/H+lMtsi3TNr5RLkmPKnbyfm9Pf8ayB4m0kPG32i9OxSMfZZsN05PydeP1NMTxHpCiOP7beZRt+5oJcnrwx29Of0oAu2x3XutjyjKA6Ls/vfu1454rRVEE4ZYcEJtD8dM/drlLXxDpP23V915PF50q4ZYHBH7tRxwefqBV8eLND87cdQkGF27TDIB9fu9aANjy41FuBbnAckDj93wTk81laa6zDVN8MsoW+I2njpt5GfTrVc+KtDHlD+1pP3Zycxt8/B4Py+/bFYuleLdGQan5upGPffOytHEc4yOuAevvz9KAO3KIbqQmIkmIAn+8Mnj/PrUpjQ3ETmI71QgN2UcZH+fSsJfFuiSOqrfEF04bynGPzWm3HjPw7bXMUc+swxyPlVjfI3nrxxyfpQBcsYoG0613WzOouC6hR9xt7fMee1WpYIXW8VrWRw5G8ZH73gdOf8K5rw94s0h9FtDc6tBFNuZmVcc/MflPy/4Vdbxf4fIlUa9CpfoQR8n0+X+eaAN5AguFPkuNseBJkYAz93r14rN0CFI9I01DE8gG5w4wAhyeTz7+9Vl8XeHy7Sf23AUI27Cw259emc/jWfoPirQ00mzWTWraNolO9FYYPXg8dvbFAHSNbwtDMDaSENNvK7hlmyPmHPTj26dKZfiJIdScQur/ZyWl6Bxtbgc9R/Wsw+LNAZGA1+EEuGDBlyB/d+70/XnrUGq+LtBbTr7brEDloGCx7sc7T04zz+NAG1paRm105/JbetsAr8YQYXg89f8KkijiMESi2mVRLkKScqck7jz0/xrB0zxf4eWztAdctgUhCGNnHXA68ZyP61OnizQMKD4gtyVbcSXXJHp06fTmgC7rypDpGryqhV3iO5nYbW+XAxngflWgqr9oV9jlzH9/Py4z069a5bxD4s0X+xb8W+tWrSyRkRoJBx24wCf51pDxToW4MNctAu3bs8xcZ9fWgDTtoolgtVSKZVX7gckleD97n+eapa86ro16wEseJFyTwSdy8jPaq48T6GDEP7etfkPzZdPn+vHH4Yqpq/iPRZNOmjOs2UpkkUqN4+Ubl445/GgDo22faJmMcpcRgEgnDDngc4zTogm222pKPl+UEn5eP4uev1rJXxLosjSFNcsiGXCgSKdp9felXxFo/mKDrdmfLXDqZF5PqfSgC5qGz7Ko+Zc3CD5sjneKtEqJZjiTIQZ64I56e//wBauW17xBpgtrRRq1nLJ9shY4kAwu8c4HYe9aq+IdIdnI1uw2vwn71PlPsc80AaoCmSI/vA204Bzjt19/rVDUpVjs4iiyHddRrhyw5Mg9icfpTf7d0oOgOsWHAwymZPmP51n6nr+mCG1RtYs3Y3SHKyDoGzjg9Md6AOgconnOfN+78wG48ew/wpPMRZoUxNllODhtuPc9M/Wsz+3dNYzKmu6dlxmMeanycf73NSx67pT7GTV9PZCp6TLyfXrQAmoFUisArS4N2oG/cWPJ49cVem2JBcMxnK8ltoYt0/hxz+Vc7qusWaLpaSavZSyfbULsjKBtw3UbuB05rTfVrQpMqazpwkZv3ZLqQnsRu5PX0oAuBovPb/AI+t3kg42ybdv8t3/j1VJo18/RxHJJsWRmAlDbm/dt1zznnvT21axMpI1WwEe3aFMq8N653fpWfd6nY/2lo/m6nZu8bSF2SVVB+Qjpu4/WgDWmEbQyr5l0oaQAsgbcDkdOOn6YqZtoknYvL90ZHOFHPI96pf2ralSo1Ww3bsht64C56Y3dcd6edSti0u3UrHBUeWN4O0+p+bn9KAI5MLrOmIHLDyJSCxO442cnn39KtpJGIoz5spDSEAkHJOTweOlZc15Ztr+nOby1aSOCVWIkUddnbOe1X1vFKxZvbIsHPmYPVecAc8Hp+tAEhkQJdEzy4DYY4/1fA4Xj/GqwXPiKU7sEWajORkfO3+FWGuNySeVdWpfOUJ5AHvzz3qmrxf8JFcSJPGZTaIoUsMffY/XvQBeLqv2VTctlumQP3vHfj8eMU0yxRwu73jbfN27zjgk42jjp2qUNJmPc8WAv7zHr7e31pN03ltloS+/I642Z/nigDPiMS6/qb7gjrbRB2G3Kj5zn1/OrUDp5lmn9oPKzRsyq2z98OPmOF7ZHTA5qjZuT4k1dY9vmeTDjcxx0b2/rWuPMEi48vy8fN659vagCsro1tGVv3YNLgSjYSxz937uMdumfeqVs2zV9ckkmMaKIuRg7BsJz09/etWP7T5S+aIfN3c7Scbc9vfFZlgJBrGtmMjeWi2hs7f9WP60AaYdTcqgny2zd5fHIz96ogymKA/bDzJgN8o8w8/L0/l6VYzJ53RPK2/8C3f4UwC4xFkRA7jvwTgD29+lAGXavs1DXHeXyQGj/eE5Cjyxzgis/wZ/wAjD46/7DMf/pus60dLEgvdbKGMn7SNqtkY/dp161neDP8AkYvHf/Yaj/8ATdZ0AdXRRRQAV554MTHxR+IEmVA+1wDkD/nyta9Drz7waG/4WX8QGXB/0yAYLf8ATla9sfrn8KAO5VyRb/v4zu74/wBZx25/HvTSZCkm25iyHxu25CjP3Tz1oiWTbbbraFSo+YBs+Vx/Dxz6dqrtdQpc/YpFtlupS0qQFxmRFIy+Mdsj/GgBsDRp4gvmOARbRFmLdAC/vxWkJEJXDKSwyvPUe1ZKEvrWpqqBytvEAjNw2d/B44z071oLHhoMQRAIpGQeY+BwvHT8ulAEoljK5DqVztyCOvp9axrU51jXfJcRygRDzGAKqdhIP/660VjKwqqWsIHmZKAgADP3unXv/WqNvHcDUtaZoTJG/l+UrkhX+TkDIx1oA0lMnmxgyR/cyy45Y8cjnpTQ0vlwnzoSWfk44Yc8Dnrj+VCqfPjb7Og/d4MmRleR8o46f4Vwx129i+LenaA1qi2UmkNd+QGXEMgmK+YDjn5eMD1oA6ywBEurGFlEhuer8jOxPSr5MvnMFaLy9nAIO7dk8n2rH0jfI2uB4BMPtpARujDYnrxWsy/6RIfswOYx+84y3X5fX/8AXQAo88iD54j/AM9MA88fw81z2iLcm31AwSornUpATJ8w27hle3PpW5CpC2v+iCPC9AR+546DH5cVkaZHKLW5Etm0n+nysFPGB5hw4z+fFAGyPP8AOcK8YURjaDkkH3rj/GzMPiD8P1LJtNzdfLg5JFu3P0HNde+PMk/cFiU6cfvP8+9cF8QJ2T4qfDiOKM+Y015mTjG3yCCPrQB1vhd5H8P6e8JGCCX8wHONx/X61ot9s2T7fs4fd+6zuI2/7Xv16Vl+F4ynh7SVa3ZiFySMKIzzyRuP6ZrQZFNvcqbF2DPkplf3vT5hzj88dKALLmQM5O3ywnAAO7NZXhx7l9E0holQRNEDKJNwcccY98+tX5kjV7iQw4Jiw0vHIGeOuff8ay9AWI6Tof8AozSsluCsoAxENoz379MDNAGv/pe3/lhnzff/AFf/AMV+lU9eaZdH1UkKYxbP5ezJfO05z/8AWqURoLYD+z3IM2TGdnB3f6zrj39fauH+NmtXfh3wReXmmKILie6t7d5GCsJEdgrYBP8Ad45xQB3tssqCBQIxAIQD13buMY9sZpy/adkW8Qb937zGcY56e/So7cKJoMW78QYE2AFA4+XGc579McdaZbxoLezC2MsQVsrGxXMR55OGx+WetAFLxXHLJ4f1IeXGcqBHhdxIyOo49+9au2QSkKkPlBMD+9u/wrE8UGODQNSk+ziNmdM79uJCWUBupHtz6VskKbp2+zuW8vHmAjDDP3euc/h+NACos5EO9IMnPnYz6cbeOfxrO8RrnTMPGnNxEoC4OR5i9c4q8qoXsz9lkUqp2nI/dcdDz36cZqlqBhhsYx9mCq15GAkmOWMo+Ycn6igC+InV5gsMAQKPL7ZPfPHA6U5YssnmQw8r85xnnjpxyOtMkVN10TbyNlAGwR+8GDwOf5460qKvnwYgkBEZCsSMIOPlPPX/AAoAztYtoJYLT7dBbhhdx7BgNn5uOverz2i4l22tqQB+6yvU478cc+lZmtn/AEfSgimDOoR/JKQCfmJPr16itOTYRd5t5iON2D/rOB93n/CgBzWyGaP/AEW3MeCWJUZDdscfWsfWrGKSLTPOs7dZBfRkhEVhgE9zjtitvgXSfu5N3lnD5+UDI4PvXnvxh1248K+BbbUdLi8qePUIVjWYbsbnIJIzz1PegDumsYVWXbYWjY/1a7QN31445+tONhbCQYsbXZg5bYuQfTGKa3lvDd74bjDbd5XP7z5RymDn27dDVokfaQNsmdnXnbjPT60Ac3rFja+donn6daJI96AyqiMPut3I56dq1H0228uYrpFizq2I1KqN445J28d6hv8AaZNEVBIoNzkLISG4RutXtkZinGLoAy8/M+c5HK8/d+nHWgCH+yrHew/sux2BcqfKXk85GMcdufesfV7XSbXVdEa+tdPtkkeSPayIFLlQAvTk5PtXRSBC9xkT52Ddjdgjn7vv9OelebfGNRu8EspZY11i2P70twN6dc9/rQB3h0iyCKw0fTy4fGNi8Lnls7fTnFK+jabvlP8AY1idoG0+Snz+3TirP7ryV4utvnccvu3bu/fb9eMe1LOYgt0W+0cAbtof0/gx/SgDDl0bTP8AhI7SL+yrJY2tpHZRAuN25RyMYJ5PNXV0LSyI92h2ILsS/wC6T5fQ9OaV9x8UWoUny1sn65zkuvv149KuRCN47XbJdbdxK7twJPP3sjOPrQBR/wCEf0lQ7LodluU7V/dJ8w9fasweF9EbXL3Oj2rqtshCeVxnLdO2TiuhZ4lhmYyXODLgnDZByBgcfd+nFcR8RtUuNJ0vxXe2Vw9tPBaWoWZFBZSZCOO/Q+lAHRL4W0JvILaBZqWXLfu1/d8dD60z/hFdCCEjw9bZaTBXYnTP3uvT2rYhkjD2kZmlaQxZXIOHGBy3HX8qiEluLeNjdXGx7jCsc5Lbj8nT7uePp3oA5q38LaH/AG3rGdFtpliSHy4ljGeVOcZIH8q0U8J6DvjiPh+3VWQuX2rtU8fKec5+gxxU1pKiaz4iaUmJE8nMiYLY8vrwM/nmthWT7WqedJ5giz5Z6EZ+9060AYK+FNBMcbHw/ApZsFdi5T3ODjH0zWdZ+F9BN7rLf2DDJ5MqqiogBb5FPHPv3xXUwSwNBaMl1IyuxCMTzIeeDx9azLKdYLnxHLcXfkwJcqTIGBMY8pM9Rx+NADf+EP8AD3mFf7Et8Y3bgowT6dc5pi+EPD0sUZbQ4139VPBX64b+VbXnQm9KC5Jk8kSeWMFQufv9P60yKSIpYkXsjh/uNx++478fjxigDmLDwpoSS6o/9krMI7oKip1A2J05HqevNS/D60gsdY8b21pGIoE1mPagJOM6fZnv7mtTTZsR6u085iRb4qHUkleEGOR/iOapeDP+Ri8d/wDYaj/9N1nQB1dFFFABXl3h7UFsfib8QfNhvpke7txi2t5JMH7Fbc5Xof1r1GvPfBpC/Ef4jMcri8tvnOMD/Qbf/PpQBvjWrRFhAsddxD93NpOc9uePm/HNeeavrkFx8btCU2+rC3g0u4l8oW8wlLtIvO3GSvH0r1xJlZ7cC5jJdCdvGZOByP8APevLNWnP/DROihb6FFOiyruIB3/vx+769f1oA6qDxFZnVdSkey1hVkSNDiymBGA2e3HX0FYPj7xxq+l+IvAekeG1sok8QzTwvNqVpLK8QjCYIQSIc/Mc5PPH49valV1XWnVlibEW6RjkD5O4z/hXO/EH4dWvjfxF4U1HUZ4GtNElmklsp7QTR3YkCDactgAbO4brQBn/AA4+IE/iTRNVn1202z6Zq8um/aNMjkaG5MfPmIMkhT3BJHTnnFcx8ZvEEn/CXfDNIb3XrTSNQubxby3sHuoZp1Xy8ApDiQkEnAAzya9msrG00qztrPS7e1sbSM7UghiWNAOThVGAPXisDxLYeGLiSHxHr6xyTeF/Pu0nWV82g27nYoh+b5UBwQTxwOaAOX+Et9r2meFtSn8XjWGs5NUmXSVvY5JbxbQ/6vzRgv2P3+fXtWHcarZD9oDSpgurbLbQpE2vby+YSZT95SNxXB69K9tLjcqh1yRnGeSP84rySC8M/wC0lBGlzGwj8O7WbjE2ZNw288djQBj/ABQ8b6hofhBNU8O6lJpgu/FEdpNcSW8YKwtCS3EqsB90HJGRj61t/DbxnqN7q3jNNQ1R9b8K6ZNDHYa2sKbpi4+dAYVCSbWIG5V9z1GOh8QeC9M8a6Ylpqk93DHZaz/aCG3dQWlQsADuU/L8x46+9dfZ30Go6XDfadcRS29zCs0Ew5VkZdyt9CCDQBk6X4i0nUb62t7S5unmwyqrwyKGwMncSuM4Br598BfFDxbqlj4Tnh8S/wBt67f6ybS90T7PbYS0B5mPlxq8eBj5mOOc44NfTo87zIvnj27TvGDkn256Vynw28PaD4I0l/DGh6hNci3P2txcyK0gErOASVVRgmNwOP4TQBpza3YxXs8bjUd5JRitrKVG0kfKQuPxFeZfETxHp6fF3wDcF7kRwLebg0DrgtEVBCkcn3Fevh33z4uYiARtJH3Oeh5ryv4ltJ/wuz4dgMpQRXrbRnIPlHmgDp/C3ifSYvD+lpNeTRyRRfOi274J9DtTH5VoSeKdFkSRV1W5QuQQy275T2GU6fXNW/CLzP4b0Zl2qhgHmBw27pxjPTn1rUIuzFJtkt/M3/IShwFz0Iz1xnmgDm77xToyw3cv9pzkNCVEbQPsU4PI+TP55qp4a8U6MuhaSG1GRGigUOiwuVY7ehOzkfTFdRqhm+xX+5o/K+zttABDZwc5Oen0qv4fS5TQ9IRWiRVtUEikMW+6MYJP86AKI8U6MFA/tW4JD78m3bJGc7fudP1968v/AGiPEum3Xgyzhsr15XfVrYsjRMoVRknGV+nrXtym68uMboDJv+fggbMnp74xXjn7UQk/4RHRRIy7TrluI9mQcbW6+vNAHokXivRMpJ/akmBHs2iF9pP977nX9PakXxXocaQqdYmJjOSzQtl+vB+T+WK6KPzQygbPJEYwOd27/CmxG58uDzWhLc+btBweONv6daAON8ReJ9Fn0i5hh1MySSyRsqsjLtG9eB8vTg9c1qnxZoXnO/8Aa5G5doQI2FPqPl60vjBbhtAnWVoubqHZsDfc81OvPXr7Vut9o3TYMITaPKyDkNznd7dOlAGD/wAJXoQaE/2wcICCDGcScdT8v8sVieIPHfh+yXTLRtVM891fRqmUccBtxztXGAB3ruf9I8yH/VGPafN4Oc8Y2+3XrXlPxgef/hLPhkk6xl2148JnBXbxnPsaAO2Hi3QZRMy61hZAAuEPycYyPl/nUo8V6CHVjrMZAXbtPQ+5461tP9pxPs8jP/LHIPp/F+PpTwJfOGRH5Wznrnd/hQByOs+KNDk/s1V1SOTZeI7NhuAAx5wP51efxVof+kA67Epc4XOP3XA4HH48+tWNaIE2irdQxySNeAZVeFOxjkZ/CtRxP5c20Qbt37rIOMcdffr09qAMf/hKtDaZXGtQ7ApXZngn1zjNeW/tEa5pt18PbOG21OO6kTVbZnYEZAD5Ocele37W837qeVt/HP8AhXjX7TbOnw+0tZki819WtgQg4PzE9+3FAHoqeKtDdJVTxBZgscodyjyxgcY79+tS/wDCT6IZt412yEZXbs81evrmtFYZRFJiC03BgI+ONvHXjr16VKbceY4EFvs2/KSOd3vx06UActqviLSGv9DA1eykWKdmkl8wcfu2GTg4GSe9ajeI9GZGVPEGnK5bIYzR8DPTrUWp2sJ1rw8LiC280vIThV+8Iz0zyfw5rVe3zEcWVoX34weBtz1zt647UAUT4i0bfLjxDpoDrhB9oj+Q85PXnt19K8l+POtaZcz+Bvs+r2dwsOswtO6TIwUBlyzYPA/SvaHtUxKUsrQ4XMWQPmOO/wAvA/OvE/2jYIF1P4fQG2hR59VQSFFXH3kyM4yRzQB64PEGleUg/wCEj0sv5m4v50fzLnO3G704zTj4g0l/PCeINMywxH+/jPlnH+9zzVz7FF5aH+zrLfvwy8YC56g7eTjtx9aa2n26pN5el2RIOUG1Rv8Ar8vFAGIdc0Q+LUnOr6cSliU3faI8cyA9c57dK1Rrulnyj/bmm4H38Tp8/Hb5uKqtptgfEkif2baErZhhmMbSd546e3WrY0uzJt9+jWHzg+adiHyzjt8vzc8dqAGtrFmY2Ca3pgkMm4HzEICZ+7jd1x3ry/40a3p8PhXxXNb3lu80wsYotsqsCwlz0HYd69S/six25/saw378Y8tPu5+99307V4z+0JplpZ+CvE01vY26yfarBY8QgAfMMgdhnvigD2e01W3eK1dtSsCDEDIBIvzMQORzwOtP+3oI4wNRsGkEmXbcACmegG7g4xzVLT9B0p7e08zQtOwYFZn+zx8NgfLjGalGh6WYo2OgaeGZsMvkx/KM9enP0oAqadfK2qa6Yr21DNLGIfMfK8Rjtxn8DW19pH2gH7Ta/ZymMZ+bfnrnOMY7Yrm7HQtK+26439iWVy0VwojjMCdPLQ4G7gdT6Vp/8I5on2jYfD2nhNu4S/Z48Z/u4xnP6UAX0lnaKDM9mzhv3+3OCOfu88Hp1zXD+MJJB4F+IclrKglCT7SztjiBcjtg9cY7108XhzRXWFn8PaejPksPIjOz68c/hXBePNE0e2+HPju5i0e1M0KXAjYQKGT92uCp7AZzxigDuvBcksvhXRJI5ImgbToCuQS2/YOpz0/WtqP7Ti38xoM4PnbQeTj+Hnjn1zXD/D3w9o1x4I0G4uNBspJm06FzI0KHexQZ69/rW8vhzRGaDPhqzXzAS5MEX7o+hx/TNAD9Bad01gwNH5n9oSBTJuIwNvv6Z6cVU8Gf8jF47/7DUf8A6b7OqWheGtBnS/c6LZzkX8sYHlp8oBx+Q/Opvh/aW9jrHje2s4UhgTWY9saDAXOn2Z4H1NAHZUUUUAFef+DN/wDwsP4kbFVj9utcAtjJ+wwe3H1/SvQK8s0XWP7O+InxFhbS9TvElvbX57OAyAf6DBwTkY/DnmgD0mPzvOi3QQhAnzMHyVb+6Bt5HvkfSvKLySX/AIaR09DbW7S/2E/ymTAVfO5YHbyfbj612cfiaMSow8P+JAY12LutGIx9N36nmvK7zU4ZP2irK5fS9aZbfSTshWFvNyXJ3EbslefpQB7Rb7pL/WgsaykNGvlu3yt8g46cdfes7xP430rQJ57JpobjVY4UeLTYpR9oneRtsaKn+0w69hycDms2DxVarea15mk6+o3qZSLVl8sBByTu46E8Y4r548O+G9a+IHxWuPH2rW3iKx0VrkT2L2Vu/nyxL8sQVv4V2gZYZzzjrkAH1L4Ys9VtdGtv7dmS81OWVp7lt3yQlsnZGMfdXhR37k5rz/4ueJtK0DwP46j1a4Nu2pRT2Fr8kkgkne1O1MqpCk++B712aeJolSJf7E8SkIRgmzck9epzz+NeRfG1E8R/DHxdGmkaus0N2NQikks2CxeWF3lzk4+QyenWgD2fwj4k0rxbpdvrHh5lutPlVkW58t4zlWwVAdQ2Mg89OK8702N3/abvGNvFmPRI9+G/1WdvTjnk47cGtL4Yyw+FfAvh/S20PxEJ7WyWOZUs32eY3zyHGf77Nz1rk7HXrQ/tBXV8mn60HisPJMS2rtIwCoAGXOcck5+lAHqtvqtjpWi6hea5c2dparqEqmS8mWKMZk4+ZyBn0/Ssf4N6pp+pfDLQ49NexvpbXSLOC4WCeNz5gt1BjkAPysOmGrlPHc0Pif4V+K9HOmawZpnuJoSLJtvmq/mIpK5A+YAH0rL/AGZfs3hn4VW/n2WsNcapJJdyNDaSMoGdqlWA7oqnI9aAPeEUiSE/ZwuEI3ZHydPl/wA+leO+EfE2hyePr+3j1PSp7mazs4Fh+2RlvMW5vy6quSSyhkJUcjcOmRXoZ8UWSyiQ2et5RNuDZSY+uMda+ZPhz4fSL9oXVdWbT9Sazt4n1CDybcsQ8vygkDgLky4/3aAPrdAXEimCNhwVy2d49TxXlvxLj3fGDwZMEUNDDMVcHkghtyn2wPxzXa22uwKJUGma43mHczraOOfrnj8K82+IGtW6/FbRrhre/UC0VCJLdgFJ83sR7jP0oA9X8Oxsuh6Lvt0dlgUlwAPK+XqASTz04zV0qPs0oOng7pcmL5PnOR8/XHvzzxXM+Htf0qHSNKiaS9V7eAKQlvLsJ24OcLg+1WW8SaOkbRtfal80nmFvs025ec7c7OnbFAG3qIAtdRk8gKfIIMuB+8G08evHvUWjKr6Zpchgy4tkxLgfJlRkevNYOq+LNHbS9RdLq7zLAyKj2soCnaRxlMDr1pdI8V6LHYWJa9ut0VsiGNbaUqeOvCYJ47UAdJGieTCDp4QCUsI8J8hyfn4OPfjnmvHv2nVRfD3h9RCsbSa7AScDMmFYbj/LmvQz4m0PyolOpX+In8zcYJcvyflPycjnp7V5B+0XrWm39h4eWzurmVv7XSZhJA4Eagc7dyjj2GaAPoQqonZxbgt5ePNAGSP7vr/SoIbeJUswLBYxHnYAFxBx9e/TisVPFmhbpJhqVyVZQu37PLhfQgbOtIfFehxmDdqd18metvL8+R/F8nPWgCXxKscOjSFbdbfzLyEtkKd58xfm64yfzrXkhjL3rGyDF4wrNhf34wfl69unPrXF+IvE+htpyQrqUzsb2GUmWGXIAkBIHyegOBWt/wAJZoJe4kGrXOJVC48iTEfGMr8nBoA34ok822b7HsZIyFbC/uRx8nB9u3HFeV/FaNU8a/CxIrf7Op1qVjGccfLkngkc9fxrtF8XaAJIX/tW5IiGwqYJMOTjlvk68V5X8UvEOnn4l/DJVvp5ba0vJp5pJIn3DgAfwgnv0FAHujxoUu82W4P95fl/fcY9f51KI0F0JPIAfy9vm8dM/d9a5z/hKtCkt5tuq3W2Rs7xDJlPZfk6VIfGGgiTzTqMm0rt2+RJtz6/d60AWb0RxTaHEkX2cG5YrDlePkY+/wBeK0Ggh8q6H2NsSSbnXj94ePm6+w/KuXvfFejm90jy9QkdIpXMjNFJ08thk4XHerv/AAk+ieVIP7akHmvvVthyo4+UfL04/WgDoNqfbWfyG8zywPN7EZPy14t+02QPBOg28KfZw2oxsFZcldoLYr01vF2heY5/tYAFQu3Y2FPPP3evNeO/tE69pd74f8PQWmoNd+Ve5kO05IC9W4A/SgD3IJALCRjZzEPIHeMD5mbj5uvTp+VWm2G5nPkSlhEAXA4cc/KOev8AjXPp4n0RLbadd4Lhw+3kLwdv3en61M3irQtzt/bUYEigKOmw+o4/nQA6/wBi694bVVdBtm2qxPy/uxwevNX0itzahfstyE+0Z2nduDbvvdfu55/pXL3vifRW8RaJJ/a0EkUCTiSTnrtUc9hn6Vrr4k0UxoBr9vu8zdvLLkj+706frQBrSrExvN0M5JQB8E/OMH7vPX6YrxH9opM698P/ACvMHk3gkEbZPR48Zz35r1yTxLou2UDXrNC33T5iHZ9P/r14p8fda0668V+B3ttRt5o4Z8ySowIX95Hy2OgoA99i8nyLYLFdKu/Kg78g8/e56fXii68sW10WiunXd8yxltzcD7vOcfTHeqEOv6UUiDeINPYqcs3nxjf14xnj8PSiTXdLMMyr4h09XZiUfz4jsHpjPP40ABb/AIqq6BViosFztB3ffbpg1etvKX7GEjuVzH8m8sdox0fnr9c1zsPiDSG8U3sn9qacgNlEqTfaIiCdz8dc5HXFasev6QGiDa/prFVw4+0RjecdevFAFpDALaMKt7sNx33lt249e+3PrxivHf2kNy+DtULMBDJqdir467QCcfyr1oa3pmxF/t7Ty+/cx86P5l/u4zx9a8c/aBv7K58L3aW9/aTGXVYGAEytgLAcnA7CgD2yzeJXtUVp932YFVwdm3jr23frRC0LWtkVe72NJlN24MTzw+ecdevtVLTdWsBa23/E4sGiW3RColTO7A+bOf0qyuqWflxA6tYlgcu3mKNw5468UAU7LylbX3kmkUG6AZ4fvr8iYAwM1rl0F64MkocRZKc7AMnnpjP41z+h6nZSNrP2bU7VJDethpJQw4C54JHHXoa2W1G2MrldRstmzCqXUkN6k56e1ACwSwsLDZcTkOD5e4H94Nv8XHpzzivOPirMF+EPxBbzT96ZQVbOD8gxwOPTH616FHfRBrffqlkdoPnAFfnOOMc8frXl3xRv42+DXjjyZo/MluJkVS2S2ZFHAz39qAO48AmMeC9LQ3E6umlW3mKOkYMQwV46/nXQxPGGs1FzMxMZK7v+WgwOW46/lWB8PJtngrRQ11bbBp9uI17ofLGd3PPP0roFnO6Itc2xUKfNxxk+o54H1zQBjaFNGlnePLOyA6nKqmMZJJk4U8d/8movBZz4h8dn/qNR/wDpvs6d4SnaTTbl454ELahOW35OV8xugzwfemeCWDeIPHRUhh/bUfIOf+YfZ0AdZRRRQAVwXhArH45+JMrPsxf2uWwPlAsLfn/9fFd7XC+ETL/wmfxGEIjL/wBpW20P0z9gtuuB0oA61ZP9MiH2xWBiz5IC/NyPn9cfpXjiyxt+0Zbyx6mrM1r5O8BSJBsJ8vjgHPfrxXtOZBIC6xiPbktu5Deg46e/6V41Gbz/AIaJDvDb8xCNhuJ2jyd2QcDmgD0CNbMSeKvtdxBBbvIizyziPywDEoIbPBGDg7vWt2GWGRopba9ia2MO5Ej2lWXs4I7Y9OK81+IqzXnhvxTpcLqZdV1O201T2Ak8tSOnXbmtr4MSXH/CuNGhKxMlrFJa9SDujkZACMdMKOaAOuiJMVmf7RVwT97Cfv8ArwP/AK3pWVYpE9vr6SzRQpLeujNIqMuCqDBB4OemD61ur54WEeTCvXzAHPy/7vHP6V4V8QNV1P8A4SZ30y8aCDRLh9VnQA+XN++iiCvnqNpY0Ae4lsTTg3ijbGCUwv7vr85/+vxxXkWhlx8e5pUnWRJRLG74B80C3hORjpzg8V7GGlZpCqRGMqDGdxyx9+OB+deQ6RII/jg4mjAeS4uUXByFYWsDcfgDQB33hqTOmTFbhbfOpTLltp3fvTlegGT+daFjaQ6bYvY6fPBbWlrAkEECqNtqqrhe+cYA6+leeePNQ1TTvhVqkmivt1K51B4IJFLZiZ5yAy5Gc12HgnVrnXfBun6lLDBJLc2sZJLY8yTGHDDHHzA+tAG2JG8+BTeRtmLLRhRmT/bHPArjPDUMUelWuotNDbXty3kTSNtzNGjyFI8nGMGR+n949a7ZVZZI2aCJMRY3DkqePlHtXiPxPt5NT+FmjafAWVr26+82S6lQ8gIzz/DQB7Nany7dlN8gcy4zhfkPHye5/WvMPiLcNH8ULMtI3lJawpwM7Wf7QB055rvfB13eah4N0S8ltoDcTQQyH94SCCoy+dvX2/WvOPi5MsHi95Z0BgSOyQkHByxuQOnPWgD1nRg0el6UglXaLdAysDuf5R0//VU5klNupW7t9xkA37OCM/dA3de3X8Kp6ZN5WjafM0SmJLMM0pOCuEHY81yPwn8Yf8Jt4cmmm0m2try2vNslqvCqjfNHKAR3HP4UAdhrTyDS9XxOpAtn2IoO6M7D1xyfyqTSN62NgokXyhbJ8jAl84HOSen4VX1xWGka03kRRZtn/fAjMnyHr0Ix7mp9PhASyP2VGC2qqLg43DgfL64PX0oAsK03l25a5gzvIcqnDjn5R83B6evSvGf2jGklPhaB5I3P9peYAoICqDGMNycnLDpivYY4dsVqq6fEqq5O3KjyeT8wwOvfj1rx74+24k1Dw6WiSBo7iSUAYYS/voACfc0Ae0FpVknzNFsCgqCDlTzy3PT8uhpI2mb7OfPhYFcybVPz8cFeeP1rN1+6Gm6brV89lFiG1Zw7EHz9qMdpHX259a4n4LazrOq6SLbxHbQ3F/YSkfaUAHlo8ayIAP8Adfbx6UAdj4kLNp1uJmjlLX8AUoCAv70Yzz1H+RWxmffcASwhQB5fyklDjktzyM/SsDX4wmn6cosUtwdTiOxQpx8/3+O59ueaj8d+JdO8HaFqOsatYtJBujjxGqs9yx4Ax7c9ewNAHTbpPOT95Hs2EsuDuJ4wRz069q8a+KLSN8avhbHIyO4lnYlRgdB06+lesWrw3Ulte21pG6SWwaK5G0EKcEJ64PX0rxzx7IifHb4awi2SzEKSM0IK4UvuAHHHVaAPbm8/ypdksHmbvkJQkKPQjPJ/KpD5nmtiSPZt4XbyD6k56e2Pxqn5SrBdBdMQ7pcmMbP33I+c9s9+eeKkliU3Fw32NWZotpkyv7wf3PX8+KAKGoEDVtCE7q0heQ5X5Qx8s8gZ/wAal13UJNK0HUtQkkt/9FjeYbgQuFGcHnrVG6WNNa8NxiBbcgTbY/l+T930GP6VjfFWKL/hA7+0+yRxm+u4YAgxmQvKgLYHU4yfwoAt/DHxReeMPCNtrF7DBaTyhkktlBPlSKzA5yc9AOK4L9pLLWPheN2TzTNKSy9CQgzj2Oa6H4Z3dlb6x4z0AxwnUrbUJpRCXUSSwvgrwedvOM9Oa5X9oZQI/DwaAQ+XaXb+V18sBE4444z2oA9riN0tqMvbFw+AQDt2Z6detSt9oLT48jZtHl5znOOd3tVO1giOnWwFipTerhQVwD/z0/r61PNCmbxvsZcyKAxyP32B069unNAGXfD/AIqfQldYvM8mcsFAxnC9M84z6VqILoxREx2vmGT95gnGzJ6cdelZlxHt8UaOFj2IlpMNvdPucVD4q1G08O+FJ9Wn06aWOxzOsCMNwbPB69yffr0oA3JFnCTeXFbl8/uskgH/AHuOP1rw39oFYv8AhMfDyqi+b9lZ3wOAPPhAzx6kivTvCGsQeKvBw1c6Nc2wvhuktJGBZj04IOCOPbp0rzX47Nt8UlioMdvogmZfVRdxZH5CgD1vXL1dH0G51G7gtI47WCSafac7Qqkjb8vJJx1xXnnwEtL+x0LW9O1KKK4v47xLomZj0niSTBO04wCeMdeKXxhrFl4vgsPCPha0kvpZzHLc3EMwMVhBvBbzHBPzEAgL1pw8Q6P4X+KWvaRrCXcP9uyW01phCEdlXY3z54G5Rj8aAO0trWJvGGrBLeBwlpBtRlAUHL/7PH61tJYwl4i+n2YyuXIAJVvQfLyOvPH0rItwr+KPEAeOV0FrArBQctw5wOev0xWxAkST26rFOGWEhXYkhRx8rHP3vrQBGtlG8aGTTbHzC5DgAEBcnkHbycY4469a8Q+PkMP9gXUcdpB8msIqgLjCC2JYDI/lxXuEccQhtcW92F80sqlmypyeW+bpyeuRXifx+EY0efbGWJ1R5SqHJO205PB9+aAPYLTSLHyYU/sjTjB5CkN5a5L46Y29OnOfwqnpf9g6lPLbWen6NNd2jiK/hiCMbViCcH5eeR7VpW0sAijnKXAxZqxI3bQmM4Hbdx9a8d+C1rDp3jBJ5ILpbnXNN/tIYLEczyDLnP8AdK9c0Aej6Fo+nONYePSLKd1v3jCSRKBtG0YGQcAegrWfQ9LEkwGg6ayKoKHyE+dvTG3jtz71zj6zpHh/Q/EGoa5dtaWQ1aTc8bYbduUADZz1H5ZzTvGPjrw1o+manK+tQJeS2bNboJtxlOw7fLAJ5yR0oA17HSvD+oRwy2ujaNcQtuWWSKOJ1jccFcgc85H4V5p8RdF04/CnXGh06yFzLqBiSTylBjBnAHPJ4HarnwJ05NBvNT0P/TQ8S299hmbYrzwK0isOgO7JANP+Im6f4Y3CW5LvPrIVcEcnzj1I6dKAOn8G6Bo9z4Q0uSXw5pzubCB1Z4YyZm8sZycZHPc+tbK+GtDaSFD4a01UdNzN9niwh4+UjHP4ccVR+H7Qy+CrBg12mbCHeCWIT931j/8ArV0cZjN1AUln3eUSqkNtZeOWyOvTrzQByPhbw3oU2keY3h3T5Xa7mU7reLKjzGGc+gxVr4f2lvY6x44trKCO3t01mPZHGoVVzp9mTgDpyas+FTGdAtyZZlDXkpUx5O4+Y3DEDp/nNM8F8+IfHeP+g1H/AOm+zoA6yiiigAr5d+LmsapD4v8AF2l6O15GRqUWo3LWzMu+GKwtcqxBHy5Iz9ec19RV8/6r4eur/wCIPxj1FwEsf7Pjs4pN2CJjaW7EfkE/OgD1O314Sx297/wj2tlzCAAI1OFODjG/B+vWvJIr5k+Mlvdrouqqsd8yJb7BvX/Q845bqc7sZxiu78EfEjw1qnho6gmuKDptipvLaTCsuxBucKRk88Ajg1zmnaPpfj251SYa7f25fVUns7y1YQzuDaoGUHHA2n9KAMjWPGWl+IfGUXh7TrLVL27XXY9QuYI4z8kcUfK53YzuHqK1tJ1LxH4N1HVLey8D6xq2n3Ny8tjLGyxNEsh3NE4LEABs/NXZfDzRNO8O6drGn6awtYbe/MSztsaU8ISWbnJJz19a7SRlE0xa62BYxlcriPr83/6+OKAPCtQk8feLbi203WPDV7oHhmOUsxspGkvGjAxsLh8fNnk46Vztn4bv9H8NfEJbzTdbubJoDBpssi/MkMbFyJDuyMEDrnpX0nFJDmy234cyAlPmT/SOOvA5x1+XFYukLDNp+qRS3EccUmozRvuVMPlsFCCMHI49aAPLD8c9Fj0ua6Xw/rkpurYLaybGVL7YuHwR9wLzz3rnrDxvp2neNbTxNqtlqFpZLeTu2UL7N9nENo55xx+BB717Z4jtLGz8G+IbOzeGOG206VEtYwgW2HlNjAAyN3XnNeY/DvwToHjrwzaNr8zzmDUHuVtklULPiKNMtxuK4wOCKAKCeMdJ8S3HhXRtNhvtQ8nV5dQuoLaIMdilnXIBOcFlP4Guz+FOr2cXgqO1TSdckPmzRTOkDkZWRhgHPGBgcYrY+Hnhbw7oGl2l3pdnaabdySyQCZdjSSoJWxHuI56DpzxVbThF4c+IeuaZFqH2bTdWtzqMZLJttrlWxKADwMhkbmgDfbX7cHzxouvBljMQzasRt+m7H49a8xl1aK8k8F6Ymn6nJJElzdFFtsiQCNkyBu5wX65r2e5lQXEiPdhgluXaDgHGfv569iPSvH/hs9/rupWPiTUoxp1jDbGw022Yo322MsWeXpxkhemOlAHH/DvXPH1p4Wa20PR5dRtUn8u2julf9z5I2swYMM5cD5TkVX1jVdT8b+ENWu3t7ltdis7B5ZjbFYvMjkkLkkcKOTjtwa+krR4NkUxv1CmXYrNsGWZslBwOp/GvKPhVl9G8crG+W8kAckFSTPgcc0AYUV5470DTFWL+2fFlpe6c8AQ2RgezkdcKy4+V06c9a2Phg9j4d8U6ppAtNaT/AIl1hOYxDKWDorK2R1254weK9nsiyx2SmdR+4GYu7HA5554rzfx5cat4b8R6V4q0i3k1lJ4zpl1BaIvmS/OWj2knA5yDQB0WueI7OPRtUkW01bfLA3ElnIFB2kD7wwBViy8SaesMEhg1dfLgEZH2KbZjAOcBcZ461xLfF7Q9SsNX0zVPt2i6uYJEFpfwGPy5NuDGJBwx710vxNu5oPh/eiC98k3VvDaKFHzKZZFj8zOc8BjQBqp4h06NLYBNaIjOVzZznfkHqdvzCvKPjVrNjNqekeUupFwDLiW3lUgmeDgBl6fKeB6133wblMHgPSNPlvxNLYy3Fk7SNuacxyMMgk+mDXE/tAXn2WWG7yt39ls5LjEYPRbmEheD2x1oA2fiz8QPD9t4a1TTV1C6h1jUolt7e1kgkRzuIUlVZeOGPNZEHiGbwb4s1WbSfDXiTV9Muba28g21vIqh0jEbCQMo5+UEGuh+G/g+1uNPbxP4kjs73X9TVb9prmEM1oWG5VGTgKBtwAB0NelxmQzRfv4ihTJQLy5/vA56f5zQB8763418cazcppi6NqXh/T7y9V4b+4t5JJrJQSCpG07mJ5XHTpUN1p+pw6ivhm/bxJqXhlZ5NQXVZYZ2df3DDyiCmQS5LZ6c9q931ozNFpGZklY38ZLxqVUgbjjqfStNvPdLsJdwFs4QmPPlcdG+bn9KAOH+HXimwl8E6FNO+o+atjHC6pZTsowMZ4QjPHUV59421Wxb43+FJUmvJEtUhLebbS78bpecFdzdugrpvAvjKDwjcJ4O8XA6PLaiVbS5uU2wXS+YxDJJnGMEDaR+Nct4j16y1v4w+DtQ066ivLaR7VVuI0Zf45gQMnoTQB6L468W2Nn4L1uWyu9VjuWhYxSC2nQxuSFXDFMKMkVk/CHxFbp4QaHVdT1a9vbaaW0kmkgnkPyucHhTg4I963PincZ8OWmnT3UO7VdUtrRCoxhfNDEdTnhDk+9cnL4yfwN4i8WaGthc3Oqahfm80qJYG8qZpVX70mcABgSemADQBf8AiH8Q7Tw5caBcafZ6lq92JJLcWQiliklyvJ+ZPmIxmuU0bxXrni3xjYR+I9F1fSvD9netqcDzWspk+VdscbEKckOSeOMV1Pha38a63450TVvHNlplhDZxXH2W1tWMjbyoVmZiT1HTHavUx9o8td08G7zOojOCufu/e6+/6UAeSfEHdPr1l4j8FyEa/FHJayLc2c6I0TrgtkJ1U4POa8m1bVtQ+1ahp3iTW7nWLy0t77Fw9vIgO+GIgBSuVHB7CvreQy/v9ssanb8mV+4cdTzyPyrxW1so7j9o/VIpQJYpbBvNQfdbdDECcE9wcUAX/GvjKB/h5Z2/h7Wb+DUr2SCGK6WGTem7BbBKYPy5xj2re8DeNtO1LwhY3V/qV295PbhJ3+zyDEijaxGFwDkZ+tczoWleKh4j0Pwvf20cmieHboXcOsOCEuYghWKEDP8ArF3EE9to4rp/hAbuLwbd2jz24+xahdW0QZP9UFmbh8Hk89eOtAFmfxVpB8TafN9skFulrKu9reUFiWUY6e2c4rn/AIo+I9HuPDNhZRapPIW1O2V1MT5lXzQWVvlHGATx6V0vinWrPw7r51XU2229ppckkjIgZiPMUAKM5JJwAOnNcRpet+KvG/ivwvBrHhebSNMtp21VLxiSsyqGEakHGxjnODmgCHwD8S/B+heGbjSNV8SmzuILq4C71b92hlO0J8p4I5weeTWTB4z8L/EXxzffabg2mmz6Jcac7vyxPn8MpxgZBDDIr1q68D6BcC+luNF0aae4umuWeS33BmIAJbJ+8RkentXlnwptbax+PHjK106GGGOK3lWONVAVP3qADA6DigDufA8PgfwTpUFhoWq2dvGvzXDFl33LYxuc4znvgVY8Wy+EPFeg3umajr9hi4GBOWi3xDPG0kcYPfr713KLN+53eT0/e4B64/h/H1ppE5QER25fzMHk42Z57dcUAeNfC7xzZSajrmneINWtrPWYLeGAXTsgW5WMMomRs4bqpINdx4g8caLpOiXl/F4i064ntLR3WETRnzpAODgc8nHA9awvFvhi81XxTf6z4cmWHxDpBia3XICXKMmWhk4GFOOuawNf8fS+K7RPB8vh+60rxDfzxQSWt5EdqoHDPIrAYZNqnn370AdH8LfiHb+IPB1hdeIdc0611eKV47tPNjQSEMcYB6DBHI9K4H4t61pd7LKLXVbEFn1B1ZJlYH/RkA6f3iCor034a2hgfxHavbWiiPW55HVeihkRhtBHqfaud8RaX/avii1sobeDzbmfVIQ0qn5VaKNS36kjtmgC94u+IujaP4Ka4tddsJL65sFhs7GKRHPnsvB45AGRnOAMVz+oaXcadH4cufBvjLw3b6hY6Z/Zk7X8qMGUkMXXB6g54rqfhz8MrXwrbvcahFZ6rr8kYEmpTDLOQMBACPlQAKOOetd0LXLW++ysxkHzeASpx0Xjnn6UAfPfg7wVpmqXuo61428XWB1iS6mQxRXMZgdfumQI3GSCcEdM5Fdz4Z8F/DPQEMdlPodxLsXy5rqSKZ1YZ+YknntxjtXX+GLFf7Pu2S0tnJv5sCVCMJ5mO4PYcdq3PsUe6Yixshj/AFR2jnj+Ljj8M0AeO6r8QdB8E/FS/u9U1gT2Wp2FsC9rAJlaRCyEllPy+uPem+JNdsLn4cWog1eyaZtZEqgTAkqZWIJzggYOc4r1+80i0voTa3um2UtrNEyygqOp4IAx0PPOc14DoGiRaNr+m+GjDHdaPPqMN5awyoM2qlplMeTkspKA9e1AHqvw51qyk8AaWIdasFc2USxK7KDC2zGGG7nkH0rJ8JfExtY+JXiDRru406LRrKPFtPuAMzqQrncWxjJ4FXPhLYwN8MNMlm02wmlSJgrOF/eBXblmK8dx36Vx/wAPdMtZ/EPhy/udNsDb6zDqkqjylYf65WQYI7L0NAHpng7UrZ/D9qqahZxussjOrPklfMbjBII7cmk8CyrNrvjqSN0kQ60mGQ5B/wCJfZ96ytKTQdC8FWOo69p+l21um43E9zHGuz5jjsSx9ADS/B7VNO1lvGN/oiIumy62PI2JsVlWytF3AYGAcZ6d6APQ6KKKACuK8LmQeJfiD9nEZmOrQ7fMJ2/8g+0645rta870i7kj8U+PLYaPdahE+rQl2iZAo/0C04O5h6Z4oAqePfhp4a1u21DUbvRbTzYbKTY0G6N2cAkZC4DDjvVL4BefJ4duJI/s5QzxCUjPa2iHy++etdXrWo3R0/UZv+Ec1BZWtXjMnmQ/d2n/AG687/Z8vbi38ITNFoF7cRreMY5YmjwCIkRsAsDnINAHqHh+K4RtbMXll21FyokYlduEz0Fbp8/zpNoi8rYNmSd27nr7dK4nQdRupBq8dx4f1KdH1B3OHj4I24By45GB04rZOpz+dLN/wjOqeZIoR2DQ5ZRn/pp70AbiG7zbb1gA2/v8E8HH8PHIz61l+HhMtjc+Vtdvt0wPmMfu+YQcce3T9arrqcqGAjw1rP7gbY/miO0Yx/z15/GsrQtVlks5ln8O6tNi9mlUqIsK3mHHWTqKAOh8SPcJoGsuqRbVtJDFknJOw/e44/DNcB+ziki+AVxsaM3Mpc5OQ2E4A9MV0fiLUZJdC1hB4c1dXurWRXYiIj7hAziT+VcH+zvqjw/Dy3mXQtSuJPPmHnW4jKEbhwMuM9B2oA9Q8HtKfDlkVUNmSTf5jtkDzG5GR+lYfxQsb8aTHr+lpE2p6HMbuBAC/nw7cSxsBzyuemfuim+E9ULaBY58P6rN5Lu6SRCPbuLtnH73nrjmtdtUOydD4Z1orOd0g2xEMcY/56+1AHBeL/iBD4nsYtF8A31heX+rW7CSX5i1jDtPmPIMfLxwAecnpW54Tt5NP8F+HLVEjNvFaIjGRSHAA+UqPXnnpUwXS9Mu7/VNP8FahZ6hcQlJriO2iXeMZ+bEn45rK0nU2fSdI3eHtXmeGFfLlCxqORzj5+hoA9G037WLKLeLcyeZ823IGz2461438Kwyab8SSoOwSMse3JOP3vpg9+1ek6VfyR2aJ/wjOpRoGEoAaI/NnqPnryH4V3hh0H4il9P1KQXGpTxvKqR4iUA8NlhyNxzigD32zRxFZny4yghALkkODgYAGOnXPNLGk/kQh7e3DiTLKrZVBk8g45PTsOtYMOu7PIk/4R7Xg6R+WP3K428dg+OwpV1eOKCKNND17ZG29R5WTnnqd/I56GgCD4k6Faa94N1u01CzhYNGWikADMrBflk7YYH37V5rDrGo391oXgTXreC48Q2d/btNMgP760iHmCYjGNpAUHJPzZ4rvvEusJJ4f1RDpGtReemWeeAbB0HdiBVi3utOTVV1j/hGtWGqNbC1a4+yfOYgc7eG6Z5oA5C90Px/4Tn1G98KW2hanY3F1JeppsyFZoHk++EcYGM/SuM8Axag3iiSw8UGKbVbJzHOz4kQmS6RmUZOCMECvbxrsKG3/wCJNr+YgQpNsx6jHPPP45rw7w9q9t/wtDxLMbDUfmv0YL5BZ1PnA7SOxJHSgD6LZH23SraQkbQIwWAEvHQ8cDt3p6IRcR/6NEqiLHmAjKdPlAx0/wAKwjrdvKlwG0vXwJxhv9GkBHGPl5+X8MU+LX7czrJ/Z2uqyJ5YVrSXaRxzjoTx160AP1ZSI9ER7aKA/b1JjQqVXhzkdOvXj1rSmjZobnFjDIxbiNmAE3Tk8cd+uelctqus2tvLo0a2WqkJebh51tIznKOeCQSTzWlJrlpJFMjWWvASncSLSYFenAOOOnQUAXde0DTNfhktda0q0vbUp/y2UMe/A4yPqDXy9oul6hPr9hHoNhFNqOhFJo7MShQ/k3Ep8sMehK19M/2/a+eX+x60GYBMfYptuPpjAPPWvB/grqUVj421UiHUpLfz5AMQs7n73DAAk0Ael+D/AAfqF3qZ8U+NbG1k1x5MW9hHIDb2MZP3lGMGT1avQ2iXzLoi0jJZQN3y5l46H+XNYn9t2fl+V9m14gP5m77JPnrnGcdPapTrlmVnk8jWcy4UqLKfK8Y+UbePwoAlnYJ4l0qIBEX7NKRGCuVxt7dcc4yOOlaQBEUeLRf9ZnZlfk5Pzf1455rlZPEFp/wktk4tdVKJayJlrGfdnco6bcnp1rU/tixwiFNZHlvvB+x3PPfBO3kc9DQBqTKx+1kWcbsVwMsP3wx0Pp6c1454fy37UGuQsNiw6Urqi42jIjHpXpsmtae32gbdZBmGDtsbkbeMfL8ny/hXkPhnXLVf2kPEl48d9sbTUiC/ZZTIMeX1QLuHTqRQB7jEuYLX/QI0HmE7AVxEefmHv9PWvOPFHhe88M67f+LfCtpPciaQtqmkGXMd7GVG6SNT92QHJ967KPWtO2W6Bta/dNuBazuct14Y7ORz0p0ur6cyTgtrA84gkrZ3IKYx935OOnagDzLSZb/4n+PNMvtZ0q40zwzZ2jXdpZ3DDffNvADyKOig4IU+lewwQoI7IfYkTZyFypEHHb+XFco3iDTv+Etec/2gqGy8k/6BcA53+mz9a1V8QaWiwYk1UiHjmzuDu4x83yc0Aak0QFrMosBIGmyY9y/P833/AOuK8d+GaLcfHL4nXHlCVogsITP3gcfLzwM7a9Im8Q6T5LRNc6su+TfuFpcBhznAOzp7V5V8NtY0+P4t/EyaSS6SG6kiCPDbylhwQSQFyp+ooA9zhjVfsYFoE2R4HI/c8D5f6celMaONreMNZPtM2dnHyndneeemeayI/E2jKYB9rvz5a7fmtZvn46t8nJ4pkfibRVhRDqV58r79728gLc52nKdKALMGJNW8QrJDJLH+5UopOWHl8gZOO/bFaZt4PtiTG1Zpo4iqynnAJ5Uc9f8AOa5DS/E2kf2x4g333kCWWMo4iO44jAJ6H9QK2v8AhKdDZs/2uq5TG0rj/gXK9f09qAOG13SNc8LeJo/EngzSbrVbe/4vtHlnCGJwuFlRicAkDBBz+Fch8N77VNT8eS2/ieyka8ttRvZ2t4ZN/kNIsR27sj5V4r2RfFOhfuAdfhPlD58lR5vGOePXnjFeNeD9Z09fjj4kkfVobO3V5ZllG0iYMYhjkY5APPWgD3mURedeMbS4kYxAMy9JV5+Veeo/CnlYjcWBNtPuCtsbtFwMhue/TvWQ3izQS8pGv24DqAoDKfLPqOP55pW8UaE0sTjXrfZGMMu5cOexJxkY9sUAM0OOL+yHD2ssyHUJWCxgZB80kN16D6/hWyY4Q1+32aclwN+D/rfl/h5/DtXI+GPEWiQ6QkcmtW0Tm5lkPzqdwMjEA8YwR3rXk8UaIyThPENujSfdYMh8v6DHP45oA2ohH9qiPkTKywcOx+VR/dPPX/Oa8Jid5Pih4TJJZHMbKExgAPc9cH8a9eTxZoCyK5160KBNuwuoBP8Ae6Zz7dK8QGs6avxR8FSjUoI4RDvuGYgBWVp8A8DGQ1AHbar8Lb9DfxeHfGGu6Ro1xI5n0+ONZRhuW8k5BUHOPzrb8U+Ao9QstItdE1XUtEvNHt9lreW4DAR7drIc8EkAZ6V0LeJtEKShfEFmrM3yt5iHZ04Hr+NOk8SaOWlkXW7Ew+XjyxIvDeuevccUAebeCPButaoug3HjPXIdZ0K1Hm2FlFbAAy4OGnI4bbg49zXdeBY0h13x0kSbEGtJhcYx/wAS+zpnhTXtKj8PaUjaxYQtHEPNjeYZJxyPmwRz7UvgCeK51rxzNBPHcRPrSFZIyCpH2Cz6EenT8KAOxooooAK4nw6inXfH7PJJEDrEILxfeH+gWf1rtq4/wtv/ALe8e+U6JJ/bMWC4yB/xL7OgDX1Zonh1OIzy7/sjb4sfKqkH5gcdfxry79mhgfh1YGS6lEj390UVPuygED5uOw+lesar5gsdQJkj8v7M21cfMp2nknPIrzP9mMP/AMKp04hk2tc3Jfjl/wB4eRzxQB3Gisj2upnz/IX+0pBvhA5O4ccZznpWxI6LJeM11IuyMFlwMRDB+Ycf49Ky/DrlrS/a3eNCdRl5c5B+fkcY5/OtmRpR5+2SEYUbNwPynB+9z06elAEaSIJrWM3UjOyFlUgfvQAMk8e46YrL8PBV0lMyvalr2X7uzLnzW+U9Rz+dbIEvnR/NHs2HeMHJPHI56df0rK8Li4OjxEOmTczF9+T8vmPwOnPSgA8QyRx6FrzveyKI7Zy+Mfuf3ZPHHpzzmuC/Ztt/I+F2iu12xNwk0yw8YIMpG48ZzxjrjnpXo2tNcrpGqNG1vuWFzDvB2j5P4/x/SuK+AKXEfwn8OLLsWH7NIehDZMrnI/2cGgDoPCASPw5oqLceQXLEKpQiXljtzjp34wa15HX7Ldj+0XG2TaZRtzCePlHGO/fJ5qj4W+0f8I9pXlGLbtPm7t2cc/dz7+taoF35c2Tb79/7rrjZx97369PagCtqhQxXkf2jLi2bMPy8cH5unXt6Vy+lxhdM0XEjRMbVSIwV/eDaMk4Hbtiuq1UzrZ6gSYxD5DbCM7gcHOf06VgaV5yaLpCho/L+yIZN2dzHaMEdsfWgDa06eEWNmBdynfIVViOXOT8p46f4V5H8IAH8H/EIzSZL61dAorfd+6O4717DZNcGC1zJbsxJLkZwVyeF5615P8Lt8vg/x8VxhvEF1jAOc5jz05oA9iBUXKR+fyI8+VxyM/e9ariRWitCt/kM3D/L++4PHTH5elW/3nnj7nk7ffduz/KoFF3i33C33Z/fYzwMfw//AF6AMbxTMx8OauYrnzWHyYXjyjkccc961mkAuJ4xfKpSEHyiFzH1+c55/Pjis7xUJR4dvxIqDLrt8vJJG5evTmteUXG6UxrAR5eI92Qd3PB9ulAEUMoY2YF6j7kLdB++GPvD+fFeF+EHkm+Kvi4o/nRjVoFZkHT962On0717zEJgIN6wjCfvNpPBwOF9vrXh3gaNj8VvG/nbSYtatlCJxjcHfPbPJoA9qlZjHehb9UION2F/ccDg/wA+fWp8sLlV+0Kf3eTHgZPP3qbcef5Fz5MMTSZ+RWPD8D73H1H4VJiX7TnZH5Oz72fm3Z6dOmKAMTUMTXWgETC5H2pnEqZw2I354OMVsS+ZHFIXuVTLgh2UAKCR8v49M+9Zl/H/AMTDQfOEcUiyudicjPltwDx/KtFzctFJmCFn8zCqzHBXI5PHXHagB5b99N+/QbUHyYGU6/Mf89q8H+AUon8X62xJlkS5mR5ApALDr04HWveCJfOmIiiKlRtOeWPPB46V4N+z7G3/AAlviSSZY45DqV38iYwpBXIB69/SgD3VJG8mNmvYSWlwHCgBhuPyDnr2/Cnlzm6AuYwVHHA/dcdW5/HtTVWYwRbreBW8zLLu4UZ6jjr3pzLJtuSIIWJ+4N3+s4/i449O9AGa+4+LbQM2cWMmcDgnen5VoxeYIIQ11G7luX2gBxzwBnj/AOtWYy/8VnBwBtsG4yvH7wfj/StGNZPKtgbOFSGyyhxiLryOOT+XWgBJpZFS7Iu7dAv3WZf9Vx/Fzzzz2ryfwsv/ABkz4vZc8aRbhiBwWO3mvWJVcw3P+hwsWPyoWGJen3uOP1rzHwpbsv7RfjWUnj+zLQbR7gf4UAeoRvIUt83UDFmO4hcCQYPC88fr0p26ULOftMPDgKSnCDj5T83J/LrSKjhbYG1hAB+YBh+64PK8c/p1pkqsYZx9jibMgwhYYkHHzHjr7e1AFBmI8WTkbF26ep8xgOPnbrznHH0961RIS8AE8R3AkgDmQY6rzx+tZJAbxVe7VWRxp8Y8s4APzvwTjvWkiv5lr/okYwhBYMP3PA+Ucc59sdKABpHEORcwZMu0NjjG7G3r97t9a8i+FEM0fxR+LMm9In+2Q7WfkKCrEEj6V6vJExt41Onwn9+CY9wwo3f6zp174/WvMPhdGsvxE+K4aJJs38C+WxG1v3bcHNAHrCtL5sA82EoUJdQPmY8crz0psbTmGImW3LF/mKg7SuTwOetOVALiEi2jAWMjeMZTp8o9v8KiEQENqpsYhtkzsBGIuvzD/wCt60AZmktM9/r7W/l+YLpVXzPu8IuenPettvO81wDHs2/L1zu56+3SsTTl3trm6A3Gb0YjBIzhY+eePf8ACtd44zcTObYl/LC7+PnHPyjn+frQAsf2r9x5oh+6fN2k/e7bfbr1rwn4bvdP+0J43SExSsiHe0pOPLMi5C8dePpXukUMata7bVk2IQp4/dDA+U8/yz0rwj4Xss/x/wDHUjW7S7FUKFXGz951OT/L8qAPdnN2GuCot9m0eTuJB3d93t06U4C486LPk+VtJk5OQ3+z7VDNDGyXgezeXeoDj5f33Hbnt05xTxDCLmF/sxDJGVWQ4wg/u9aAMrwo0x8PWvk+Uf3sm/cTwu9unHXp1rUc3u248tbYsD+4BY4xj+Pjj8Kx/C6xS+HtLY2rSgys6kDb5Z3N8xBPT6Z61qT28DQ3gawdxIwLqu0GY8c9f54oAsMs/msNsXkGPr/Fu9OmMV4NaxPJ8cPAVq8abRpEk7F1JJ2tN689xXu8oRJZH+zvuEHMnGCOfl65z/nNeKWCofjp4DIjYgeH5yuP4Ms/J5P8zQB7UIZtsx8i137v3fXBXj73HB69KbdWybZ91vbeT5Z5K5OfcY6dO9OkWM284a1lZWk+ZOMtyPmHPTv+HSmX4Tyb5jEwYW5zIcYYYPH4e4oAyvDdjE+gaPmxtHja3XzTIg3D5eMAjnn1qr4EjEWueOkSKOJV1pAEQYAH9n2eK1NB8saRoQ8uVibVSrqPlX5B97HHPasrwGVOu+OyqOg/tteHznP2CzoA7CiiigArzvSLjUE8U+OYbXR47+3OrwszvcLGFb7BZ8YIOexzXolcZ4b2f25488wyhf7ah/1W7d/yD7L+7zQBPe3+sG0uXbw5GrPAwZjep0APHTnqa88/Z6udTh+F+nvaaCl0i3Fy0cn2pE6ytnAIyOmK9euhC0WoiU3BjMREg+bGNp+526eneuF+BFvBb/Dfw+kYnjG24dFO4BgZm5btnpigC/4bu9UeyuQ/h4zL9smlG66X5X3nAw3PFa8t5qkiyCTwxvE3yyg3cR3Ljv6/SnaCFi03LtKu6/lI8oHn9433uTx61oyGNjqBM12uAA+0N8ny9Y+P5ZoAzBf6mJhIPC8u+NdiMLqHIHHA546Vn+GdR1FtDt8eHriVVkdlb7REOd7HPzNnviupUoL2JfMnLeUcDnYRkcn3/wDr1j+FTGPDumBWljBkfaEAwTufg4yMUAVr68vnsr5H8KTbLiNjKDcQ/P8ALj5vm9K5z4V3V7bfDnQmTw/PIEs9glWeLlMk8DdnHtXf3Bhe3uxJPOE3hXIByvTgcdDn36mkSC1sYjBbq0UMNvtWCMbUVBnpxjNAHN+Hby8/4R/Tv+KcupPKUGNhNDxkfeG58jr3rRFxcCCSL/hGb7y5G8x1EsHLZzn/AFlWdAVU0jRFMjxt5IKpGPkf5M84GMd+oq400XkysbucKJ9pYrgqcj5R8vTt/WgDA1nULn7DfSHw5foXgZZJXkgOBtOOBJyPpWJaXd9HpOn48OTyNBboiyPcxKCMD7vzHGfxrsNbmT+z9YVZWeRLVi0bAbU+U4xkY5+prDs9iwaWkbzbzaqQq/cYbRyeMZoAs6Zd6qIoU/4RhY4oiCmLuM7SepAxx1NYVro7eFvC+sW0GmXsjX19JeyyyNCQWeRTg4kHbAH0rtNJMTWFh5Zuyu5tpfcDnn7+e3pn2pviQqNEvNzbl3pkPgAfMvHIxQAxtRuTJ5p8PakX27c77fp6f62q8eouiQRr4a1VVh/1Y/cfLxjj9771syTRrcyqbhgyxbmjwMKOfm6df8OlQwTxNHY4u5HEg+QkD998ueePTnjFAHL+JtRePQLxV0DUrdZJEdmcw7Sxdev7zv0rVbUWlMryeG9WJlTY+fJ5X0/1lP8AED7tCu/JladhcIpD4XafMXKjjoP8mtOSaJZbrddOpSMF1wMRjn5hx1/PpQBkjVWQxEeHdYBhG1MLFwOn/PSvFPBOoG3+JXjOSHSb4iTXbc+XtQMpEbHbyfvegB/GvoRZUeeEJcMcxlgmBhxx83T/ADmvGvAiQz/Ebxm0Uzy/8VDb5kJ28rbtkYAweeO1AHpD6mCsyt4f1nbMdzgKnJ/CTj8KmGsnzfN/sHWNxXZny06emN9aTyIsFyzXrqBJguQv7vp8o46fXPWpXlTz5lNwwZYgzIMfIOfm6df8OlAHJ6hrLR6roaR6LqaLHJL8romSPLbhfmOT7VfOsJsK/wBga3tMnmkeSPvZzn7/AK1Ndsx1fw7iUzqfNPmnjf8AuzzgDH8qviZfs5zfsR9o2eYAuc7v9X0/D196AMz+1wZZH/sDWt04COfLXkD/AIHx1PSvGfgje/2XrOtNHpmoyhtTvVKxIrNjcgAwTn5e5z3HWvfg6yT3kcd2/mKqgqAD5JIOCOO/XnPSvMfgxYfZNR1smV5WOp35L5+Vj5kYz0wTQB2sGtJFbxRx6DrgRDlQYQSDz1+en/2xGPN/4k+tDzT85EB/+K4/CtaCVHt7Z0u2dWfh/l/e9eOn8sdKdNIoguD9rEYVsF8D9304/wD1+tAHIt4kSPxaCdM1cgWJXyxZsXGJOv0PrmtFNet1jhUaX4gxEdy5tJCfxPermD/wmEhJIUaeOecD94fw7fpV+Mlo7QrebgRndtX99x+nrxQBiDxDbbZAdL8QDedzf6HL19vT6CuB8NaqV+MPjPUJtJ1hYLi0tIkAs38zhSCcDkDrzXqrzhbe5Zr+NQsu3zMLiLkfIfU9ufWqaD/iqr+QSbNtlGpyOB8znOc4oAgj8Q2yJGP7O17EYwu6ymOfrxz+NMHiC02uv9n+IMO24/6FPkH2OOB7DituKQn7H/pkb7kJwAP33A+Yfz49ajaRjbvtv4g3n7Q+0YHzf6vGevb1oA5WLxDbv4jv3fT9bVJLSOMBbCYNwz5PA46jBFag8R2geJhYa/mMbRmwuMH68c/U1JEGHibWX80REWkIEjAYT/WHJ55x15ArWRpPNt1a5Q/IcqFGZenzD0/DPWgDAbXrRYlUWfiIhZPMz9huM59Dxyvt0rgfAN9FY+N/iHJPYaysV/ewuphsZtw/dnngZXrXraTfuoc3sTEyFd+Bh+T8o56/4Vm2Pyahr8vnrATLGPMcDC4jXnrj+VAESeJLIOrfYdeyq7OdOuMY9/lxn3qP/hItPgWFWh1392Sw3WNwS3XgkrzXRByZdvnJ9zO3HP8AvdelQRO5jtD9thkDE5YKP33H8PPHrxmgDj9G8SWDvrEcn9oweZetIrRWcu7GE74OOnTj6VsDxVpDPK32q+Quu3abSUBcZ5AKdef0qXQyyLrRjkhgb+0X+dlGOidcEcnpWxK0gNxtuIlATKhl/wBWcHlueR+VAGBH4s0QNFjUbljGu0hreT5+nLfJ14rxz4W6lpdj8WfHFzPfywpOYZFaNCd+GYkMApwPyNfQKtIZ4gZoSpjJYAYZjxyOen514v8ACAyN8TfHckbxxbprcESD765fhenP50AejP4p0NlnA1e4XzcYIhf93x/D8n881J/wl2hCVX/tOUhVK7fJfB9z8vWtxmmAuf38AwRsyPuDA4bmns7rc7d8Xl+WTt/iznr9KAOK8MeJ9GTQtPjk1GaJ4dzsqRE7hubhtqkY57GtOXxXoTxTp/bM0fmnIYRMCnsuU/nmr3hh5P8AhH9MPmRfMMtk53dTweOa0lacRTF5rcsHOxsEAD0PPWgDnrrxboJincavkNCyBChC5wefu9f0ryjRNY0ZfjB4bv7jVI0jtPDpiyOQXLtlWIGOhzmvddRaRbW8JdfLEDEKoIYHByc+nTtXA6JYzD4l6Bdxxnyx4a2SOwJB/eKQAT3yfyoA6M+LvD/lFf7fjBZ9wbIyBnO37vTt61DqPi/QTaXxi1yFmeEqkYPRsHpxnJ/GuoP2nYQDDv39SDjbn69cVT1rzP7H1PdtKfZ32BQS33T1oAwNE8VaGul6WH1y2RordVkj3D5jtA5yM8e2KZ8ObiK71XxvPb3Iuon1pCsoxhh9gs/T06fhXQ6MsqaZpgCx+ULVA5YHfnaMY/XNYngXzP7d8deeEEn9tJnZnH/IPs8dfagDr6KKKACuO8LEr4i8ckSrH/xO4QCwzn/iX2XH412NcFoE2pJ4p8cLZafbXUJ1iIs0tyYyp/s+z7bDntzmgDrbtZmhvwlzHkxkIpUfujtPJOeeeeaw/h5p93pHhTQtPv5oUuYbTEsClWy2c5BB6DPbjmrgu9eIYnQrEE9R/aB5/wDIVBuNcDKy6FYbl+Uf6d/D7fu+lAEXhMsuhRN50cW+8nPzYO8GV/lGOM/SteV5FS823cCkcISv+qOP4ueeee1cr4WutZGiRKmjW06LNKVd745J8xsnmPsc1qyzayVf/in7F/MP7xTej5sDgn93zQBthn+0IBNFt8slkx8xPZhz061j+Ept/h3SzHNEA+7gj74y3A96QXmueZuOgWgONu8X4zj0+5WX4autZbQtPJ0O3mCLujke9G4ZzzynBwaAOr3uFnP2iDhwFJHCDjhuevX06im3jskdwfNQBYSwU9Qefm+n4VlNc6xtZf8AhHrZg53MPti/MfU/JyeBUF7eaz9kuZm0KCOQwsGcXgJxg+i5OPSgDQ0B5P7G0f8AfR7Wt1LA8l/lBG08fyq/mTyz++iz5nB28Yz069a5rR7rVhpmmsPD0UnlwIEkN2u4AqOmVyOKsrdaoFKnwxGF37wBdRY3f3unX3oAu+IHddH1YmWNVW2fbgcp8pyT1/lWRAZPs1htmi8r7OpKfxE7Rzn0qt4j1DVV0XVHfw35TSW775BdISQF6nbycelQWV3q8tpZv/wj0IYQqhke+AJ4HH3TQB1umNIbSzLXcMhOdxVQPM68DB4xx69Kj8RuyaPOzMceZGB5ZIIG9RjI5qpZSa1FBEp0awGwfLtven/kPiqfia71FNIZW0YYeaIsYplcZ8xe3yk80AdM4n85tpj8rZ8oIO7dz19ulRx/av8ARvMaDOP320Hk4/h/H1rIl1G/MjO3he7d2XYzedbklfT7/T2qJb6/TyNnhO6AgGIsT242DGMD5+KAJ/E4lOiyfaGT/j5i2GMMcDzFxuA5/pWufP3zbTEF2/uwQchuc7vbpXHeIb++OlGP/hGbqIPcxOd00BDN5innD9TjH5VrjUb4+ax8LXu6UYk/fW2WHoT5nNAG4PO3pny9u35sZzn29q8x8KaNqWneLddvNQtnj/tDXxLGwB2vGtuQGHPTtzXZNqV8syOPC1+WRdqsJrfKj0/1lZWo6jeJd6Mkfhm+jWOclE823/uN0/ecdfagDr2N15cgUQ+Zu/d5zt2+/vUh8zc33NuBt9c89fbpWAL+6aNom8KX3lMSzKZLbBPXp5lB1O83vIfCuoeZIoWRhJbZI5wM+bzQBYvvNOu6H5h+YCYvsPyk7B7/ANDWgwvNmQLfd5vfONn/AMV+lcjd6xdrr2jIvhu/jZEm2RmS3yRtAO395gY75xWoLy4VRH/wid9sD+Zw9scP13f6zr70Abp+0/vseTn/AJZE59P4v/rVw3w+0S+0PWb+HUAolnmvLpSjFl2vMpX9O3Wt5tSvNsp/4RTUD53+sHm23zYGOf3vNZj6zdr4mjZPDuok/YSDFvtw4XeOceZ07daAOxTztke/yy38eM4/CmuJ/LkKiHfu+TJOCPf3rCj1G4jjiWPwvqYSE/IA8Hy/T97Tnv5dkkbeGdTKytvYboCCeOT+99qALKI//CXXDhRtFiignHJ3t+NaKG4/cbkiHXzMMePTbXJ/25MfEt3GdF1KR2tEBhHk7gu5uSd/Q59a0odSlVYAnhzVV8rhMmH5R/38oA2mE5jcFIS2/gEnBXPU8dcVnW4P/CSamyhWb7NDgEKO78E9fzqsL9zE8Z8O6mEaTeykxctnOf8AWetZdtrUzeI9UD6DqhLwQqyhY8gfN1w3fPYn8KAOvj84eRuiiA2/PhvunsF45H5U1xMYyPIgZvMyFL8bc/e6df8AOaxRrJTyiPD+sgxAquEQ4H/ffNJ/be0bToGtAFvM/wBUp5zn+/QBZthnxBrJiVHl8iEbWwATh8AkZP51pgTCWMeVHs28nfyp9BxyPyrk7bWHbV9VafRtWMVwkS7Vh+ZQAwOef5VoDXgHEv8AYmt71XaP3Hb/AL6/+vQBsjzvLhzbxBi2XXdkIOeQccmsrRyzah4hKRRO32pQBwN37pOpA/nUH9tRxxwouha2VjIZB5GcHnvu9+9ZOnayJbzW0l0nWZIpbkEiOEgphE4JBGDx2oA7f5/tR/dR+Vs/1m75s56Yx0980xPNAt1+zRKOd4V/9X6Y45/SsUa2nmGb+xtbDlNh/wBHPTPTG7GaZHrFtbiBf7L1/EAIUm3lfPbnk7vxzQBa0KRriHUiIkkxfyJtbgYDDnp+NasisftH7iJty4GW/wBZx0bjgfnXGeH9chlttQSaw1sB76WQGO1myPm6EjkfStZtatJUnJsdeUTcNi0nUjjHy8fL+GKANvyx9oib7Og2xkCQYynT5R7f4VwfgbQHttYv9deCK4TUnQL13QeWXBb5vXI6V0a+IbUSK32LW8hdgzYTYP5jr71l+HNZtl0S086z1UNE7uBBZzhTlm9M56980AdSyZS6H2KM7nHHGJenzH/6/pTpYz9qZxAufKIE2eev3celYy65Z7ZNtprf7xg5P2Ofj6ccDjoKS48Q2YMkn2PWtxjKY+wzBccnpj9aALHhtC+gaOZLdZHSJfmbrGcdRnmr01uv2WdV0+KQNLuMR2gScj5j2z359K5rwvrdsdC0pXttW3QQqMpZTBCQMc4BB/WtB9bshFIjw64okkLZ+xzgg56AheBQBqX0aiDUG8gJugIMwxl/lPHHPH9aZpEQFhpJa3DulsoEpAzH8q8c88/05rF1LxBYmy1Jlj1XzJYCu2Szm2KdpxgMMD3PT1qXSvEWnR6Zp+432UhVeLSXB+Uei4P4ZoA2Xhja2VTp25RPuEeF+U7s+Z1x7+tV9aVRpmssIDG7WzbpSF/efIcd+3vjrVJvEOlRxpG97fqVffua2ly3OcH5OnaqWt+JdJbRtVKXlwzS27hUeF1UfKRxlMDOe+aAN7TkBh01jblnW2AE/wAuEGFyvXPPHTjisD4eoseseOFS3Nso1pP3Rxx/oFn6Ejnr+NT6f4q0VbS0LahICkKoU8l9pOBz9327VV+G88VxqfjaW2uJLiJ9ZQrLIMFv9As/YfTpQB21FFFABXG+GCo8ReNtyStnXYQPLzwf7Os+TjtXZVxfhp9niLxrm5WDdr0K/Nj5/wDiX2fyjPc0AdJK8H/EwDR3Rwo8zG/5vl/g564/u45p1usX2iDbHcgiD5WYttC5HDZP3vrzSTSKEvR9vSPYMk/LmDjqf5809HBvEQXaMfK3eTxlhn7/AK47elAGZoAV9FsjIsrHz3YeWWGDvb73PT68VdnaHyL0tHeEZ+cJv3N0+5j/ANlrN8KlE0LTEjulhUySYQhQZfmY7R/Pj0rUlnTyLojUI02NhpPl/c9OD2/P1oAc5RZpNiTGQQ5yd2wjnj03frWT4SCp4b0NZY5wxhBGwMFHH8WDj862pWzLKgnT/VZ8o4yOvzH2/wAKyvC7BdA0NDdRqzW4wgCjzfl7fTrxQBdbyRbzErehfO5A37icjp32/Tik1XAtNSIEu/7M2S2Sn3W6DOM+tPlnC27t/aMKYn2eY23Cndjy+vXt61DrMwFhqqLcxl0tWPlDGY/lbk/X39KAGaK0Y07RlImLm1XaUDbB8g+9jge2aszGJYU3G62+cACu/Oc9++39Ki0mRVstLj+0RqWtlIiOMyfKOR9Pb1qVZ/8AR0YX8DZm2+ZhcNyfkHPXt68UAZHi3amh68yrOzmAhw2dv3f4c4H1warweUslvtS4aQWifMpIj246dcbs1J4zk3eG9eX7Uj7YceWoXMXA4PPf3xUcciJPFG9yqt9nUpCAMgD+P6dvSgDd00Qi2svKiu1XDbBKXyvrvyfyzn2qPxFD5umbAB81xCfnwR/rV9eKn02RGs7Ipe+erJlXOAZhjr/+qodcw1jGDKD/AKVCOoGf3q/L0oAtSlTNPmScERDcFBwBzyvH3vp7UyJUzZ7Zrg4Qld2fnGBy/HX64qV5CHuMXEQCKOCP9WcdW56flQrtutwZ4zuU5AH+s4HK89PzoAxPEQQ6TGvmO2b2IZlIBz5g4G4dOK1JGiLXq+fcBlA34B+Tj+Djr9M1R18l7K2DyLIDfRKTHxgeYOO/I71pySOq3J+0Qjb93I/1fA+9z/hQAqMn2iNBLKWEW7aQcEepOOtZd8EfUdBYTbx5rld+Azjyzz0/wrWaRhPt8yILszt/iz69elY91Ju1bQBJIskjGU74wQrYjOce3PrQBpO8YtpGNzMFEmC+PmBz0HHTtSySReZdg3EoKICygf6sYPI46/nQz3AtyRcW3mebgMUJXbn7uM/exx9akLTZnIlhACjYCp+U4OS3PI/KgDMuGQ+INHAfcfImKknluF5xVvfF5MTG7nAabCtxljuPyHjp2/rVW5V28S6SxIbFtNuKg4z8nNaMImaOMvJC0gYh2VTgjJ4HPB6etAEMrRmO7Ju50AYBiMfuunC8f41TOB4rbLnA0/8AH7/Xp/n0rUYT7ZdskQbP7vKHCj355/Ssz5z4tlAPAsVwSpwD5h7/ANKALkZj22O27mIOdmf+WvH8XH49qWSSFbeQm6kC+dguOSrbh8o46Z4qePztkO+SItj94VU4P+7zx+tJi42N88W/f8p2nAXPQjPXHegDJjQHxldP82RYoN3PHznp2rRjVWisitzORjKk9ZPl/i4/HtVC3Uf8JVfyKwBFtGpz25J9a0keY/Z90kB3ZL4B+b0280AV5JY1trpnu5wqy4L7eYzkfKPl6dOx6nmq6PnWtXDOYo0t4cyDqv8ArOfTitHdN5TkSwbt+AdpwFz0PPWqURc6rqggMayiOLaWBIBw2MjjigCxE6NPahbt2PlFgnGJRx8x4/w60xZ4gkf+mud0+wMwHzHn5OnT/OasKLgTRlpITEE/eAIQS/HIOeB145pifajHHukty5f5sKcbfQc9aAMiOVY9T19pZ3gRBFmXB+QbOozkd+1avynUABcHesRzFjggn71Zen+adX1/yHjDiWIL5g+UfIOuDz+la6iYTtuMZi2jaMHdn/CgCGKWMw2RF/v3t8j/AC/vuDx0/ljpWVpDbZdeZpzbr/aH38dPlQd8jk8VtoJtkHmmDfn95gHB4P3f0rH0FZD/AGyYRGJBqL/60cHhOePagDYMii4mU3OCIwxj4+Qc/NSI432ii73EqSBgZmwBz+HXipiJQz7RHt2/LnOc+/tSDzxJDuEO3afMwTkNxjb7df0oAxfD6iGyuMyC1LahMSSoHmfvDxyT1rWaUf6UPtcalcZzj9zx3+vXmsbwkJG0gmMRODezFi+Bx5jcjbkZrbb7R/pG2KA5I8vLn5hjndxx+tACB/8ASiv2lDiPJi4z/vetZfhwhdE0zEqRBlYmMbfnzk4GPz4rXO8O7Msars+/nnPp06VmeGyx0LS2QRyIYgxbfkgY4I45z+FAFreRFMxv0A87AfC4TkfJ9e3rzTr1xtuUMitiAnyMgHvz+PT04qQiby22ww7vMzgtwRkcnjrUd75gS7ISNU8g4l3fMTg8EY6D1z+FAGd4ZlUaJokf2iONjaqfJG3MgCDp9Par3mk2kjDUYc+aVE2Fwvzfc64z29ai0RGXS9JCojotsgMjN8w+UdOOc/hVs+f5J/0WDf5n3PM4xn72dvXvjH40AU9Ykxpmrk3KMq27fu8AGP5D1+vvVjTTts7BfNAHkD5DjLcDn8Pb1qDXlc6Nq+6NFU2z7XVjub5D144x+NWrFSILT92pUQgbyeQcDjpQAqyOYYj9qgYtJjeF4cZPyjnr/hVHxLk+H9X86X92IHx5eVZRt6EirnlsYoA1lBlZclNwIj5Pzjjr+XWs/wAUKw8O6xiBVLRnlTkuMAZOP88UAadqHRIUWRTEsQGCDvJ9c56fhXNeBC51zxyZXjd/7Zjy0Ywp/wCJfZ9OTXSQr++jPkKV8kDzj97/AHcdfeua8AoI9a8cKIVgxrMf7tcYX/iX2fpQB2FFFFABXHP4e8RWmua1e6JrekQW2p3SXbQ3mkyXDxusEUJAdbhAQRCD93jJ612NFAHKGw8bnOfEPhrn/qAz/wDyZSHT/G5/5mLw3/4IZ/8A5MrrKKAOK0zQvGWnWMNpB4i8OmOLO0voM2eST2vB61ZOn+Nj18Q+Gv8AwQz/APyZXWUUAclJpvjaSN0PiLw4AwKkjQZ8/wDpZUGnaJ4zsLC2tIvEfh1o7dBGjPoMxbAGOf8ATOtdpRQByZ07xsRg+IPDRGc/8gCfr/4GVFeaR40urWeB/EXhxVmQxsyaDOGAIxwftnvXY0UAcfbaT41gt4YV8ReHCsSBFLaDPnAGP+fypP7O8a4x/wAJB4ax1/5AM/8A8mV1lFAHC6r4c8YalY3FrL4j8PRpOMO0WhTBu3rdn0py+HvGACY8ReHcqoUH+wps4H/b5XcUUAcmmn+N1UKPEPhvA4/5AM//AMmVDeaP41u440fxJ4eUJIkvyaFOMlWDAH/TOmRXZUUAckdM8aHfnX/DJ3jDZ0Cb5h7/AOmc0n9meNNyH+3/AAzlBhT/AGBN8o9v9MrrqKAOJvdA8Y3cUUb+IfDqLHMs48vQplyynIz/AKZ61K+j+MHEobXPC5EvMgPh+b5+3P8ApnPSuxooA446P4xMhkOu+GC+3Zu/4R+bO30/4/OntUD+HvF7XFnKviDw4n2Td5aJoMwUZXHT7Z6V3FFAHHNo3jBo/LbW/CxTdv2nw/NjdnOf+PzrmnPpPjFxKH1zwuwlGJM+H5vmHv8A6ZzXX0UAcZ/YnjH7XDcDxB4aV4o2iUDQJsBSQcf8fn+yKVNF8XokaJrXhZUjYsgHh6bCE9x/pnB5NdlRQBxsmi+LpI5Uk1rwsySnMinw9MQ59T/pnNR/2D4x/tGS9/4SDw350kIgYHQZsFQSf+fz3rtqKAOPTR/GCLEqa34XVYhiMDw/N8n0/wBM4pDo3i8oUOt+FtpcSEf8I/NgtnO7/j865Gc12NFAHDQ+HfGEWpXl6PEXh1pLpVSRW0GYrhRgf8vef1q0mk+MkWMJrvhhRHwmNAm+X6f6ZXX0UAcf/Y/jHYyf254X2M28r/wj82C2c5P+mdc1EdB8YNLdvJ4g8NyC5VUkVtBmKkAEYx9s9zXa0UAcaujeMFlSVdc8MCRE8tWHh+YFU4+Uf6Z04HFMTQPFiRxRprPhZUicyRgeH5vkY5yR/pnB5P512tFAHBp4Y8WiS/aTX/Dcy3rBpUk0CUjgAAf8fft3zVg6F4vN19pOu+GfP2eWX/sCbLL6H/TOldpRQBxa6D4tVbdV1nwsBbHMIHh+b93xjj/TPQ1HB4e8XxJMp1/w3IssxuGD6BMfnyDn/j87YFdxRQBx50jxiXlc674ZLSqEkJ0Cf5gM8H/TPc0g0fxkskTrr3hoNEpRMaDPwpxx/wAfnsK7GigDhbHw34vtLVLdfEXh6RElaZS+hTZDFie14PU1ZOjeMf33/E/8N/vjl/8AiRXHJwB/z++wrsaKAOObSPGZkkk/4SHw4JHXYWGhT9P/AAMqGz8P+MbW3tIk8ReH2FquyNn0S4J6Y5/0zn8a7eigDjTo3jIoyf8ACQ+HdrPvP/EkuM5+v2326Usuj+M5PNJ8ReHQZU8tiNDuBxz0/wBM689a7GigDi7fQ/GUEduq+IvDx8iPy0LaJcEkcdf9M5PHWlbRPGLRCNvEPh7aH8z/AJAtzndnPX7bnHt0rs6KAOJu9B8Y3UF3DL4i8P7blCkmNFuOhGOP9NwOPSpo9J8aRiML4h8OgRrsX/iR3GMfT7ZiuwooA5D+yvGuIx/wkXh792dy/wDEkuP1/wBN5/GqmoeHfGN9YXlpN4l0ER3Qw5GiTkj/AHc3hA/Ku6ooA44aT41Fx5w8SeH87Nm3+xLjbj12/bMZ96u+CvD97oUerPqmow6heajeC7eSG3aBVxBFCFCtJITxCDkt1NdJRQAUUUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Rapid atrial tachycardia with 2:1 atrioventricular conduction. Sweep speed is 25 mm/sec.",
"    <div class=\"footnotes\">",
"     P: P waves.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36947=[""].join("\n");
var outline_f36_5_36947=null;
var title_f36_5_36948="Spleen anatomy PI";
var content_f36_5_36948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F61816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F61816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Organs inside the abdomen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36948=[""].join("\n");
var outline_f36_5_36948=null;
var title_f36_5_36949="TMD nerves";
var content_f36_5_36949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 625px\">",
"   <div class=\"ttl\">",
"    Nerves of the temporomandibular region",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 605px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Company. Copyright &copy; 2011 Wolters Kluwer Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36949=[""].join("\n");
var outline_f36_5_36949=null;
var title_f36_5_36950="Management and outcome of galactosemia";
var content_f36_5_36950=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management and outcome of galactosemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     V Reid Sutton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Sihoun Hahn, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Elizabeth B Rand, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36950/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/5/36950/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Galactose is a sugar found primarily in human and bovine milk and milk products as part of the disaccharide lactose. Lactose is hydrolyzed to glucose and galactose by the intestinal enzyme",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    ; the galactose then is converted to glucose for use as an energy source (",
"    <a class=\"graphic graphic_figure graphicRef50614 \" href=\"mobipreview.htm?43/16/44301\">",
"     figure 1",
"    </a>",
"    ). Free galactose also is present in some fruits and vegetables, such as tomatoes, Brussels sprouts, bananas, and apples. Altered metabolism of galactose caused by deficient enzyme activity or impaired liver function results in elevated blood galactose concentration and the condition known as galactosemia.",
"   </p>",
"   <p>",
"    The UK Galactosaemia Steering Group has published recommendations for the management of galactosemia based on evidence and clinical experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/1\">",
"     1",
"    </a>",
"    ]. These recommendations, summarized below, should be tailored to the individual patient.",
"   </p>",
"   <p>",
"    The management and outcome of galactosemia will be discussed here. The clinical features and diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=see_link\">",
"     \"Clinical features and diagnosis of galactosemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIC GALACTOSEMIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Management overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main goal of long-term treatment of classic galactosemia is to minimize dietary galactose intake. Galactose should be excluded from the diet as soon as galactosemia is suspected.",
"   </p>",
"   <p>",
"    Other initial care should be provided as needed to treat jaundice, sepsis, and abnormalities of the liver, kidneys, and central nervous system. Supportive therapy typically includes intravenous hydration, antibiotics, and treatment of coagulopathy, although problems usually resolve quickly after dietary treatment is begun.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nutritional therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Galactose restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate diet intervention is necessary for infants with suspected galactosemia. Minimization of dietary galactose is accomplished by excluding milk and dairy products from the diet. A dietician experienced in dietary therapy of inborn errors of metabolism should provide consultation in dietary management.",
"   </p>",
"   <p>",
"    In infants, human milk or formula based on bovine milk is discontinued and a soy-based formula is given. Soy-based infant formulas appropriate for galactosemia include Alsoy, Isomil, Nursoy, and ProSobee. Lactose-free infant formulas",
"    <strong>",
"     should not be used",
"    </strong>",
"    because they have not been proven to be safe for patients with galactosemia.",
"   </p>",
"   <p>",
"    Once foods are introduced, ingredients containing lactose and galactose should be minimized. In addition to milk, butter, cream, and cheese, other forms of milk that contain lactose (eg, non-fat dry milk, whey, or casein) should be avoided. On the other hand, lactate, lactic acid, and lactalbumin do not contain lactose and are safe to eat. Fruits and legumes are insignificant sources of galactose compared to endogenous production, and in most cases should not need to be significantly restricted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Calcium supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate calcium is provided by soy formula in infancy as long as appropriate volumes are taken. However, as the amount of food increases and formula volume declines after approximately one year of age, calcium supplements should be given. A nutritionist familiar with galactosemia should evaluate the patient's diet for calcium content and supplementation should be provided as needed to ensure that the dietary intake of the individual with galactosemia is meeting the RDA (Recommended Dietary Allowance) for calcium. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28631?source=see_link&amp;anchor=H11#H11\">",
"     \"Dietary history and recommended dietary intake in children\", section on 'Dietary Reference Intakes (DRIs)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other nutrients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other requirements for calories, protein, vitamins, and micronutrients are similar to those of normal individuals. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10938?source=see_link&amp;anchor=H2#H2\">",
"     \"Introducing solid foods and vitamin and mineral supplementation during infancy\", section on 'Infant nutritional requirements'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with galactosemia should be followed throughout their lives. The UK Galactosaemia Steering Group recommends out-patient follow-up every 3 months until 1 year, every 4 months until 2 years, every 6 months until 14 years, and then annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/1\">",
"     1",
"    </a>",
"    ]. These recommendations should be tailored to the individual patient. Girls may need to be seen more frequently to assess pubertal development.",
"   </p>",
"   <p>",
"    In addition to laboratory monitoring, additional evaluations are performed to monitor the problems that may develop in children with galactosemia. Neurodevelopmental impairment, cataracts, growth delay, and premature ovarian failure should be detected promptly so that appropriate interventions can be undertaken. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Outcome'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Biochemical status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Red blood cell (RBC) galactose-1-phosphate concentration is monitored intermittently to detect serious deviations from the restricted diet. Frequent measurement is not necessary because levels reflect galactose intake only in the previous 24 hours, have high intra-individual variability, and do not correlate with long-term outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. In addition, because of endogenous galactose production, levels are elevated in some patients who comply with the lactose-free diet, as discussed below.",
"   </p>",
"   <p>",
"    Urinary galactitol (the alcohol metabolite of galactose) concentration may better reflect more subtle, long-term increases in galactose intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. Urinary galactitol levels do not correlate with either development of complications or with RBC galactose-1-phosphate levels. In addition, intra-individual biological variability is high, limiting the usefulness of galactitol in disease monitoring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We find obtaining blood samples is more practical because of the difficulties collecting urine in young children. In addition, urinary galactitol measurements may not be widely available. Normal values for both galactose-1-phosphate and galactitol vary among laboratories because of methodologic differences.",
"   </p>",
"   <p>",
"    We recommend testing RBC galactose-1-phosphate every 3 months in children younger than 1 year of age and then every 6 months from 1 to 3 years of age. After age 3 years, we obtain either RBC galactose-1-phosphate or urinary galactitol levels every 6 months until age 14 years, then annually.",
"   </p>",
"   <p>",
"    If the levels of galactose-1-phosphate or galactitol are increased according to the reference laboratories standards, we obtain a complete dietary record for three days to identify a possible increase in galactose consumption. If we find that galactose consumption has increased, we recommend appropriate dietary changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17488756\">",
"    <span class=\"h4\">",
"     Endogenous galactose synthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood and urine concentrations of galactose and its metabolites remain elevated in classic galactosemia, even with dietary restriction, because of endogenous galactose production. In one study, the endogenous galactose production rate (0.53 to 1.05",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per hr) was variable in galactosemic adults (homozygous for the Q188R allele) and in a range similar to that of normal adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/7\">",
"     7",
"    </a>",
"    ]. The rate of endogenous galactose production correlates inversely with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/8\">",
"     8",
"    </a>",
"    ]. Because the rate of endogenous production exceeds the amount of galactose in a non-dairy diet, elevated galactose levels likely reflect endogenous production rather than noncompliance with dietary restrictions. The variable production rate also may contribute to the variability in phenotype, even in patients with similar genotypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Developmental status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurodevelopment should be assessed regularly. It should include yearly evaluation of speech and cognitive function after age two years. Referrals are made for speech therapy as needed and for evaluation of neurologic signs if they develop.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cataract detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ophthalmologic evaluation to detect cataracts should be performed at the time the diagnosis is made. Eye examinations are scheduled every six months until age three years and then annually. More frequent evaluations are needed if cataracts are detected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/14/22761?source=see_link\">",
"     \"Cataract in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-natal growth velocity for height and weight are lower in individuals with classic galactosemia than in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/9\">",
"     9",
"    </a>",
"    ]. Endogenous growth hormone production in girls with classic galactosemia is in the low-normal range of [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/10\">",
"     10",
"    </a>",
"    ]. It is unclear whether final height is impaired and whether exogenous growth hormone or estrogen therapy plays a role. The diet should be assessed at least annually by a dietician with expertise in metabolic disorders. At each clinician visit, we review a record of the patient's diet kept by the parents for the preceding three days. Dietary records are reviewed more frequently if growth is delayed or if dietary intake changes significantly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Ovarian function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary ovarian insufficiency occurs in most females with classic galactosemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/11\">",
"     11",
"    </a>",
"    ]. Follicle stimulating hormone, luteinizing hormone, and estradiol concentrations are measured in girls at 10 years of age. If gonadotrophin concentrations are increased and estradiol level is low, we refer the patient to a pediatric endocrinologist for consideration of estradiol therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborn screening has resulted in early diagnosis and treatment of galactosemia. Withholding human milk or bovine milk-based formula feedings and providing a soy-based formula usually results in resolution of the clinical features. The principal cause of early mortality in classic galactosemia is sepsis, most often caused by Escherichia coli.",
"   </p>",
"   <p>",
"    Most patients are healthy and intellectually normal during childhood. However, they frequently develop neuropsychological and ovarian problems during their teenage years. The natural history of galactosemia has been documented in a survey of 350 patients over a broad range of ages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Neurodevelopment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals with classic galactosemia have intellectual deficits, although some have average or above average intelligence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12-18\">",
"     12-18",
"    </a>",
"    ]. Many affected children have speech and language problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12,18-21\">",
"     12,18-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a survey of 177 patients with galactosemia who were at least six years old and had no other cause for poor outcome, 45 percent had developmental delay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ]. The mean IQ scores of the group declined slightly (four to seven points) with increasing age. In cross-sectional studies, cognitive function appears to decline with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12,14\">",
"     12,14",
"    </a>",
"    ]. However, a longitudinal study of cognitive function in 23 patients demonstrated stability of cognitive function over time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Problems with speech are frequent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12,19,20\">",
"     12,19,20",
"    </a>",
"    ]. In the survey cited above, they were observed in 56 percent of 243 patients who were at least 3 years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ]. The majority had delayed acquisition of vocabulary and difficulty with articulation (also known as verbal dyspraxia). The speech problem improved with time in only 24 percent.",
"   </p>",
"   <p>",
"    Affected adolescents and adults often have focal neurologic findings, such as tremor, ataxia, and dysmetria (impaired ability to control actions) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. In the survey cited above, abnormalities of coordination, gait, and balance, as well as fine motor tremors, were seen in 18 percent of patients who were more than 3.5 years old, and two teenagers had severe ataxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dietary compliance and RBC galactose-1-phosphate levels do not appear to affect IQ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12,15,23\">",
"     12,15,23",
"    </a>",
"    ]. Whether cognitive function correlates with genotype is uncertain because data are conflicting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of galactosemia\", section on 'Genotype-phenotype correlation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Ovarian failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature ovarian failure occurs in most females with classic galactosemia, affecting 81 percent of 47 girls and women older than 14 years of age in the survey [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ]. In another report, most galactosemic women had increased basal FSH and LH levels consistent with hypergonadotropic hypogonadism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In girls who menstruated, menarche occurred at an average age of 14 years; most then developed oligomenorrhea or secondary amenorrhea within a few years, and few had normal menstrual function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ]. Approximately 24 percent had primary amenorrhea.",
"   </p>",
"   <p>",
"    The mechanism of ovarian failure is unknown, but it appears to be an acquired condition. Galactose and galactose metabolites, such as galactose-1-phosphate and galactitol may be toxic to the ovaries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/25\">",
"     25",
"    </a>",
"    ]. The toxicity of galactose is supported by a study in which the number of oocytes was reduced in rats with prenatal exposure to elevated galactose levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of premature ovarian failure may be influenced by the patient's genotype. In one study of 53 females, ovarian failure was more likely if the genotype was homozygous for the most prevalent mutation Q188R (odds ratio 8.3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most affected women are infertile because of their ovarian failure. However, spontaneous pregnancy has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/28\">",
"     28",
"    </a>",
"    ]. Pubertal development and fertility in males with classic galactosemia are normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cataracts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sublenticular cataracts occur in approximately 30 percent of patients with galactosemia. Typically, they are detected after two weeks of age, but they may be present at birth. In a survey of long-term outcomes in 350 patients, dietary treatment began later in infants with cataracts than in those without cataracts (77 versus 20 days), although one child had been treated since birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"     12",
"    </a>",
"    ]. Approximately one-half resolved with dietary treatment, although 2 percent required surgery. Retrospective review of another cohort of 100 patients found no correlation between development of cataracts and dietary compliance, but corroborated the lack of significant effects of cataracts on vision in most patients with galactosemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/14/22761?source=see_link\">",
"     \"Cataract in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DUARTE VARIANT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with Duarte galactosemia (ie, who have one Duarte allele and one classic allele:",
"    <span class=\"nowrap\">",
"     D/G)",
"    </span>",
"    may be able to tolerate dietary galactose because GALT activity is impaired, but not absent (typically approximately 25 percent of normal) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a nonrandomized pilot study, the clinical, biochemical, and cognitive outcomes were similar among 28 children (aged 1.1 to 6 years) with Duarte galactosemia, whether or not they followed a galactose-restricted diet during the first year of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/31\">",
"     31",
"    </a>",
"    ]. Based upon this information and our years of experience with the occasional patient's parent with mild or asymptomatic Duarte variant galactosemia, we no longer treat Duarte galactosemia with a galactose-restricted diet; infants may breastfeed or ingest cow's-milk-based infant formula, and foods are not restricted. Other centers, however, may continue galactose restriction for one year, citing the relatively small size of the study cohort and findings from an observational study that suggested that children with Duarte galactosemia may be at risk for neurodevelopmental problems despite residual GALT activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In that population-based study, 59 children with Duarte galactosemia who were treated with dietary galactose restriction for the first year of life received special education services at about twice the rate of children without galactosemia (8.5 versus 4.5 percent of children aged 3 to 10 years and 15.2 versus 5.9 percent for 8-year-old children) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/32\">",
"     32",
"    </a>",
"    ]. The reason most often cited was speech and language problems; however, IQ scores or other detailed measures of cognitive abilities were not provided.",
"   </p>",
"   <p>",
"    Individuals with two Duarte alleles",
"    <span class=\"nowrap\">",
"     (D/D)",
"    </span>",
"    typically have enzyme activity levels &ge;50 percent of normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/30\">",
"     30",
"    </a>",
"    ]. There is no evidence to suggest that dietary restriction of galactose is needed in",
"    <span class=\"nowrap\">",
"     D/D",
"    </span>",
"    individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     GALACTOKINASE DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Galactose intake is restricted throughout life in patients with galactokinase (GALK) deficiency to prevent cataract formation. Similar to patients with classic galactosemia, these patients also require calcium supplementation, consultation with a dietician, and regular monitoring of biochemical status, growth, and eye examination. These evaluations should occur according to the same schedule as for patients with classic galactosemia. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Nutritional therapy'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Monitoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients with GALK are not at risk of neurodevelopmental problems or ovarian failure and do not need to be monitored for these problems. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features and diagnosis of galactosemia\", section on 'Galactokinase (GALK) deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASE DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epimerase deficiency confined to RBCs requires no treatment. The role of dietary treatment in patients with generalized epimerase deficiency is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36950/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Galactosemia can result from deficiencies of three different enzymes (",
"      <a class=\"graphic graphic_figure graphicRef50614 \" href=\"mobipreview.htm?43/16/44301\">",
"       figure 1",
"      </a>",
"      ), each with a distinct phenotype. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=see_link\">",
"       \"Clinical features and diagnosis of galactosemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The main goal of long-term treatment of classic galactosemia is to minimize dietary galactose. Galactose is excluded from the diet as soon as galactosemia is suspected. A dietician experienced in dietary therapy of inborn errors of metabolism should provide consultation in dietary management. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nutritional therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Calcium supplementation is suggested for children after one year of age. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Calcium supplements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Long-term monitoring of biochemical, ophthalmologic, neurodevelopmental, and endocrinologic status is necessary for patients with classic galactosemia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt initiation of galactose restriction usually results in resolution of clinical features. Most patients who adhere to the diet are healthy and intellectually normal during childhood. However, neuropsychological problems, and in girls, ovarian problems, frequently develop during adolescence. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/1\">",
"      Walter JH, Collins JE, Leonard JV. Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child 1999; 80:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/2\">",
"      Acosta PB, Gross KC. Hidden sources of galactose in the environment. Eur J Pediatr 1995; 154:S87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/3\">",
"      Berry GT, Palmieri M, Gross KC, et al. The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inherit Metab Dis 1993; 16:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/4\">",
"      Hutchesson AC, Murdoch-Davis C, Green A, et al. Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations. J Inherit Metab Dis 1999; 22:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/5\">",
"      Badawi N, Cahalane SF, McDonald M, et al. Galactosaemia--a controversial disorder. Screening &amp; outcome. Ireland 1972-1992. Ir Med J 1996; 89:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/6\">",
"      Palmieri M, Mazur A, Berry GT, et al. Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia. Metabolism 1999; 48:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/7\">",
"      Berry GT, Nissim I, Lin Z, et al. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet 1995; 346:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/8\">",
"      Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U. Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol Genet Metab 2004; 81:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/9\">",
"      Panis B, Gerver WJ, Rubio-Gozalbo ME. Growth in treated classical galactosemia patients. Eur J Pediatr 2007; 166:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/10\">",
"      Rubio-Gozalbo ME, Panis B, Zimmermann LJ, et al. The endocrine system in treated patients with classical galactosemia. Mol Genet Metab 2006; 89:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/11\">",
"      Fridovich-Keil JL, Gubbels CS, Spencer JB, et al. Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 2011; 34:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/12\">",
"      Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990; 13:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/13\">",
"      Kaufman FR, McBride-Chang C, Manis FR, et al. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 1995; 154:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/14\">",
"      Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 1993; 152:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/15\">",
"      Cleary MA, Heptinstall LE, Wraith JE, Walter JH. Galactosaemia: relationship of IQ to biochemical control and genotype. J Inherit Metab Dis 1995; 18:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/16\">",
"      Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology 2004; 18:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/17\">",
"      Ridel KR, Leslie ND, Gilbert DL. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol 2005; 33:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/18\">",
"      Hoffmann B, Wendel U, Schweitzer-Krantz S. Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia. J Inherit Metab Dis 2011; 34:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/19\">",
"      Nelson CD, Waggoner DD, Donnell GN, et al. Verbal dyspraxia in treated galactosemia. Pediatrics 1991; 88:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/20\">",
"      Pannbacker M. Management strategies for developmental apraxia of speech: a review of literature. J Commun Disord 1988; 21:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/21\">",
"      Potter NL. Voice disorders in children with classic galactosemia. J Inherit Metab Dis 2011; 34:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/22\">",
"      Schadewaldt P, Hoffmann B, Hammen HW, et al. Longitudinal assessment of intellectual achievement in patients with classical galactosemia. Pediatrics 2010; 125:e374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/23\">",
"      Hughes J, Ryan S, Lambert D, et al. Outcomes of siblings with classical galactosemia. J Pediatr 2009; 154:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/24\">",
"      Kaufman FR, Donnell GN, Roe TF, Kogut MD. Gonadal function in patients with galactosaemia. J Inherit Metab Dis 1986; 9:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/25\">",
"      Gibson JB. Gonadal function in galactosemics and in galactose-intoxicated animals. Eur J Pediatr 1995; 154:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/26\">",
"      Chen YT, Mattison DR, Feigenbaum L, et al. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981; 214:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/27\">",
"      Guerrero NV, Singh RH, Manatunga A, et al. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 2000; 137:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/28\">",
"      Noelmans L, Jacquemyn Y, De Naeyer S, Eyskens F. Pregnancy and galactosaemia. J Obstet Gynaecol 2006; 26:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/29\">",
"      Widger J, O'Toole J, Geoghegan O, et al. Diet and visually significant cataracts in galactosaemia: is regular follow up necessary? J Inherit Metab Dis 2010; 33:129.",
"     </a>",
"    </li>",
"    <li>",
"     Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Metabolic and molecular bases of inherited disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York 2001. p.1553.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/31\">",
"      Ficicioglu C, Thomas N, Yager C, et al. Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening. Mol Genet Metab 2008; 95:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/32\">",
"      Powell KK, Van Naarden Braun K, Singh RH, et al. Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med 2009; 11:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36950/abstract/33\">",
"      Openo KK, Schulz JM, Vargas CA, et al. Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet 2006; 78:89.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2945 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-41.196.66.12-750F5500E3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36950=[""].join("\n");
var outline_f36_5_36950=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIC GALACTOSEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Management overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nutritional therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Galactose restriction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Calcium supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other nutrients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Biochemical status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H17488756\">",
"      Endogenous galactose synthesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Developmental status",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cataract detection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Growth",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Ovarian function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Neurodevelopment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Ovarian failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cataracts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DUARTE VARIANT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      GALACTOKINASE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2945\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2945|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/16/44301\" title=\"figure 1\">",
"      Galactose metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/14/22761?source=related_link\">",
"      Cataract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30886?source=related_link\">",
"      Clinical features and diagnosis of galactosemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28631?source=related_link\">",
"      Dietary history and recommended dietary intake in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10938?source=related_link\">",
"      Introducing solid foods and vitamin and mineral supplementation during infancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_5_36951="Diaphragmatic paralysis in the newborn";
var content_f36_5_36951=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diaphragmatic paralysis in the newborn",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Suzanne K Whitbourne, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Ian J Griffin, MB ChB",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36951/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/5/36951/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important of the respiratory muscles is the dome-shaped diaphragm, which separates the thoracic and abdominal cavities and is innervated by the phrenic nerve. Injury to the phrenic nerve associated with birth trauma or cardiothoracic surgery can result in diaphragmatic paralysis, which may lead to respiratory distress in newborns. The initial treatment is supportive, and spontaneous recovery occurs in most cases.",
"   </p>",
"   <p>",
"    Before addressing the clinical features, diagnosis, and management of the disorder, reviewing the embryology and physiology of the diaphragm is useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAPHRAGM EMBRYOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diaphragm develops from four embryologic structures:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Septum transversum",
"     </li>",
"     <li>",
"      Pluripotential membranes",
"     </li>",
"     <li>",
"      Dorsal mesentery of the esophagus",
"     </li>",
"     <li>",
"      Body wall muscles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The septum transversum is first recognizable at the third week of gestation as a mass of mesoderm located ventral to the cervical somites. During the fourth week, it descends and partially separates the thoracic and peritoneal cavities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/1\">",
"     1",
"    </a>",
"    ]. The openings that remain between the thorax and abdomen are the pleuroperitoneal ducts.",
"   </p>",
"   <p>",
"    During the fifth week of gestation, myoblasts and neuronal elements from the third, fourth, and fifth cervical somites penetrate the developing diaphragm as the downward migration of the septum transversum continues. As a result, the phrenic nerve is comprised of the third, fourth, and fifth cervical nerve roots [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/2\">",
"     2",
"    </a>",
"    ]. The migration continues until the eighth week of gestation. At that time, the septum transversum fuses with the pluripotential membranes and the mesenchyme ventral to the esophagus, closing the pleuroperitoneal ducts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAPHRAGM PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diaphragm has two components: the non-contractile central tendon and the contracting muscle fibers. It is innervated by cervical motor neurons three, four, and five, conducted via the homolateral phrenic nerve through the neck and mediastinum.",
"   </p>",
"   <p>",
"    Contraction of the diaphragm has the following effects that promote air movement into the lungs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      It decreases intrapleural pressure.",
"     </li>",
"     <li>",
"      It raises or inflates the rib cage using the abdomen as a fulcrum on which to lean.",
"     </li>",
"     <li>",
"      It expands the rib cage through its zone of apposition (the lower third of the rib cage apposed by the diaphragm) by generating positive intraabdominal pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the adult, the diaphragmatic muscle fibers radiate circumferentially and insert peripherally into the inner surface of the lower six ribs and costal cartilages anteriorly (costal part) and the upper three lumbar vertebral bodies posteriorly (crural part). Anatomical differences between the newborn and adult result in decreased efficiency of the neonatal diaphragm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Neonatal diaphragm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to the adult, the newborn diaphragm differs in its attachment to the rib cage, its flatter shape, and its fiber composition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Inefficiency of the diaphragm may be exacerbated by the newborn's highly compliant rib cage and horizontal configuration of the ribs, which reduce the mechanical advantage of the intercostal muscles in lifting the rib cage in inspiration. The newborn's recumbent posture, compared to the upright adult, also contributes to diaphragm inefficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Rib cage attachments",
"    </span>",
"    &nbsp;&mdash;&nbsp;The attachments of the diaphragm to the rib cage render the neonatal diaphragm less efficient than that of the adult. In the newborn, muscle fibers from the anterior diaphragm radiate laterally and attach to the xiphoid process and the seventh rib [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/7\">",
"     7",
"    </a>",
"    ]. Fibers from the posterior diaphragm join the eleventh rib, while posterolateral fibers blend with the transverse abdominal muscles. The large angle of insertion into the lateral wall limits the zone of apposition. As a result, most of the movement of the neonatal diaphragm is in the posterior portion, in contrast to the piston-like movement of the adult diaphragm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pressure generation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the neonatal diaphragm is flatter (that is, it has a larger radius of curvature) than the adult, the maximum transdiaphragmatic pressure generated by contraction is less [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/7\">",
"     7",
"    </a>",
"    ]. This is expressed by Laplace's law,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;P = 2T",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    r",
"   </p>",
"   <p>",
"    where P is the transdiaphragmatic pressure, T is the tension developed by the diaphragm, and r is the radius of curvature of the diaphragm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Fiber types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult and neonatal diaphragms differ in the relative proportion of type I and II muscle fibers, which affects their ability to withstand fatigue. Type I fibers are recruited first and generate a low level of force; they are relatively resistant to fatigue. Type II fibers are the last to be recruited, generate a high level of force, and are easily fatigued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/9\">",
"     9",
"    </a>",
"    ]. The proportion of fatigue-resistant type II fibers is less in the neonatal diaphragm (25 versus 55 percent) compared to the adult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Body position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diaphragm is less efficient in the recumbent newborn than in the upright adult. In addition, diaphragmatic function may be impaired more in the prone than supine position. In one study, diaphragm thickness and shortening were assessed by ultrasound in healthy term infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/11\">",
"     11",
"    </a>",
"    ]. In the prone position, the diaphragm was thicker and shorter at both end-expiratory and end-inspiratory volumes, and diaphragm shortening was greater during tidal breathing, compared to the supine position. The reduced resting diaphragmatic length in the prone position would be expected to impair diaphragmatic strength, while the additional shortening during tidal breathing would increase diaphragmatic work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic paralysis typically is caused by injury to the phrenic nerve. In almost all cases, this is caused by trauma during birth or cardiothoracic surgery. In rare cases, paralysis results from neuromuscular disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Birth injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extreme lateral traction on the shoulder during delivery can injure or transect the phrenic nerve",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the brachial plexus by stretching their cervical roots. The traction occurs during delivery of the shoulder in cephalic presentations and delivery of the head in breech presentations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Involvement of the third to fifth, and especially the fourth, cervical roots results in diaphragmatic paralysis. Brachial plexus palsy is associated in 80 to 90 percent of cases, while diaphragmatic paralysis occurs in approximately 5 percent of brachial plexus injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors associated with diaphragmatic paralysis are similar to those for brachial plexus injury. The risk of brachial plexus injury is greatly increased by vaginal delivery of a macrosomic infant (&gt;4500 g) (odds ratio 21.0, compared to normal weight) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/16\">",
"     16",
"    </a>",
"    ]. Shoulder dystocia may be a contributing factor. In one review, shoulder dystocia complicated the delivery of 75 percent of macrosomic infants with brachial plexus injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/17\">",
"     17",
"    </a>",
"    ]. Diaphragmatic paralysis occurs more often after breech than after cephalic deliveries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14\">",
"     14",
"    </a>",
"    ]. Malpositioned forceps also may result in phrenic nerve injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cardiothoracic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phrenic nerve injury is a recognized complication of cardiothoracic surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/19\">",
"     19",
"    </a>",
"    ]. Causes include electrocauterization, stretching, blunt trauma, or complete denervation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/20\">",
"     20",
"    </a>",
"    ]. The incidence of clinically diagnosed diaphragmatic paralysis after cardiothoracic surgery in children is variable, ranging from 0.5 to 2.2 percent of open and closed procedures in retrospective studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. The incidence may be slightly higher (3 to 4.6 percent) in infants and younger children, and occurs most often after Blalock-Taussig shunts are performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prospective assessment of injury by percutaneous stimulation of the phrenic nerve detected a higher rate of injury than did retrospective studies. In one report, unilateral phrenic nerve injury was detected after cardiac surgery in 6 of 50 infants and 4 of 50 children younger than 15 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/26\">",
"     26",
"    </a>",
"    ]. All were symptomatic. No associations were found with age, type of surgery, length of bypass, aortic clamping, circulatory arrest, or degree of hypothermia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other procedures that may be performed in sick newborns can lead to phrenic nerve injury, although this complication seldom occurs. Diaphragmatic paralysis has been reported after cannulation of the internal jugular [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/27\">",
"     27",
"    </a>",
"    ] or subclavian vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/28\">",
"     28",
"    </a>",
"    ]. The disorder also has been associated with insertion of chest tubes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/29,30\">",
"     29,30",
"    </a>",
"    ] and repair of esophageal",
"    <span class=\"nowrap\">",
"     atresia/",
"    </span>",
"    tracheoesophageal fistula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Neuromuscular disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuromuscular disorders are rare causes of diaphragmatic paralysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/12\">",
"     12",
"    </a>",
"    ]. Causes identified in case reports include congenital myopathies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/13,32\">",
"     13,32",
"    </a>",
"    ], spinal muscular atrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/33\">",
"     33",
"    </a>",
"    ], myasthenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/34\">",
"     34",
"    </a>",
"    ], and congenital diaphragmatic muscle hypoplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/35\">",
"     35",
"    </a>",
"    ]. Other causes include high spinal cord trauma and botulism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic paralysis occurring after birth injury typically is unilateral. The right side is involved most often (approximately 80 percent of cases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14\">",
"     14",
"    </a>",
"    ]. The most severely affected infants have bilateral involvement, which occurs in less than 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14,36,37\">",
"     14,36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Onset",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of symptoms is variable and may occur soon after birth or later in the neonatal period. Recognition may be delayed in infants receiving assisted ventilation. These patients usually do not become symptomatic until weaning from the ventilator is attempted.",
"   </p>",
"   <p>",
"    Newborns tolerate diaphragmatic paralysis less well than older children or adults. Their anatomic differences result in increased respiratory dysfunction and earlier presentation. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Neonatal diaphragm'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Phrenic nerve injury associated with cardiothoracic surgery or other procedures usually is suspected when the infant cannot be weaned from the ventilator or develops respiratory distress after extubation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/38\">",
"     38",
"    </a>",
"    ]. Some infants present with complications of diaphragmatic paralysis, such as atelectasis, pleural effusions, aspiration, or respiratory infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/20,26\">",
"     20,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected newborns typically have signs of respiratory compromise. These include tachypnea, mild to severe respiratory distress, cyanosis, apnea, or a weak cry.",
"   </p>",
"   <p>",
"    Some affected infants also have gastrointestinal symptoms. These typically include respiratory distress or tiring during feedings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients with left-sided diaphragmatic paralysis may have frequent regurgitation as a result of displacement of the lower esophagus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stomach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most infants with diaphragmatic paralysis caused by birth injury have an associated brachial plexus palsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. This is usually the proximal type (Erb's palsy), although it may be total. The affected limb typically assumes the characteristic \"waiter's tip\" position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected infants may have decreased movement of the rib cage on the affected side, with corresponding prominent movement of the unaffected side. Paradoxical movement of the diaphragm (rising with inspiration and falling with expiration, also known as Kienboeck's sign) may result in a seesaw movement of the abdomen. Rare infants have the \"belly dancer's sign\" in which the umbilicus moves toward the affected side during inspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Auscultation usually detects decreased air entry on the affected side. If the right diaphragm is affected, percussion (although rarely part of the newborn examination) may reveal dullness at the right lung base caused by the caudal displacement of the liver [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/42\">",
"     42",
"    </a>",
"    ]. Hyperresonance may occur over the left lung base if the left side is affected, due to the caudal displacement of the gastric bubble.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic paralysis should be considered when respiratory dysfunction develops after a traumatic delivery, especially in a large infant with breech presentation. However, respiratory distress and hypoxemia may indicate primary pulmonary disease or congenital heart disease. These diagnoses should be excluded. The disorder also should be considered when weaning from mechanical ventilation is unsuccessful after the child has undergone cardiothoracic surgery or other procedure, such as chest tube placement.",
"   </p>",
"   <p>",
"    The diagnosis is confirmed by echocardiography or fluoroscopy. The former is preferred because it can be performed at the bedside and involves no exposure to ionizing radiation. In addition, one study suggested that echocardiography was more reliable in detecting hemidiaphragms that required surgical plication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/43\">",
"     43",
"    </a>",
"    ]. Diaphragmatic movement during breathing typically is minimal or paradoxical, rising with inspiration and falling with expiration. The diagnosis may be missed in infants receiving positive pressure ventilation or continuous positive airway pressure because the affected diaphragm may not be elevated or move paradoxically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other imaging tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The affected hemidiaphragm typically is elevated on an anteroposterior chest radiograph. In general, an affected right hemidiaphragm is at least two intercostal spaces higher than the left, and an affected left hemidiaphragm is one intercostal space higher than the right [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/39\">",
"     39",
"    </a>",
"    ]. Other radiographic findings that may be seen include atelectasis on the affected side and shift of the mediastinum away from that side. The stomach bubble may appear elevated with left-sided paralysis.",
"   </p>",
"   <p>",
"    Evaluation of the upper cervical spinal cord with magnetic resonance imaging may be useful in infants who present with diaphragmatic paralysis and quadriparesis. In a small series, this technique was used to demonstrate the extent and severity of the injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Electromyography and physiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other methods are available to assess neonatal diaphragmatic function but are not used clinically because they are difficult to interpret",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    invasive. These include electromyography, measurement of maximal inspiratory pressure during crying, and phrenic nerve stimulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/19,26,45-47\">",
"     19,26,45-47",
"    </a>",
"    ]. The technique of magnetic stimulation of the phrenic nerve may be a useful and noninvasive way to assess function but remains investigational in newborns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment of diaphragmatic paralysis is supportive. With supportive care, spontaneous recovery of diaphragmatic function occurs in most cases.",
"   </p>",
"   <p>",
"    Mildly affected infants may respond to supplemental oxygen administered by hood or nasal cannula. If oral feedings are limited because of respiratory distress, nasogastric feedings can be used to provide adequate nutrition.",
"   </p>",
"   <p>",
"    More severely affected infants require mechanical ventilation. In less severe cases, continuous positive airway pressure (CPAP) may \"splint\" the diaphragm, reducing paradoxical motion, and allowing the infant to breathe spontaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Negative pressure ventilation also has been used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Although the technique is cumbersome, it avoids endotracheal intubation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most newborns with diaphragmatic paralysis associated with birth trauma recover in the first 6 to 12 months after birth with supportive care. Conservative management also usually is successful after cardiac surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/25\">",
"     25",
"    </a>",
"    ]. In some cases, symptoms will resolve with little objective evidence of improved diaphragmatic function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diaphragmatic paralysis caused by avulsion of the phrenic nerve is permanent. Loss of contraction leads to muscle atrophy and eventration of the diaphragm. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43235?source=see_link\">",
"     \"Eventration of the diaphragm in infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surface recordings of diaphragmatic action potential amplitudes and phrenic nerve conduction times in response to percutaneous phrenic nerve stimulation may help predict whether recovery will occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14,52\">",
"     14,52",
"    </a>",
"    ]. Patients with absent or markedly reduced diaphragmatic action potentials or very prolonged conduction latencies are unlikely to recover and likely will need surgical plication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Surgical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;If patients have persistent severe respiratory distress or a prolonged requirement for mechanical ventilation, surgical plication is performed. This procedure immobilizes and lowers the diaphragm, resulting in increased resting lung volume and improved action of the intercostal and abdominal muscles during breathing. Respiratory improvement after application of CPAP (8 to 10 cm H2O) may identify patients who will respond to plication because both interventions stabilize the diaphragm and increase functional residual capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The appropriate timing for performing surgical plication is uncertain. In general, the procedure is considered if mechanical ventilation is required for at least two months and there are no signs of recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/14\">",
"     14",
"    </a>",
"    ]. However, some clinicians recommend earlier intervention to prevent complications of long-term mechanical ventilation, especially when injury follows cardiothoracic surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plication usually is associated with rapid improvement in uncomplicated cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/22,55-57\">",
"     22,55-57",
"    </a>",
"    ]. In general, mechanical ventilation can be discontinued within one week of surgery, even in preterm infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data on long-term outcomes following plication are limited. In one report, six children with phrenic nerve injury due to surgery for congenital heart disease or birth trauma had return of normal function one to seven years following diaphragmatic plication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pacing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic pacing may be considered in bilateral diaphragmatic paralysis, although experience in young infants is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36951/abstract/61-64\">",
"     61-64",
"    </a>",
"    ]. However, it is not helpful in unilateral paralysis because of the difficulty of synchronizing contraction of the normal and paralyzed hemidiaphragms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diaphragmatic paralysis typically is caused by injury to the phrenic nerve. In almost all cases, this is caused by trauma during birth or cardiothoracic surgery. In rare cases, paralysis results from neuromuscular disorders. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diaphragmatic paralysis occurring after birth injury usually is unilateral, and more commonly involves the right side. The onset of symptoms is variable and typically includes signs of respiratory distress, cyanosis, apnea, or a weak cry. Other associated findings include respiratory distress or tiring during feedings, gastrointestinal reflux, and brachial plexus palsy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination includes decreased movement of the rib cage on the affected side, with corresponding prominent movement of the unaffected side. There may also be a seesaw movement of the abdomen. Auscultation of the chest usually detects decreased air entry on the affected side. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of diaphragmatic paralysis is made by either echocardiography or fluoroscopy. Echocardiography is the preferred modality as it can be performed at the bedside and involves no exposure to ionizing radiation. An elevated hemidiaphragm on an anteroposterior chest radiograph is indicative of diaphragmatic paralysis. Other radiographic findings include atelectasis on the affected side, and shift of the mediastinum away from the affected side. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial treatment of diaphragmatic paralysis is supportive. With supportive care, spontaneous recovery of diaphragmatic function occurs in most cases. Supportive care includes supplemental oxygen and mechanical ventilation as needed by the infant. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical plication is indicated in patients with persistent severe respiratory distress",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      require prolonged mechanical ventilation. Generally, surgical plication is associated with rapid improvement in uncomplicated cases with discontinuation of mechanical ventilation within one week of surgery. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Surgical treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/1\">",
"      Schumpelick V, Steinau G, Schl&uuml;per I, Prescher A. Surgical embryology and anatomy of the diaphragm with surgical applications. Surg Clin North Am 2000; 80:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/2\">",
"      Tarver RD, Godwin JD, Putman CE. Symposium on Nonpulmonary Aspects in Chest Radiology. The diaphragm. Radiol Clin North Am 1984; 22:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/3\">",
"      Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 1982; 307:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/4\">",
"      Rochester DF. The diaphragm: contractile properties and fatigue. J Clin Invest 1985; 75:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/5\">",
"      Yellin A, Lieberman Y, Barzilay Z. Postoperative unilateral diaphragmatic paralysis in children, a plea for early plication. Thorac Cardiovasc Surg 1991; 39:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/6\">",
"      Mearns AJ. Iatrogenic injury to the phrenic nerve nerve in infants and young children. Br J Surg 1977; 64:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/7\">",
"      Devlieger H, Daniels H, Marchal G, et al. The diaphragm of the newborn infant: anatomical and ultrasonographic studies. J Dev Physiol 1991; 16:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/8\">",
"      Gibson GJ. Diaphragmatic paresis: pathophysiology, clinical features, and investigation. Thorax 1989; 44:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/9\">",
"      Celli B. The diaphragm and respiratory muscles. Chest Surg Clin N Am 1998; 8:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/10\">",
"      Keens TG, Bryan AC, Levison H, Ianuzzo CD. Developmental pattern of muscle fiber types in human ventilatory muscles. J Appl Physiol 1978; 44:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/11\">",
"      Rehan VK, Nakashima JM, Gutman A, et al. Effects of the supine and prone position on diaphragm thickness in healthy term infants. Arch Dis Child 2000; 83:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/12\">",
"      Sivan Y, Galvis A. Early diaphragmatic paralysis. In infants with genetic disorders. Clin Pediatr (Phila) 1990; 29:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/13\">",
"      Bergen BJ, Sangalang VE, Aterman K. Isolated myopathic involvement of the diaphragmatic musculature in a neonate. Ann Neurol 1977; 1:403.",
"     </a>",
"    </li>",
"    <li>",
"     Volpe, JJ. Injuries of extracranial, cranial, intracranial, spinal cord, and peripheral nervous system structures. In: Neurology of the Newborn, 4th Ed, WB Saunders, Philadelphia, 2001. p.813.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/15\">",
"      Donn SM, Faix RG. Long-term prognosis for the infant with severe birth trauma. Clin Perinatol 1983; 10:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/16\">",
"      McFarland LV, Raskin M, Daling JR, Benedetti TJ. Erb/Duchenne's palsy: a consequence of fetal macrosomia and method of delivery. Obstet Gynecol 1986; 68:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/17\">",
"      Gilbert WM, Nesbitt TS, Danielsen B. Associated factors in 1611 cases of brachial plexus injury. Obstet Gynecol 1999; 93:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/18\">",
"      Stauffer UG, Rickham PP. Acquired eventration of the diaphragm in the newborn. J Pediatr Surg 1972; 7:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/19\">",
"      Van Smith C, Jacobs JP, Burke RP. Minimally invasive diaphragm plication in an infant. Ann Thorac Surg 1998; 65:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/20\">",
"      Watanabe T, Trusler GA, Williams WG, et al. Phrenic nerve paralysis after pediatric cardiac surgery. Retrospective study of 125 cases. J Thorac Cardiovasc Surg 1987; 94:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/21\">",
"      Mickell JJ, Oh KS, Siewers RD, et al. Clinical implications of postoperative unilateral phrenic nerve paralysis. J Thorac Cardiovasc Surg 1978; 76:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/22\">",
"      Shoemaker R, Palmer G, Brown JW, King H. Aggressive treatment of acquired phrenic nerve paralysis in infants and small children. Ann Thorac Surg 1981; 32:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/23\">",
"      Zhao HX, D'Agostino RS, Pitlick PT, et al. Phrenic nerve injury complicating closed cardiovascular surgical procedures for congenital heart disease. Ann Thorac Surg 1985; 39:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/24\">",
"      Hamilton JR, Tocewicz K, Elliott MJ, et al. Paralysed diaphragm after cardiac surgery in children: value of plication. Eur J Cardiothorac Surg 1990; 4:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/25\">",
"      Kunovsky P, Gibson GA, Pollock JC, et al. Management of postoperative paralysis of diaphragm in infants and children. Eur J Cardiothorac Surg 1993; 7:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/26\">",
"      Mok Q, Ross-Russell R, Mulvey D, et al. Phrenic nerve injury in infants and children undergoing cardiac surgery. Br Heart J 1991; 65:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/27\">",
"      Pleasure JR, Shashikumar VL. Phrenic nerve damage in the tiny infant during vein cannulation for parenteral nutrition. Am J Perinatol 1990; 7:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/28\">",
"      D'Netto MA, Bender J, Brown RT, Herson VC. Unilateral diaphragmatic palsy in association with a subclavian vein thrombus in a very-low- birth-weight infant. Am J Perinatol 2001; 18:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/29\">",
"      Arya H, Williams J, Ponsford SN, Bissenden JG. Neonatal diaphragmatic paralysis caused by chest drains. Arch Dis Child 1991; 66:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/30\">",
"      Odita JC, Khan AS, Dincsoy M, et al. Neonatal phrenic nerve paralysis resulting from intercostal drainage of pneumothorax. Pediatr Radiol 1992; 22:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/31\">",
"      Man D, Wheildon MH, Eckstein HB. Paralysis of the right hemidiaphragm following primary anastomosis for oesophageal atresia and tracheo-oesophageal fistula. Z Kinderchir 1982; 37:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/32\">",
"      De Reuck J, Hooft C, De Coster W, et al. A progressive congenital myopathy. Initial involvement of the diaphragm with type I muscle fiber atrophy. Eur Neurol 1977; 15:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/33\">",
"      Bertini E, Gadisseux JL, Palmieri G, et al. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy. Am J Med Genet 1989; 33:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/34\">",
"      Heckmatt JZ, Placzek M, Thompson AH, et al. An unusual case of neonatal myasthenia. J Child Neurol 1987; 2:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/35\">",
"      Bosman C, Bachelet V, Boldrini R, Bertini E. Diaphragmatic paralysis due to partial diaphragmatic hypoplasia mimicking a localized muscular dystrophy: a case report. Clin Neuropathol 1988; 7:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/36\">",
"      Aldrich TK, Herman JH, Rochester DF. Bilateral diaphragmatic paralysis in the newborn infant. J Pediatr 1980; 97:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/37\">",
"      Commare MC, Kurstjens SP, Barois A. Diaphragmatic paralysis in children: a review of 11 cases. Pediatr Pulmonol 1994; 18:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/38\">",
"      T&ouml;nz M, von Segesser LK, Mihaljevic T, et al. Clinical implications of phrenic nerve injury after pediatric cardiac surgery. J Pediatr Surg 1996; 31:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/39\">",
"      Greene W, L'Heureux P, Hunt CE. Paralysis of the diaphragm. Am J Dis Child 1975; 129:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/40\">",
"      BISHOP HC, KOOP CE. Acquired eventration of the diaphragm in infancy. Pediatrics 1958; 22:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/41\">",
"      Nichols MM. Shifting umbilicus in neonatal phrenic palsy (the belly dancer's sign). Clin Pediatr (Phila) 1976; 15:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/42\">",
"      Smith BT. Isolated phrenic nerve palsy in the newborn. Pediatrics 1972; 49:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/43\">",
"      Miller SG, Brook MM, Tacy TA. Reliability of two-dimensional echocardiography in the assessment of clinically significant abnormal hemidiaphragm motion in pediatric cardiothoracic patients: Comparison with fluoroscopy. Pediatr Crit Care Med 2006; 7:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/44\">",
"      Mills JF, Dargaville PA, Coleman LT, et al. Upper cervical spinal cord injury in neonates: the use of magnetic resonance imaging. J Pediatr 2001; 138:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/45\">",
"      Rafferty GF, Greenough A, Dimitriou G, et al. Assessment of neonatal diaphragm function using magnetic stimulation of the phrenic nerves. Am J Respir Crit Care Med 2000; 162:2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/46\">",
"      Diament MJ, Boechat MI, Kangarloo H. Real-time sector ultrasound in the evaluation of suspected abnormalities of diaphragmatic motion. J Clin Ultrasound 1985; 13:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/47\">",
"      Shardonofsky FR, Perez-Chada D, Milic-Emili J. Airway pressures during crying: an index of respiratory muscle strength in infants with neuromuscular disease. Pediatr Pulmonol 1991; 10:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/48\">",
"      Zajkowski EJ, Kravath RE. Bilateral diaphragmatic paralysis in the newborn infant: treatment with nasal continous positive airway pressure. Chest 1979; 75:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/49\">",
"      Bucci G, Marzetti G, Picece-Bucci S, et al. Phrenic nerve palsy treated by continuous positive pressure breathing by nasal cannula. Arch Dis Child 1974; 49:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/50\">",
"      Raine J, Samuels MP, Mok Q, et al. Negative extrathoracic pressure ventilation for phrenic nerve palsy after paediatric cardiac surgery. Br Heart J 1992; 67:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/51\">",
"      Weisman L, Woodall J, Merenstein G. Constant negative pressure in the treatment of diaphragmatic paralysis secondary to birth injury. Birth Defects Orig Artic Ser 1976; 12:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/52\">",
"      Brouillette RT, Ilbawi MN, Hunt CE. Phrenic nerve pacing in infants and children: a review of experience and report on the usefulness of phrenic nerve stimulation studies. J Pediatr 1983; 102:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/53\">",
"      Haller JA Jr, Pickard LR, Tepas JJ, et al. Management of diaphragmatic paralysis in infants with special emphasis on selection of patients for operative plication. J Pediatr Surg 1979; 14:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/54\">",
"      Jog SM, Patole SK. Diaphragmatic paralysis in extremely low birthweight neonates: Is waiting for spontaneous recovery justified? J Paediatr Child Health 2002; 38:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/55\">",
"      Affatato A, Villagra F, De Leon JP, et al. Phrenic nerve paralysis following pediatric cardiac surgery. Role of diaphragmatic plication. J Cardiovasc Surg (Torino) 1988; 29:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/56\">",
"      Ribet M, Linder JL. Plication of the diaphragm for unilateral eventration or paralysis. Eur J Cardiothorac Surg 1992; 6:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/57\">",
"      Schwartz MZ, Filler RM. Plication of the diaphragm for symptomatic phrenic nerve paralysis. J Pediatr Surg 1978; 13:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/58\">",
"      Smith CD, Sade RM, Crawford FA, Othersen HB. Diaphragmatic paralysis and eventration in infants. J Thorac Cardiovasc Surg 1986; 91:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/59\">",
"      Gallagher PG, Seashore JH, Touloukian RJ. Diaphragmatic plication in the extremely low birth weight infant. J Pediatr Surg 2000; 35:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/60\">",
"      Stone KS, Brown JW, Canal DF, King H. Long-term fate of the diaphragm surgically plicated during infancy and early childhood. Ann Thorac Surg 1987; 44:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/61\">",
"      Alonso Calder&oacute;n JL, Garrido Garc&iacute;a H, P&eacute;rez Dom&iacute;nguez T, Mazaira J. [Simultaneous, bilateral and permanent ventilation with a diaphragm pacing in childhood: the implantation technique and indications]. Cir Pediatr 1994; 7:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/62\">",
"      Brouillette RT, Ilbawi MN, Klemka-Walden L, Hunt CE. Stimulus parameters for phrenic nerve pacing in infants and children. Pediatr Pulmonol 1988; 4:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/63\">",
"      Brouillette RT, Marzocchi M. Diaphragm pacing: clinical and experimental results. Biol Neonate 1994; 65:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36951/abstract/64\">",
"      Radecki LL, Tomatis LA. Continuous bilateral electrophrenic pacing in an infant with total diaphragmatic paralysis. J Pediatr 1976; 88:969.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4990 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-F93BED5DA7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36951=[""].join("\n");
var outline_f36_5_36951=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAPHRAGM EMBRYOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAPHRAGM PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Neonatal diaphragm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Rib cage attachments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pressure generation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Fiber types",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Body position",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Birth injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cardiothoracic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Neuromuscular disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Onset",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Signs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other imaging tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Electromyography and physiologic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43235?source=related_link\">",
"      Eventration of the diaphragm in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_5_36952="Vulvar lichen planus";
var content_f36_5_36952=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vulvar lichen planus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Elizabeth Gunther Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36952/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/5/36952/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen planus is a relatively uncommon inflammatory dermatologic condition with subtypes that can affect the skin, mucosa, nails, and scalp. Vulvar lichen planus is a subtype of lichen planus that is characterized by erosive or papular lesions on the vulva, with or without concomitant vaginal involvement.",
"   </p>",
"   <p>",
"    Erosive vulvar lichen planus is the most common manifestation of vulvar lichen planus and can result in severe tissue destruction that leads to urinary and sexual impairment. Although high quality studies to guide treatment of vulvar lichen planus are lacking, superpotent topical corticosteroids are well-accepted as the first-line treatment for erosive disease.",
"   </p>",
"   <p>",
"    Vulvar lichen planus will be discussed here. An overview of the different forms of lichen planus is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link\">",
"     \"Lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20848790\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of vulvar lichen planus has not been clearly established. Vulvar disease is not an uncommon manifestation of lichen planus in women. In one series of 37 women diagnosed with lichen planus, vulvar lesions were present in 51 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20848761\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology is unknown. Lichen planus may be related to an aberrant cell-mediated immune response to antigens in skin and mucosa. The disorder is often associated with other autoimmune diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvar lichen planus typically occurs in women 50 to 60 years of age (range 29 to 82 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Affected women frequently present with complaints of intense pruritus or vulvar pain, soreness, or burning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/6\">",
"     6",
"    </a>",
"    ]. Other prominent symptoms include an irritating vaginal discharge that does not respond to standard therapies for vaginitis and dyspareunia (sometimes with post-coital bleeding). However, this clinical scenario is not specific to lichen planus, as it occurs with most vulvar disorders (",
"    <a class=\"graphic graphic_table graphicRef55449 \" href=\"mobipreview.htm?5/25/5532\">",
"     table 1",
"    </a>",
"    ). The coexistence of vulvar lichen planus with cutaneous or oral lichen planus is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs and symptoms of vulvar lichen planus can be constant or intermittent. A minority of women are asymptomatic or have only minimal symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three types of lichen planus affect the vulva, erosive lichen planus, papulosquamous lichen planus, and hypertrophic lichen planus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Erosive lichen planus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erosive lichen planus is the most common type of vulvar lichen planus. The desquamative, erosive, chronic dermatitis often also involves the vagina. Recurrent exacerbations, slow healing, and scarring are common. Scarring can cause significant anatomic disruption, including severe stenosis of the vaginal opening and urethral obstruction. Dyspareunia and difficulty with",
"    <span class=\"nowrap\">",
"     urination/dysuria",
"    </span>",
"    are the major symptoms.",
"   </p>",
"   <p>",
"    Lesions are characterized by glassy, brightly erythematous erosions with white striae or a white border (Wickham's striae) often visible along the margins (",
"    <a class=\"graphic graphic_picture graphicRef60224 \" href=\"mobipreview.htm?39/37/40530\">",
"     picture 1",
"    </a>",
"    ); occasionally, a violaceous border is noted as well. The lesions may occur on the labia minora and vestibule as isolated lesions on an otherwise normal vulva, or they may be associated with marked architectural destruction, including loss of the labia minora and narrowing of the introitus. Small, localized lesions on the labia majora are less common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/9\">",
"     9",
"    </a>",
"    ]. Anal involvement is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vaginal involvement",
"      </strong>",
"      &minus; Vaginal involvement has been reported in up to 70 percent of patients with erosive lichen planus; in contrast, vaginal involvement does not occur in lichen sclerosus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/12\">",
"       12",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=see_link\">",
"       \"Vulvar lichen sclerosus\"",
"      </a>",
"      ). The vaginal epithelium in lichen planus is friable, easily bleeding upon speculum insertion or with coitus. It may have small areas of inflammation and increased vaginal discharge, or it may be massively inflamed and denuded with a seropurulent exudate, pseudomembrane, or serosanguinous vaginal discharge [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/9,13\">",
"       9,13",
"      </a>",
"      ]. In severe cases, adhesions and synechiae develop, which can lead to narrowing or obliteration of the vagina.",
"      <br/>",
"      <br/>",
"      Vaginal involvement can occur in the absence of any vulvar involvement, and vaginal",
"      <span class=\"nowrap\">",
"       synechiae/adhesions",
"      </span>",
"      can form in the absence of any symptomatology if the patient is not sexually active or menstruating. The Papanicolaou smear may show atypia if the cervix is affected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Vulvo-vaginal-gingival syndrome",
"      </strong>",
"      &minus; The vulvo-vaginal-gingival (VVG) syndrome is a variant of erosive lichen planus that involves the epithelium of the vulva, vestibule, vagina, and mouth (",
"      <a class=\"graphic graphic_picture graphicRef73340 \" href=\"mobipreview.htm?38/43/39602\">",
"       picture 2",
"      </a>",
"      ); additional sites (eg, skin, esophagus) may also be involved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/13,15-18\">",
"       13,15-18",
"      </a>",
"      ]. Although all three areas can be affected, the lesions may not be concurrent. The gingival epithelium is usually involved, and erosions, white plaques, or a whitish and lace-like reticular pattern may occur on the buccal mucosa, tongue, and palate. Scarring and stricture formation are common and a major cause of long-term morbidity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/18\">",
"       18",
"      </a>",
"      ]. VVG is particularly resistant to treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Papulosquamous lichen planus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papulosquamous lichen planus consists of small, intensely pruritic papules with a violaceous hue that arise on keratinized and perianal skin. It is associated, occasionally, with milky striae on the inner aspects of the labia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/19\">",
"     19",
"    </a>",
"    ]. Resolution of papulosquamous lesions is often followed by postinflammatory hyperpigmentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypertrophic lichen planus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertrophic lichen planus characteristically exhibits hyperkeratotic, rough lesions on the perineum and perianal region (",
"    <a class=\"graphic graphic_picture graphicRef62561 \" href=\"mobipreview.htm?12/51/13110\">",
"     picture 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/9\">",
"     9",
"    </a>",
"    ]. The appearance is similar to squamous cell carcinoma. This type of lichen planus is rare and can be difficult to diagnose clinically because it resembles other hypertrophic vulvar lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of lichen planus is primarily based upon the presence of characteristic clinical manifestations. A biopsy may be obtained to support the clinical diagnosis; the most developed lesion is chosen for deep shave or punch biopsy. If an ulcerated area is biopsied, it is important to include a small portion of normal epithelium along with the affected tissue. When present, the classic histopathological features of cutaneous LS are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Irregular acanthosis of the epidermis",
"     </li>",
"     <li>",
"      Liquefactive degeneration of the basal cell layer",
"     </li>",
"     <li>",
"      A band&ndash;like dermal infiltrate of lymphocytes in the upper dermis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyperkeratosis is present in areas of keratinized skin (",
"    <a class=\"graphic graphic_picture graphicRef52303 \" href=\"mobipreview.htm?0/58/936\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Because of variability in histological findings, biopsy shows these classic features in only 70 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/8,20\">",
"     8,20",
"    </a>",
"    ]. The typical histopathological features of lichen planus are often not found in mucosal lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/5,9,10,21\">",
"     5,9,10,21",
"    </a>",
"    ]. Tissue biopsies in erosive lichen planus, however, are frequently diagnostic. Immunofluorescence studies may show shaggy staining of the basement membrane zone, suggesting deposition of fibrinogen, IgM, cytoid bodies, and, occasionally, granular IgG or IgA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other inflammatory and erosive diseases of the vulva may mimic lichen planus. Some examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lichen sclerosus",
"      </strong>",
"      also causes architectural distortion and labial adhesions, but does",
"      <strong>",
"       NOT",
"      </strong>",
"      affect the vagina. Erosive lesions due to lichen sclerosus respond to therapy better than those related to lichen planus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=see_link\">",
"       \"Vulvar lichen sclerosus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bullous disease",
"      </strong>",
"      (eg, cicatricial pemphigoid and pemphigus) can have clinical vulvovaginal features identical to lichen planus; immunofluorescence studies on biopsy specimens are necessary to make a definitive diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=see_link\">",
"       \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Plasma cell vulvitis",
"      </strong>",
"      is an uncommon erosive disease that results in tender, velvety, raised erythematous lesions of the vestibule and, rarely, the clitoris; oral and vaginal involvement are unusual [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/24-26\">",
"       24-26",
"      </a>",
"      ]. On histological examination, plasma cells contribute to one-half of the dermal infiltrate.",
"     </li>",
"     <li>",
"      <strong>",
"       Behcet's disease",
"      </strong>",
"      causes recurrent oral and genital ulcerations and ocular inflammation. These three major criteria are often associated with the minor criteria of arthritis, thrombophlebitis, acneiform skin eruptions, ulcerative colitis, and neurologic involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/27\">",
"       27",
"      </a>",
"      ]. Behcet's disease is extremely uncommon in the United States. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Crohn's disease",
"      </strong>",
"      may affect the vulva or perineum; the vulvar manifestations may precede or follow bowel involvement by many years. Vulvar signs of Crohn's disease include edema of the labia majora, labia minora, and prepuce; edematous perianal skin tags; ulcers; fissures; sinuses; and fistulae (",
"      <a class=\"graphic graphic_picture graphicRef73032 \" href=\"mobipreview.htm?29/32/30212\">",
"       picture 5",
"      </a>",
"      ). Vulvar edema may be an isolated and unilateral finding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/43/25273?source=see_link\">",
"       \"Perianal complications of Crohn's disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Erythema multiforme and Stevens-Johnson syndrome",
"      </strong>",
"      produce lesions of the mouth, eye, and genitals consisting of painful, shallow ulcers and bullae of the labia and surrounding skin. The acute onset and systemic symptoms help to differentiate this disorder from lichen planus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of erythema multiforme\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"       \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A",
"      <strong>",
"       lichenoid drug eruption",
"      </strong>",
"      can be indistinguishable clinically and histologically from lichen planus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/29\">",
"       29",
"      </a>",
"      ]. A positive history of medication use and disappearance of skin lesions following withdrawal of the medication suggest this possibility. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link\">",
"       \"Drug eruptions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Desquamative inflammatory vaginitis (DIV)",
"      </strong>",
"      is an intensely inflammatory vaginitis, also called lichenoid vaginitis. The purulent vaginal discharge has an elevated pH and consists of sheets of white blood cells and parabasal cells, indicative of desquamating vaginal epithelium. There may be bacterial overgrowth, except for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/16/32004?source=see_link\">",
"       lactobacillus",
"      </a>",
"      , which is reduced or absent. Whether DIV is a form of lichen planus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/30\">",
"       30",
"      </a>",
"      ] or caused by an unidentified bacterium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/31\">",
"       31",
"      </a>",
"      ] is controversial. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=see_link\">",
"       \"Approach to women with symptoms of vaginitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vulvar lichen planus can also be confused clinically and pathologically with",
"      <strong>",
"       vulvar intraepithelial neoplasia (VIN)",
"      </strong>",
"      , differentiated type [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32952?source=see_link\">",
"       \"Vulvar intraepithelial neoplasia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral and genital lesions of lichen planus, especially erosive disease, are persistent and tend to be resistant to therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/1,33\">",
"     1,33",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Treatment'",
"    </a>",
"    below). In contrast, the natural history of most cases of cutaneous lichen planus elsewhere on the body is spontaneous remission within a couple of years. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link\">",
"     \"Lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Associated malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between lichen planus and squamous cell malignancy is uncertain; the best evidence is for a possible association between oral malignancy and oral lichen planus, which causes chronic inflammation of the oral mucosa. A slightly increased risk of vulvar malignancy in women with vulvar lichen planus has been postulated, but not confirmed in large series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/19,34-40\">",
"     19,34-40",
"    </a>",
"    ]. By comparison, the risk of malignancy associated with lichen sclerosus appears to be 4 to 5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data on which to make evidence-based recommendations for the treatment of lichen planus. Pharmacologic intervention is largely based on personal experience, anecdotal reports, local custom, cost, patient preference, and extrapolation from studies on treatment of nonvulvar lichen planus.",
"   </p>",
"   <p>",
"    Erosive vulvar lichen planus is extremely difficult to treat; no single effective therapy exists at this time. By comparison, hypertrophic and papulosquamous lichen planus respond well to therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/42\">",
"     42",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of all chronic vulvar disorders requires patient education, behavioral modification, support, and medication. General principles of treatment include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An explanation of the chronicity of the disease and the need to continue treatment even after symptoms improve.",
"     </li>",
"     <li>",
"      Emotional support and reassurance that the condition is manageable, despite dyspareunia and anatomical changes.",
"     </li>",
"     <li>",
"      A description of good vulvar hygiene, including cessation of scratching (",
"      <a class=\"graphic graphic_table graphicRef64538 \" href=\"mobipreview.htm?35/49/36635\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Written information sheets.",
"     </li>",
"     <li>",
"      Review of the patient's medications and discontinuation, if possible, of any drugs associated with lichenoid reactions (eg, beta-blockers,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/15/28918?source=see_link\">",
"       methyldopa",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/6/4200?source=see_link\">",
"       penicillamine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      , nonsteroidal antiinflammatory drugs (NSAIDs), angiotensin converting enzyme (ACE) inhibitors, sulfonylurea agents,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      , gold,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      , quinidine,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8263?source=see_link\">",
"       hydrochlorothiazide",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/3\">",
"       3",
"      </a>",
"      ]. Other drugs have been reported in isolated case reports. Hydrochlorothiazide and NSAIDs are common triggers for lichen planus; a three-week trial off these medications will show whether discontinuation is likely to improve symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/48/3848?source=see_link\">",
"       \"Lichenoid drug eruption (drug-induced lichen planus)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Consultation with a clinician experienced in the management of vulvar lichen planus.",
"     </li>",
"     <li>",
"      Medication &ndash; First-line treatment consists of a superpotent topical corticosteroid (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/43\">",
"       43",
"      </a>",
"      ]. Improper application of the topical medication is a common reason for treatment failure. We use a mirror to show the patient the areas of the vulva affected by the disease so she will apply her topical medications appropriately; diagrams and descriptions alone are inadequate, especially in the elderly. We also emphasize that the amount of topical corticosteroid used should be the diameter of a 2 to 3 mm dot. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment of erosive lichen planus'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      During the first week of therapy, we instruct patients to perform a five-minute sitz bath in water at a comfortable temperature immediately prior to the application of the corticosteroid. The corticosteroid then seals in the moisture, hydrating the skin. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment of erosive lichen planus",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Topical corticosteroids",
"      </strong>",
"      &minus; We prescribe a superpotent topical corticosteroid (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/44/9925?source=see_link\">",
"       halobetasol",
"      </a>",
"      propionate 0.05% ointment) nightly (two times per day if disease is severe) (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"       table 3",
"      </a>",
"      ). Therapy is continued for one to two months, and then the patient is reevaluated. If there has been improvement, the corticosteroid is reduced to one to three times weekly to complete a 12-week course of therapy; the lowest frequency that controls symptoms is prescribed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      If the medication is completely discontinued at this point, symptoms of lichen planus often return; therefore, after the initial 12-week course of treatment, we begin maintenance therapy with a midpotency (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/5/44120?source=see_link\">",
"       betamethasone",
"      </a>",
"      valerate 0.1%) or a low potency corticosteroid ointment (eg, 2.5%",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      ) one to three times per week indefinitely; \"trial and error\" is necessary to find the lowest dose and frequency that control symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/19\">",
"       19",
"      </a>",
"      ]. Consultation with a dermatologist is helpful for managing topical corticosteroids. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=see_link\">",
"       \"General principles of dermatologic therapy and topical corticosteroid use\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      If relapse occurs during the initial 12 weeks of therapy or during the maintenance phase, we restart an ultrapotent corticosteroid nightly for one month, then taper to every other night for one month, then taper to three times per week maintenance therapy.",
"     </li>",
"     <li>",
"      <strong>",
"       Topical",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      <strong>",
"      </strong>",
"      &minus; If there is no improvement with topical corticosteroids, our second-line therapy is tacrolimus. Results from small case series suggest that topical tacrolimus can be effective for treatment of vulvovaginal (and oral) lichen planus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/4,20,44-47\">",
"       4,20,44-47",
"      </a>",
"      ]. We prescribe tacrolimus 0.1% ointment. The patient should apply the smallest amount needed to coat the lesion in order to minimize burning and irritation, and then rub it in well. We begin with every other day treatments, gradually working up to twice daily. Daily sitz baths for the first week of therapy can help alleviate burning. To minimize burning, tacrolimus can be applied on top of the corticosteroid ointment or on top of a coat of petroleum jelly. We continue therapy for up to 12 weeks as long as there is continued improvement in symptoms, and then reduce the dose to maintenance therapy: one to three times weekly, as needed to control symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/47\">",
"       47",
"      </a>",
"      ]. Monitoring drug levels is unnecessary with topical therapy.",
"      <br/>",
"      <br/>",
"      In 2006, the US Food and Drug Administration placed a black box warning on the tacrolimus prescribing information because the long-term safety for the topical form had not been established and the systemic form (used to prevent rejection of organ transplants) is associated with development of tumors, especially lymphoma. To date, there is no strong evidence of cancer associated with topically applied tacrolimus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients present with erosive disease that is too severe to allow for the application of topical corticosteroids without the development of an intolerable burning sensation. For these patients, we administer one dose of intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    and begin topical corticosteroid therapy one week later. During the one-week interval prior to the start of topical corticosteroids, we instruct patients to perform twice daily sitz baths in water followed by the application of petroleum jelly in an attempt to help restore the epithelial barrier. A four to six week course of oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (initiated at 40 to 60 mg per day and tapered over four to six weeks) can be utilized as an alternative to the intramuscular triamcinolone injection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Failure of topical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of patients who fail topical therapy, manifested by persistent painful erosions or tender lacy papules and plaques, is largely based on anecdotal evidence. We do the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Check that irritants have been eliminated; consider night-time sedation for ongoing scratching",
"     </li>",
"     <li>",
"      Exclude superinfection with bacteria,",
"      <em>",
"       Candida",
"      </em>",
"      , or herpes simplex virus (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment of concurrent infection'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Treat vulvar pain (neuropathic pain possibly precipitated by lichen planus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/48\">",
"       48",
"      </a>",
"      ]) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=see_link\">",
"       \"Treatment of vulvodynia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Confirm by observation that the patient is applying the topical treatment correctly to the involved area",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to patients who fail local therapy is poorly defined. A variety of systemic immunomodulatory and immunosuppressive agents (eg, systemic glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and others) have been utilized in individual patients, but data are insufficient to confirm efficacy of specific interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/49\">",
"     49",
"    </a>",
"    ]. In our experience, intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    can be useful for managing the minority of patients who fail to improve with the treatments discussed above. We typically administer 60 to 80 mg intramuscularly as a series of four injections separated by one month, while continuing local therapy. Possible side effects include petechiae, purpura, menstrual irregularities, mild transient hyperglycemia (three to five days) localized lipoatrophy, hirsutism (very rare), sterile abscess (very rare), and adrenal suppression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Vaginal involvement",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Topical corticosteroids",
"      </strong>",
"      &minus;",
"      <strong>",
"      </strong>",
"      Corticosteroids are administered vaginally to women with vaginal involvement. In one study, 16 of 17 patients noted improvement with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      25 mg suppositories inserted into the vagina twice daily for two months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/50\">",
"       50",
"      </a>",
"      ]. In another series of 60 patients, 80 percent improved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/51\">",
"       51",
"      </a>",
"      ]. A daily dose of 50 mg hydrocortisone is effective for mild and early disease; however, in more severe cases, we ask the pharmacist to compound 100 mg hydrocortisone suppositories. The regimen we prescribe is one suppository at bedtime for 14 days, then every other night for 14 days.",
"      <br/>",
"      <br/>",
"      If there has been improvement after one month, we reduce the frequency of administration to two times per week and gradually taper to the lowest dose that controls symptoms (eg, hydrocortisone 25 mg once every other week). Concomitant administration of 2%",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/18/33056?source=see_link\">",
"       clotrimazole",
"      </a>",
"      is helpful to prevent candidiasis.",
"      <br/>",
"      <br/>",
"      If there is no improvement after one month, we prescribe hydrocortisone 100 mg nightly for up to three months until symptoms have been controlled, and then taper to maintenance therapy. The hydrocortisone is tapered based on microscopy: as the number of white blood cells per epithelial cell diminishes from sheets too numerous to count to fewer than 10",
"      <span class=\"nowrap\">",
"       WBCs/epithelial",
"      </span>",
"      cell and then to 3 to 4",
"      <span class=\"nowrap\">",
"       WBCs/epithelial",
"      </span>",
"      cell, we taper hydrocortisone administration from nightly to Monday-Wednesday-Friday, and then to once or twice weekly and gradually taper to the lowest dose that controls symptoms.",
"     </li>",
"     <li>",
"      <strong>",
"       Intramuscular",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      <strong>",
"      </strong>",
"      &minus; Patients who fail to respond to a three-month course of topical",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      are switched to triamcinolone 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intramuscularly once per month for four months. If symptoms are controlled, maintenance therapy is initiated: hydrocortisone 100 mg suppository vaginally, two to three times per week, gradually tapered to the lowest dose that controls symptoms.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       Tacrolimus",
"      </a>",
"      <strong>",
"      </strong>",
"      &minus; If the above approaches fail, we ask the pharmacist to compound tacrolimus 1 mg suppositories, which we prescribe nightly for 30 days. If symptoms improve, we reduce the frequency to twice weekly, gradually tapering to the lowest frequency that controls symptoms. If there is no improvement after 30 days, we continue the trial for up to three months. Monitoring drug levels is unnecessary with topical therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Medication that leaks from the vagina may cause vulvar irritation and burning. The vulvar skin can be protected by coating the perivaginal area with petroleum jelly or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/53/15187?source=see_link\">",
"     zinc oxide",
"    </a>",
"    , or a tampon can be cut in half and inserted in the distal vagina as a \"plug\" to control leakage.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Dilators",
"      </strong>",
"      &minus; Dilator therapy (with rigid dilators) can be effective for distending mild to moderate vaginal synechiae that interfere with intromission or speculum insertion. We determine the correct dilator size during an office visit and show the patient how to insert it and then have her demonstrate that she can perform the insertion. Application of topical",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      around the vaginal orifice 15 minutes before insertion and application of corticosteroid cream to the dilator can be helpful. When the patient can comfortably insert the dilator at home, we repeat this process with the next larger size of dilator. We have found sending the patient home with an entire set of dilators and asking her to gradually increase the size herself has not been effective.",
"      <br/>",
"      <br/>",
"      Once satisfactory vaginal dilatation has been achieved, use of a dilator can be continued two to three times weekly to maintain a patent, functional vagina. Women who are able to resume weekly intercourse may be able to stop dilator use.",
"     </li>",
"     <li>",
"      <strong>",
"       Surgery",
"      </strong>",
"      &minus; Severe vaginal synechiae require surgical release. All surgical approaches to vaginal occlusion must be followed by diligent therapy with dilators, topical estrogen, and topical corticosteroids. Isolated vaginal procedures without this follow-up therapy invariably result in recurrent vaginal occlusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment of hypertrophic and papulosquamous lichen planus",
"    </span>",
"    &nbsp;&mdash;&nbsp;These lesions are more responsive to therapy than erosive lichen planus. A two-week course of a moderate or superpotent topical corticosteroid, as described above, usually results in complete remission or significant improvement of the disease.",
"   </p>",
"   <p>",
"    Hyperkeratotic lesions may fail to respond well to topical corticosteroids due to the limited ability of the drugs to penetrate a thickened stratum corneum. We have found intralesional corticosteroid therapy useful for these cases. The procedure is similar to that used for vulvar lichen sclerosus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=see_link&amp;anchor=H15#H15\">",
"     \"Vulvar lichen sclerosus\", section on 'Corticosteroids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Treatment of vulvo-vaginal-gingival syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvovaginal disease is treated as discussed above. Treatment of oral lesions is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26361?source=see_link\">",
"     \"Oral lichen planus: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment of concurrent infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;An associated bacterial or fungal infection should be treated with antibiotics concurrently with corticosteroid therapy. Antibiotic selection should be based upon culture and sensitivity results.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     Erythromycin",
"    </a>",
"    250 mg four times per day for five to seven days or a cephalosporin (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    500 mg orally three times per day for five to seven days) is adequate treatment for most bacterial infections. We prescribe oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    (150 mg every other day for three doses, then 150 mg weekly for three weeks) for vulvar candidiasis to avoid the irritant effects of topical creams.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women report improvement or resolution of symptoms with initial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/4,5,51\">",
"     4,5,51",
"    </a>",
"    ]. Symptomatic improvement corresponds with healing of erosions and reticulation on physical examination, but scarring is not reversible. As an example, a large series in which 89 women with erosive lichen planus of the vulva were treated with 0.05%",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    ointment reported 71 percent had a good response, 24 percent had a partial response, and 5 percent had a poor response to initial treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36952/abstract/5\">",
"     5",
"    </a>",
"    ]. The response rate was similar during maintenance therapy. A reliable estimate of the efficacy of second-line therapies could not be made because each agent was used by only one to seven patients.",
"   </p>",
"   <p>",
"    Burning and itching that persist after therapy and despite the clinical appearance of skin improvement suggest superimposed vulvodynia (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=see_link\">",
"     \"Treatment of vulvodynia\"",
"    </a>",
"    ). Symptoms with characteristic skin changes suggest relapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/28/6594?source=see_link\">",
"       \"Patient information: Lichen planus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lichen planus refers to a relatively uncommon inflammatory dermatologic condition that may be generalized or isolated to the vulva. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The three types of vulvar lichen planus are papulosquamous, hypertrophic, and erosive. Clinical manifestations include irritating vaginal discharge, vulvar soreness, intense pruritus, burning, and dyspareunia. A few patients are asymptomatic or have only minimal symptoms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Erosive lichen planus is the most severe form of vulvar lichen planus and can result in marked architectural destruction, including loss of the labia minora and narrowing of the introitus. The vagina is usually involved, as well. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Erosive lichen planus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of lichen planus is primarily based upon the presence of characteristic clinical manifestations. If there is uncertainty about the diagnosis, however, biopsy should be performed. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of all chronic vulvar disorders requires patient education, behavioral modification, support, and medication. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with erosive vulvar lichen planus, we suggest a superpotent topical corticosteroid for first-line therapy (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"       table 3",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If symptoms do not improve, our second-line therapy is topical",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment of erosive lichen planus'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For women who fail topical therapy, we suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      given intramuscularly (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Failure of topical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with vaginal lichen planus, our first-line therapy is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      suppositories with 2%",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/18/33056?source=see_link\">",
"       clotrimazole",
"      </a>",
"      to prevent candidiasis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If topical corticosteroid therapy fails, we suggest use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      given intramuscularly. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Vaginal involvement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/1\">",
"      Lewis FM, Shah M, Harrington CI. Vulval involvement in lichen planus: a study of 37 women. Br J Dermatol 1996; 135:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/2\">",
"      Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/3\">",
"      Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. Semin Cutan Med Surg 1998; 17:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/4\">",
"      Kennedy CM, Galask RP. Erosive vulvar lichen planus: retrospective review of characteristics and outcomes in 113 patients seen in a vulvar specialty clinic. J Reprod Med 2007; 52:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/5\">",
"      Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol 2006; 142:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/6\">",
"      Cooper SM, Haefner HK, Abrahams-Gessel S, Margesson LJ. Vulvovaginal lichen planus treatment: a survey of current practices. Arch Dermatol 2008; 144:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/7\">",
"      Di Fede O, Belfiore P, Cabibi D, et al. Unexpectedly high frequency of genital involvement in women with clinical and histological features of oral lichen planus. Acta Derm Venereol 2006; 86:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/8\">",
"      Belfiore P, Di Fede O, Cabibi D, et al. Prevalence of vulval lichen planus in a cohort of women with oral lichen planus: an interdisciplinary study. Br J Dermatol 2006; 155:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/9\">",
"      Lewis FM. Vulval lichen planus. Br J Dermatol 1998; 138:569.",
"     </a>",
"    </li>",
"    <li>",
"     Neill SM. Erosive lichen planus:diagnosis and management. Syllabus of the post-graduate course, International Society for the Study of Vulvovaginal Disease, October 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/11\">",
"      Pecoraro V, Romano Boix E. [Anal manifestations of lichen planus]. Med Cutan Ibero Lat Am 1984; 12:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/12\">",
"      Ridley CM. Chronic erosive vulval disease. Clin Exp Dermatol 1990; 15:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/13\">",
"      Eisen D. The vulvovaginal-gingival syndrome of lichen planus. The clinical characteristics of 22 patients. Arch Dermatol 1994; 130:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/14\">",
"      Pelisse M. Erosive vulvar lichen planus and desquamative vaginitis. Semin Dermatol 1996; 15:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/15\">",
"      Pelisse M, Leibowitch M, Sedel D, Hewitt J. [A new vulvovaginogingival syndrome. Plurimucous erosive lichen planus]. Ann Dermatol Venereol 1982; 109:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/16\">",
"      Pelisse M. The vulvo-vaginal-gingival syndrome. A new form of erosive lichen planus. Int J Dermatol 1989; 28:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/17\">",
"      Rogers RS 3rd, Eisen D. Erosive oral lichen planus with genital lesions: the vulvovaginal-gingival syndrome and the peno-gingival syndrome. Dermatol Clin 2003; 21:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/18\">",
"      Setterfield JF, Neill S, Shirlaw PJ, et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006; 55:98.",
"     </a>",
"    </li>",
"    <li>",
"     Ridley CM, Neill SM. Non-infective cutaneous conditions of the vulva. In: The Vulva, Ridley CM, Neill SM (Eds), Blackwell Science, Oxford 1999. p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/20\">",
"      Byrd JA, Davis MD, Rogers RS 3rd. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol 2004; 140:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/21\">",
"      Zellis S, Pincus SH. Treatment of vulvar dermatoses. Semin Dermatol 1996; 15:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/22\">",
"      Helander SD, Rogers RS 3rd. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 1994; 30:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/23\">",
"      Murphy GM, Cronin E. Lichen planus pemphigoides. Clin Exp Dermatol 1989; 14:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/24\">",
"      Woodruff JD, Sussman J, Shakfeh S. Vulvitis circumscripta plasmocellularis. A report of four cases. J Reprod Med 1989; 34:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/25\">",
"      Davis J, Shapiro L, Baral J. Vulvitis circumscripta plasmacellularis. J Am Acad Dermatol 1983; 8:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/26\">",
"      Virgili A, Levratti A, Marzola A, Corazza M. Retrospective histopathologic reevaluation of 18 cases of plasma cell vulvitis. J Reprod Med 2005; 50:3.",
"     </a>",
"    </li>",
"    <li>",
"     Friedrich EG. Vulvar disease, WB Saunders, Philadelphia 1983. p.174.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/28\">",
"      Martin J, Holdstock G. Isolated vulval oedema as a feature of Crohn's disease. J Obstet Gynaecol 1997; 17:92.",
"     </a>",
"    </li>",
"    <li>",
"     Ridley CM, Neill SM. Genital Dermatology, Edwards L (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.14.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/30\">",
"      Edwards L. Vulvar lichen planus. Arch Dermatol 1989; 125:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/31\">",
"      Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994; 171:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/32\">",
"      Neill SM, Lewis FM. Vulvovaginal lichen planus: a disease in need of a unified approach. Arch Dermatol 2008; 144:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/33\">",
"      Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/34\">",
"      J&auml;nner M, Muissus E, Rohde B. [Lichen planus as a possible precancerous condition]. Dermatol Wochenschr 1967; 153:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/35\">",
"      Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/36\">",
"      Lewis FM, Harrington CI. Squamous cell carcinoma arising in vulval lichen planus. Br J Dermatol 1994; 131:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/37\">",
"      Dwyer CM, Kerr RE, Millan DW. Squamous carcinoma following lichen planus of the vulva. Clin Exp Dermatol 1995; 20:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/38\">",
"      Zaki I, Dalziel KL, Solomonsz FA, Stevens A. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exp Dermatol 1996; 21:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/39\">",
"      Kennedy CM, Peterson LB, Galask RP. Erosive vulvar lichen planus: a cohort at risk for cancer? J Reprod Med 2008; 53:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/40\">",
"      Simpson RC, Murphy R. Is vulval erosive lichen planus a premalignant condition? Arch Dermatol 2012; 148:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/41\">",
"      Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/42\">",
"      Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician 2011; 84:53.",
"     </a>",
"    </li>",
"    <li>",
"     Edwards L. Erosive and vesiculobullous diseases. In: Genital Dermatology Atlas, 2nd ed, Edwards L, Lynch PJ.  (Eds), Wolters Kluwer, Philadelphia 2011. p.125.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/44\">",
"      Kirtschig G, Van Der Meulen AJ, Ion Lipan JW, Stoof TJ. Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. Br J Dermatol 2002; 147:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/45\">",
"      Lener EV, Brieva J, Schachter M, et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001; 137:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/46\">",
"      Lotery HE, Galask RP. Erosive lichen planus of the vulva and vagina. Obstet Gynecol 2003; 101:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/47\">",
"      Jensen JT, Bird M, Leclair CM. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study. Am J Obstet Gynecol 2004; 190:1759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/48\">",
"      Bowen AR, Vester A, Marsden L, et al. The role of vulvar skin biopsy in the evaluation of chronic vulvar pain. Am J Obstet Gynecol 2008; 199:467.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/49\">",
"      Simpson RC, Littlewood SM, Cooper SM, et al. Real-life experience of managing vulval erosive lichen planus: a case-based review and U.K. multicentre case note audit. Br J Dermatol 2012; 167:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/50\">",
"      Mann MS, Kaufman RH. Erosive lichen planus of the vulva. Clin Obstet Gynecol 1991; 34:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36952/abstract/51\">",
"      Anderson M, Kutzner S, Kaufman RH. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories. Obstet Gynecol 2002; 100:359.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5557 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-77B11294E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36952=[""].join("\n");
var outline_f36_5_36952=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20848790\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20848761\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Erosive lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Papulosquamous lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypertrophic lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Associated malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment of erosive lichen planus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Failure of topical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Vaginal involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment of hypertrophic and papulosquamous lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Treatment of vulvo-vaginal-gingival syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment of concurrent infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5557\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5557|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/37/40530\" title=\"picture 1\">",
"      Erosive lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/43/39602\" title=\"picture 2\">",
"      Lichen planus gingivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/51/13110\" title=\"picture 3\">",
"      Hypertrophic lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/58/936\" title=\"picture 4\">",
"      Lichen planus hyperkeratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/32/30212\" title=\"picture 5\">",
"      Crohns disease of vulva",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5557|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/25/5532\" title=\"table 1\">",
"      Diagnosis of vulvar pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/49/36635\" title=\"table 2\">",
"      Healthy vulval hygiene practice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/56/39809\" title=\"table 3\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=related_link\">",
"      Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/48/3848?source=related_link\">",
"      Lichenoid drug eruption (drug-induced lichen planus)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26361?source=related_link\">",
"      Oral lichen planus: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/28/6594?source=related_link\">",
"      Patient information: Lichen planus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/43/25273?source=related_link\">",
"      Perianal complications of Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16249?source=related_link\">",
"      Treatment of vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32952?source=related_link\">",
"      Vulvar intraepithelial neoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=related_link\">",
"      Vulvar lichen sclerosus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_5_36953="Pathogenesis of dengue virus infection";
var content_f36_5_36953=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of dengue virus infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Alan L Rothman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/5/36953/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/5/36953/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substantial gaps remain in the basic understanding of the pathogenesis of dengue disease. In large part, this limitation is related to the lack of a suitable animal model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/1\">",
"     1",
"    </a>",
"    ]. Rhesus monkeys develop viremia similar in pattern to humans after dengue virus challenge but do not develop clinical disease. Careful epidemiologic and experimental challenge studies in humans have provided valuable information on dengue virus infection, but detailed data on virus distribution in vivo are available only from small numbers of patients with more severe disease, unusual manifestations, or the later stages of infection. Little pathogenetic information is available concerning milder infections, which constitute the vast majority of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE DENGUE VIRAL REPLICATION CYCLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dengue viruses are members of the family Flaviviridae genus Flavivirus. They are small enveloped viruses containing a single-strand RNA genome of positive polarity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/2\">",
"     2",
"    </a>",
"    ]. Dengue viruses infect a wide range of human and nonhuman cell types in vitro. Viral replication involves the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Attachment to the cell surface",
"     </li>",
"     <li>",
"      Entry into the cytoplasm",
"     </li>",
"     <li>",
"      Translation of viral proteins",
"     </li>",
"     <li>",
"      Replication of the viral RNA genome",
"     </li>",
"     <li>",
"      Formation of virions (encapsidation)",
"     </li>",
"     <li>",
"      Release from the cell",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Binding of dengue virions to cells, which is mediated by the major viral envelope (E) glycoprotein, is critical for infectivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/3\">",
"     3",
"    </a>",
"    ]. The determination of the three-dimensional structures of the dengue E glycoprotein and the intact virion has facilitated the understanding of this process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Dengue viruses bind via the E glycoprotein to viral receptors on the cell surface, which may include heparan sulfate or the lectin DC-SIGN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]; they can also bind to cell surface immunoglobulin receptors in the presence of antibodies to the E glycoprotein or membrane precursor (pre-M) protein, as described further below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following fusion of viral and cell membranes in acidified endocytic vesicles, the viral RNA enters the cytoplasm. The viral proteins are then translated directly from the viral RNA as a single polyprotein, which is cleaved to yield the three structural and seven nonstructural proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/2\">",
"     2",
"    </a>",
"    ]. Cleavage of several of the viral proteins requires a functional viral protease encoded in the nonstructural protein NS3. The nonstructural protein NS5 is the viral RNA-dependent RNA polymerase, which assembles with several other viral proteins and several host proteins to form the replication complex. This complex transcribes the viral RNA to produce negative-strand viral RNA, which serves as the template for the production of the viral genomic RNA.",
"   </p>",
"   <p>",
"    The assembly and budding of progeny virions is still poorly understood. The pre-M structural protein is cleaved by a cellular enzyme, furin, as one of the final steps in maturation of progeny virions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/10\">",
"     10",
"    </a>",
"    ]. Cleavage of the pre-M protein enhances the infectivity of the virions 100-fold.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW OF THE COURSE OF INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course of dengue virus infection is characterized by early events, dissemination, and the immune response and subsequent viral clearance (",
"    <a class=\"graphic graphic_figure graphicRef63173 \" href=\"mobipreview.htm?28/15/28927\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Early events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dengue virus is introduced into the skin by the bite of an infected mosquito, most commonly Aedes aegypti. The spread of virus early after subcutaneous injection has been studied in rhesus monkeys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/11\">",
"     11",
"    </a>",
"    ]. During the first 24 hours, virus could only be isolated from the injection site. The major cell type infected was not defined; both Langerhans cells and dermal fibroblasts have been proposed to be target cells for dengue virus infection in the skin. One study using human skin dendritic cells demonstrated expression of dengue virus antigens following in vitro exposure, suggesting that these cells are permissive for dengue viral infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/12\">",
"     12",
"    </a>",
"    ]. In rhesus monkeys, virus was detected in regional lymph nodes 24 hours after infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/11\">",
"     11",
"    </a>",
"    ]. In one study using a mouse model deficient in both type I and type II interferon receptors, macrophages and dendritic cells were demonstrated to be early cellular targets for infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Dissemination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viremia begins in rhesus monkeys between two and six days after subcutaneous injection and lasts for three to six days. In humans infected with \"natural\" dengue viruses, viremia begins approximately one day later than in monkeys, but the duration of viremia is similar [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/14\">",
"     14",
"    </a>",
"    ]. Viremia is detectable in humans 6 to 18 hours before the onset of symptoms, and ends as the fever resolves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In rhesus monkeys during the period of viremia, virus was frequently detected in lymph nodes distant from the site of inoculation and less commonly from spleen, thymus, lung, and bone marrow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/11\">",
"     11",
"    </a>",
"    ]. Virus was also isolated from peripheral blood leukocytes at the end of the viremic period and sometimes for one day after.",
"   </p>",
"   <p>",
"    The distribution of virus in humans has been studied in blood, biopsy, and autopsy specimens from patients with natural dengue virus infection. Infection of peripheral blood mononuclear cells persists beyond the period of detectable viremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Conflicting data have been published regarding the principal infected cell type in the peripheral blood. An older study reported more frequent isolation of infectious virus from the adherent cell population than the nonadherent population, suggesting that monocytes are the primary target cell for infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/16\">",
"     16",
"    </a>",
"    ]. A similar conclusion was reached in a study using flow cytometry, which reported the detection of dengue viral antigen in a very high percentage of circulating monocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/18\">",
"     18",
"    </a>",
"    ]. However, an earlier study using flow cytometry reported that the majority of cell-associated virus was contained in the CD20+ (B lymphocyte) fraction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The yield of dengue virus from tissues obtained at autopsy has generally been low. However, in one study using the most sensitive techniques for virus isolation, virus was isolated most often (4 of 16 cases) from liver tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/19\">",
"     19",
"    </a>",
"    ]. Antigen staining has suggested that the predominant cell types infected are macrophages in the skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/20\">",
"     20",
"    </a>",
"    ] and Kupffer cells in the liver [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]; dengue viral antigens have also been detected in hepatocytes in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Immune responses and viral clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both innate and adaptive immune responses induced by dengue virus infection are likely to play a role in the clearance of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/24\">",
"     24",
"    </a>",
"    ]. Infection of fibroblasts and monocytes in vitro induces production of interferon beta and alpha, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Consistent with these observations, elevated serum levels of interferon alpha have been demonstrated in children with dengue virus infection in Thailand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of these cytokine responses is uncertain. Interferon inhibits dengue virus infection in monocytes in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition, dengue virus-infected cells are susceptible to lysis by natural killer cells in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/28\">",
"     28",
"    </a>",
"    ]. However, dengue viral proteins are able to block the antiviral function of type 1 interferons in infected cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In one study of host cell gene expression by microarray analysis of blood samples obtained from 14 adults with dengue, a cluster of 24 gene transcripts, many reflecting type I interferon signaling, was identified as significantly less abundant in the six patients with DSS than in the eight patients without DSS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/31\">",
"     31",
"    </a>",
"    ]. These subjects had low to undetectable plasma viral RNA and IFN-alpha levels when studied. Whether attenuated interferon responses are the result, or cause, of severe dengue disease is unknown.",
"   </p>",
"   <p>",
"    The antibody response to dengue virus infection is primarily directed at serotype-specific determinants, but there is a substantial level of serotype-crossreactive antibodies. E, pre-M, and NS1 are the principal viral proteins that are targeted. In vitro, E protein-specific antibodies can mediate neutralization of infection, direct complement-mediated lysis or antibody-dependent cellular cytotoxicity of dengue virus-infected cells, and block virus attachment to cell receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/28,32,33\">",
"     28,32,33",
"    </a>",
"    ]. Pre-M-specific antibodies only bind to virions that have not fully matured and have remaining uncleaved pre-M protein. NS1 is not found in the virion; NS1-specific antibodies are therefore incapable of neutralization of virus infection, but can direct complement-mediated lysis of infected cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/32\">",
"     32",
"    </a>",
"    ]. In mice, passive transfer of antibodies specific for E, pre-M, or NS1 was sufficient for protection against lethal dengue virus infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/32,34,35\">",
"     32,34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The basis of neutralization of virus by antibody is not well understood. Neutralization clearly requires a threshold level of antibodies; when the concentration of antibodies is below this threshold, the uptake of antibody-bound virus by cells that express immunoglobulin receptors is paradoxically increased, a process termed antibody-dependent enhancement (ADE) of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/9,36\">",
"     9,36",
"    </a>",
"    ]. Since monocytes, the putative cellular targets of dengue virus infection in vivo, express immunoglobulin receptors and manifest ADE in vitro, this phenomenon is thought to be highly relevant in natural dengue virus infections (see below). In rhesus monkeys, passive transfer of low levels of dengue-immune human sera or a humanized chimpanzee dengue virus-specific monoclonal antibody resulted in a two- to 100-fold increase in dengue-2 or dengue-4 viremia titers as compared to control animals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. An increase in viral titers in blood and tissues and enhanced disease were also observed after passive transfer of low levels of dengue virus-specific antibody in mice lacking interferon receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One recent study characterized 301 human dengue virus-specific monoclonal antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/40\">",
"     40",
"    </a>",
"    ]. Pre-M-specific antibodies represented a larger fraction of the monoclonal antibodies detected than antibodies directed at E or NS1. Pre-M-specific antibodies showed poor neutralization of infection in vitro, but could mediate ADE.",
"   </p>",
"   <p>",
"    The T lymphocyte response to dengue virus infection also includes both serotype-specific and serotype-crossreactive responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/41\">",
"     41",
"    </a>",
"    ]. Dengue virus-specific CD4+ and CD8+ T cells can lyse dengue virus-infected cells in vitro and produce cytokines such as interferon gamma, tumor necrosis factor alpha, and lymphotoxin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In vitro, interferon gamma can inhibit dengue virus infection of monocytes. However, interferon gamma also enhances the expression of immunoglobulin receptors, which can augment the antibody-dependent enhancement of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Primary versus secondary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with one of the four serotypes of dengue virus (primary infection) provides life-long immunity to infection with a virus of the same (homologous) serotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/14\">",
"     14",
"    </a>",
"    ]. However, immunity to the other (heterologous) dengue serotypes is transient, and individuals can subsequently be infected with another dengue serotype (secondary infection).",
"   </p>",
"   <p>",
"    In one report, the distribution of dengue virus in secondary infections was evaluated in eight rhesus monkeys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/11\">",
"     11",
"    </a>",
"    ]. The onset and duration of viremia were similar to primary infections. Autopsy specimens from six monkeys yielded virus somewhat more frequently from various tissues than specimens from primary infections. Another study found higher plasma virus titers in secondary than primary dengue 2 virus infections, but not in secondary infections with dengue viruses of the other serotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is little information from human studies to allow comparisons of virus distribution or titer in primary and secondary infections. Several studies have reported that higher peak plasma virus titers in secondary dengue infections were associated with more severe illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. However, other studies have not found higher viremia titers in patients with secondary dengue infections than in patients with primary dengue infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The kinetics of dengue virus-specific antibodies in secondary dengue infections differ from those of primary dengue infections in several ways.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low concentrations of antibodies to the virus serotype causing the secondary infection are present before exposure to the virus. As a result, antibody-dependent enhancement of infection (see above) could occur early in secondary dengue virus infections.",
"     </li>",
"     <li>",
"      Concentrations of dengue virus-specific antibodies increase earlier in secondary infection, reach higher peak titers, and have a lower IgM:IgG ratio, suggestive of an anamnestic response. Thus, the levels of dengue virus-specific antibodies are much higher during the late stage of viremia in secondary infections, with greater potential for forming immune complexes of dengue virions and activating complement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The kinetics of the T lymphocyte response in secondary infections also differ from those of primary infections. The frequency of dengue virus-specific T lymphocytes is much higher prior to secondary infection than primary infection. Furthermore, these memory T cells respond much more rapidly after contact with antigen-presenting cells than na&iuml;ve T cells. As a result, dengue virus-specific T lymphocyte proliferation and cytokine production would be expected to occur earlier and reach higher levels in secondary infections. Studies of circulating T lymphocytes during acute secondary infections have shown a high percentage of cells expressing markers of activation and high frequencies of dengue antigen-specific cells, consistent with this hypothesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/50-53\">",
"     50-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The severity of dengue disease has been correlated with both the level and quality of the dengue virus-specific T lymphocyte responses. In two studies, the frequency of dengue virus-specific CD8+ T cells was higher after dengue hemorrhagic fever (DHF) than after dengue fever (DF) among subjects experiencing secondary infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. One study using HLA-peptide tetramers found that a high proportion of the dengue virus-specific CD8+ T lymphocytes had higher affinity for dengue viral serotypes other than the infecting serotype; a very high percentage of the tetramer-positive cells were apparently primed to undergo apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/51\">",
"     51",
"    </a>",
"    ]. However, in a recent study, dengue virus-specific CD8+ T cells were not detected by HLA-peptide tetramer staining until after the development of plasma leakage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some serotype cross-reactive T cells present after primary infection display qualitatively altered functional responses to other dengue serotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/55\">",
"     55",
"    </a>",
"    ]. In one prospective cohort study, specific T cell responses prior to secondary dengue virus infection were associated with the subsequent occurrence of DHF, such as production of TNF-alpha in response to stimulation with dengue antigens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FACTORS INFLUENCING DISEASE SEVERITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most dengue virus infections produce mild, nonspecific symptoms or classic dengue fever (DF). The more severe manifestations, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), occur in less than 1 percent of dengue virus infections. Thus, considerable attention has been focused upon understanding the risk factors for DHF (",
"    <a class=\"graphic graphic_table graphicRef58587 \" href=\"mobipreview.htm?19/1/19483\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Viral factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although DHF can occur during infection with any of the four dengue serotypes, several prospective studies have suggested that the risk is highest with dengue 2 viruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/15,57-59\">",
"     15,57-59",
"    </a>",
"    ]. Genetic analyses of dengue virus isolates from the Western hemisphere strongly suggest that DHF only occurs during infection with viruses that fall into specific genotypes within each dengue serotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. These \"virulent\" genotypes were originally detected in Southeast Asia, but are now widespread. Several studies have suggested that \"virulent\" and \"avirulent\" genotypes differ in their ability to replicate in monocytic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/62,63\">",
"     62,63",
"    </a>",
"    ], but it is not clear that this difference in in vitro replication is the factor responsible for virulence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prior dengue exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies have shown that the risk of severe disease",
"    <span class=\"nowrap\">",
"     (DHF/DSS)",
"    </span>",
"    is significantly higher during a secondary dengue virus infection than during a primary infection. This relationship can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An outbreak of dengue 2 virus infections in Cuba in 1981 followed an outbreak of dengue 1 virus infections in 1977 that involved 45 percent of the island's population; 98 percent of cases of",
"      <span class=\"nowrap\">",
"       DHF/DSS",
"      </span>",
"      in children and adults were associated with secondary infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/64,65\">",
"       64,65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective study in Bangkok in 1980, hospitalization for DHF was required in none of 47 children with primary infections compared to 7 of 56 with secondary infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective study in Myanmar from 1984 to 1988 found a relative risk of DSS in secondary infections of 82 to 103 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The increased risk of DHF in secondary dengue virus infections is felt to reflect the differences in immune responses between primary and secondary dengue virus infections described above: antibody-dependent enhancement of infection; enhanced immune complex formation;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    accelerated T lymphocyte responses.",
"   </p>",
"   <p>",
"    The increased risk for DHF associated with secondary dengue virus infections appears not to apply to infections with \"avirulent\" genotypes (see above). A prospective study in Iquitos, Peru found no cases of DHF or DSS during an outbreak of dengue 2 virus infections that was estimated to involve over 49,000 secondary infections in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/61\">",
"     61",
"    </a>",
"    ]. At least 880 cases of DHF would have been expected based upon previous studies in Thailand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Furthermore, there are numerous documented cases of dengue hemorrhagic fever occurring during primary infection, suggesting that differences in viral virulence, as discussed above, are also important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/1,15\">",
"     1,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk for DHF appears to decline with age, especially after age 11 years. During the 1981 epidemic of DHF in Cuba, the modal age of DHF cases and deaths was four years, although the frequency of secondary dengue 2 infections was similar in those 4 to 40 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A specific population at higher risk for DHF in endemic areas is infants, particularly those between 6 and 12 months of age. These children acquire dengue virus-specific antibodies transplacentally, and become susceptible to primary dengue virus infection when antibody levels decline below the neutralization threshold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. This observation is taken to support the hypothesis of antibody-dependent enhancement of infection as a primary factor in determining the risk for DHF. A direct correlation between ADE activity of pre-infection serum and the severity of infection has not been demonstrated, however [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Nutritional status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike other infectious diseases,",
"    <span class=\"nowrap\">",
"     DHF/DSS",
"    </span>",
"    is less common in malnourished children than in well-nourished children. As an example, malnutrition, as determined by weight for age, was noted in 13 percent of 100 Thai children with DHF compared to 33 percent of 184 healthy Thai children and 71 percent of 125 Thai children with other infectious diseases admitted to the same hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/72\">",
"     72",
"    </a>",
"    ]. This negative association may be related to suppression of cellular immunity in malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies in Cuba showed that DHF occurred more often in whites than in blacks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/68\">",
"     68",
"    </a>",
"    ], and a similar genetic resistance to DHF in blacks has been reported from Haiti [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/73\">",
"     73",
"    </a>",
"    ]. Racial differences have been described in viral replication in primary monocytes and in the level of dengue serotype-cross-reactive T cell responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/74\">",
"     74",
"    </a>",
"    ], but it is unclear if either of these explains the genetic association.",
"   </p>",
"   <p>",
"    DHF has been associated with specific HLA genes in studies from Thailand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/75,76\">",
"     75,76",
"    </a>",
"    ], Cuba [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/77\">",
"     77",
"    </a>",
"    ], and Vietnam [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/78\">",
"     78",
"    </a>",
"    ]. Other genetic factors that may be associated with varying degrees of susceptibility to DHF include receptor polymorphisms of TNF-alpha, vitamin D, Fc gamma IIa, blood group type, and DC-SIGN genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/79-82\">",
"     79-82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGIC BASIS OF SPECIFIC DISEASE MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Capillary leak syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma leakage, due to an increase in capillary permeability, is a cardinal feature of dengue hemorrhagic fever (DHF) but is absent in dengue fever (DF). The enhanced capillary permeability appears to be due to endothelial cell dysfunction rather than injury, as electron microscopy demonstrated a widening of the endothelial tight junctions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/83\">",
"     83",
"    </a>",
"    ]. Dengue virus infects human endothelial cells in vitro and causes cellular activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/84\">",
"     84",
"    </a>",
"    ]. Additionally, soluble NS1 protein, which can be detected in the serum during acute infection, has been reported to bind to endothelial cells and may serve as a target for antibody binding and complement activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/85\">",
"     85",
"    </a>",
"    ]. However, the effects on endothelial cell function during infection are most likely to be indirectly caused by dengue virus infection for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histologic studies show little structural damage to capillaries [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/86\">",
"       86",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infection of endothelial cells by dengue virus is not apparent in tissues obtained at autopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased capillary permeability is transient, with rapid resolution and no residual pathology.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most investigations have focused on the hypothesis that circulating factors induce the transient increase in capillary permeability. Multiple mediators are likely to be involved in vivo, and interactions between these different factors have been demonstrated in experimental animals. The most important mediators are thought to include tumor necrosis factor (TNF)-alpha (released from virus-infected monocytes and activated T cells), interferon-gamma and interleukin (IL)-2 (released from activated T cells), IL-8 (produced by virus-infected cells), vascular endothelial growth factor (VEGF, potentially produced by monocytes and endothelial cells), and complement (activated by virus-antibody complexes) (",
"    <a class=\"graphic graphic_figure graphicRef75407 \" href=\"mobipreview.htm?25/55/26482\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Dengue virus-infected monocytic cells produce TNF-alpha and IL-8, and these affect endothelial cell permeability in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]. Elevated serum levels of TNF-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/90,91\">",
"     90,91",
"    </a>",
"    ], IL-8 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/92\">",
"     92",
"    </a>",
"    ], IFN-gamma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93,94\">",
"     93,94",
"    </a>",
"    ], IL-2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93\">",
"     93",
"    </a>",
"    ], and free VEGF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/84\">",
"     84",
"    </a>",
"    ] have also been observed in patients with DHF. Other studies from Thailand have found reduced serum levels of the complement proteins C3 and C5 in children with DHF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/95\">",
"     95",
"    </a>",
"    ], with a corresponding increase in the serum concentrations of anaphylatoxins C3a and C5a [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is difficult to detect elevated cytokine levels in the circulation, because of the short half-life of these molecules. Analysis of more stable markers of immune activation has provided additional, although indirect, support for the immunopathogenesis model of plasma leakage. Several studies have shown that children with DHF have elevated circulating levels of the soluble forms of CD8 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93,94\">",
"     93,94",
"    </a>",
"    ], CD4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93\">",
"     93",
"    </a>",
"    ], IL-2 receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93,94\">",
"     93,94",
"    </a>",
"    ], and TNF receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/91,94,97\">",
"     91,94,97",
"    </a>",
"    ]. Increased plasma concentrations of soluble TNF receptor II were found to correlate with the subsequent development of shock in Vietnamese children with DHF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/91\">",
"     91",
"    </a>",
"    ], and with the magnitude of plasma leakage into the pleural space. The intensity of the immune response may ultimately be determined by the level of viral replication, however, as one study found that the plasma viremia titer was the strongest independent factor that correlated with plasma leakage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Blood and bone marrow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukopenia, thrombocytopenia, and a hemorrhagic diathesis are the typical hematologic findings in dengue virus infections. Leukopenia is apparent early in illness, and is of similar degree in DHF and dengue fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/98\">",
"     98",
"    </a>",
"    ]. It is thought to represent a direct effect of dengue virus on the bone marrow. Bone marrow biopsies of children in Thailand with DHF revealed suppression of hematopoiesis early in the illness, with marrow recovery and hypercellularity in the late stage and during early clinical recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/99\">",
"     99",
"    </a>",
"    ]. In vitro studies have shown that dengue virus infects human bone marrow stromal cells and hematopoietic progenitor cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/100,101\">",
"     100,101",
"    </a>",
"    ] and inhibits progenitor cell growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some degree of thrombocytopenia is common in both dengue fever and DHF, but marked thrombocytopenia (&lt;100,000",
"    <span class=\"nowrap\">",
"     platelets/mm3)",
"    </span>",
"    is one of the criteria used to define DHF. Multiple factors are thought to contribute to the fall in platelet count, which is most severe late in the illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/98\">",
"     98",
"    </a>",
"    ]. Bone marrow suppression may play a role, but platelet destruction is probably more important. In one study, 10 of 11 Thai children with DHF had a shortened platelet survival time, ranging from 6.5 to 53 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/103\">",
"     103",
"    </a>",
"    ]. Adsorption of dengue virions or virus-antibody immune complexes to the platelet surface, with subsequent activation of complement, are thought to be responsible for the platelet destruction.",
"   </p>",
"   <p>",
"    Manifestations of the hemorrhagic diathesis in dengue virus infections range from a positive tourniquet test to life-threatening hemorrhage. Fatal DHF may be associated with diffuse petechial hemorrhages involving the stomach, skin, heart, intestine, and lungs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/86\">",
"     86",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18985?source=see_link\">",
"     \"Clinical presentation and diagnosis of dengue virus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the nomenclature, however, the occurrence of hemorrhage does not define DHF as compared to dengue fever since a positive tourniquet test may occur with equal frequency in the two disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/98\">",
"     98",
"    </a>",
"    ]. Several different mechanisms, possibly acting synergistically, contribute to bleeding tendency of dengue virus infections. Both the vasculopathy and thrombocytopenia described above create a predisposition to bleeding.",
"   </p>",
"   <p>",
"    Endothelial cell activation and injury and activation of coagulation and fibrinolysis have been reported in dengue, particularly in severe infections. Abnormalities that have been described include increased numbers of circulating endothelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/104\">",
"     104",
"    </a>",
"    ], elevated levels of von Willebrand factor, tissue factor, tissue plasminogen activator, and platelet activator inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/105\">",
"     105",
"    </a>",
"    ], and an increased fractional catabolic rate of fibrinogen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/106\">",
"     106",
"    </a>",
"    ]. However, most of these findings are based on small studies and comparison with non-dengue controls. Frank coagulopathy is uncommon except in patients with shock.",
"   </p>",
"   <p>",
"    A final etiologic factor may be molecular mimicry between dengue viral proteins and coagulation factors. One study of 88 Tahitian children with dengue virus infection found that antibody responses to homologous peptides derived from the dengue virus E protein crossreacted with plasminogen; these antibodies correlated with the occurrence of hemorrhagic signs (including petechiae) but not with thrombocytopenia or shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/107\">",
"     107",
"    </a>",
"    ]. Another study reported that monoclonal antibodies directed at the dengue virus NS1 protein bound in vitro to human fibrinogen, platelets, and endothelial cells, and induced hemorrhage in mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Liver",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations of serum aminotransferases that are usually mild are common in dengue virus infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/98\">",
"     98",
"    </a>",
"    ]. Typical pathologic findings in the livers of fatal cases of dengue include hepatocellular necrosis and Councilman bodies with relatively little inflammatory cell infiltration, similar to the findings in early yellow fever virus infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/86\">",
"     86",
"    </a>",
"    ]. The pathologic similarities between these two diseases and the relatively frequent isolation of dengue virus from liver tissues of fatal cases suggest that liver injury is directly mediated by dengue virus infection of hepatocytes and Kupffer cells. Dengue virus has been shown to infect and induce apoptosis in a human hepatoma cell line in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/109\">",
"     109",
"    </a>",
"    ]. However, immune-mediated hepatocyte injury, for example, bystander destruction of uninfected hepatocytes by activated CD4+ T lymphocytes, is a potential alternative mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare cases of encephalopathy have been attributed to dengue virus infections. True encephalitis has been reported, with detection of dengue virus in brain tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/110,111\">",
"     110,111",
"    </a>",
"    ], but this is clearly the exception in humans, whereas encephalitis is the only disease caused by dengue viruses in mice. In one series of 100 fatal cases of dengue, no evidence of central nervous system inflammation was found [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/27/16818?source=see_link\">",
"       \"Patient information: Dengue fever (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2847719\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dengue viruses are small enveloped viruses that are members of the family Flaviviridae genus Flavivirus. Viral replication involves the following steps: attachment to the cell surface, cellular entry, translation of viral proteins, replication of the viral RNA genome, formation of virions by encapsidation, and cellular release. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'The dengue viral replication cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dengue virus is introduced into the skin by the bite of an infected mosquito, most commonly Aedes aegypti. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Early events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viremia is detectable in humans 6 to 18 hours before the onset of symptoms, and ends as the fever resolves. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Dissemination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both innate and adaptive immune responses induced by dengue virus infection are likely to play a role in the clearance of infection. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Immune responses and viral clearance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection with one of the four serotypes of dengue virus (primary infection) provides life-long immunity to infection with a virus of the same (homologous) serotype [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/5/36953/abstract/14\">",
"       14",
"      </a>",
"      ]. However, immunity to the other (heterologous) dengue serotypes is transient, and individuals can subsequently be infected with another dengue serotype (secondary infection). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Primary versus secondary infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibodies to proteins on the dengue virus surface can cause increased infection of cells bearing immunoglobulin receptors, a phenomenon known as antibody-dependent enhancement of infection (ADE). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Immune responses and viral clearance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The severity of dengue disease has been correlated with both the level and quality of the dengue virus-specific T lymphocyte responses. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Primary versus secondary infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although dengue hemorrhagic fever (DHF) can occur during infection with any of the four dengue serotypes, several prospective studies have suggested that the risk is highest with dengue 2 viruses. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Factors influencing disease severity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epidemiologic studies have shown that the risk of severe disease is significantly higher during a secondary dengue virus infection than during a primary infection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Prior dengue exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk for DHF appears to decline with age, especially after age 11 years. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Age'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plasma leakage, due to an increase in capillary permeability, is a cardinal feature of DHF, but is absent in dengue fever (DF). The enhanced capillary permeability appears to be due to endothelial cell dysfunction rather than injury. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Pathophysiologic basis of specific disease manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/1\">",
"      Rico-Hesse R. Dengue virus evolution and virulence models. Clin Infect Dis 2007; 44:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/2\">",
"      Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/3\">",
"      Anderson R, King AD, Innis BL. Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol 1992; 73 ( Pt 8):2155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/4\">",
"      Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 2003; 100:6986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/5\">",
"      Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004; 427:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/6\">",
"      Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005; 3:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/7\">",
"      Chen Y, Maguire T, Hileman RE, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997; 3:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/8\">",
"      Tassaneetrithep B, Burgess TH, Granelli-Piperno A, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/9\">",
"      Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994; 19:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/10\">",
"      Stadler K, Allison SL, Schalich J, Heinz FX. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 1997; 71:8475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/11\">",
"      Marchette NJ, Halstead SB, Falkler WA Jr, et al. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis 1973; 128:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/12\">",
"      Wu SJ, Grouard-Vogel G, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/13\">",
"      Kyle JL, Beatty PR, Harris E. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 2007; 195:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/14\">",
"      SABIN AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/15\">",
"      Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/16\">",
"      Scott RM, Nisalak A, Cheamudon U, et al. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980; 141:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/17\">",
"      King AD, Nisalak A, Kalayanrooj S, et al. B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 1999; 30:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/18\">",
"      Durbin AP, Vargas MJ, Wanionek K, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 2008; 376:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/19\">",
"      Rosen L, Khin MM, U T. Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 1989; 140:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/20\">",
"      Boonpucknavig S, Boonpucknavig V, Bhamarapravati N, Nimmannitya S. Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch Pathol Lab Med 1979; 103:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/21\">",
"      Hall WC, Crowell TP, Watts DM, et al. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 1991; 45:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/22\">",
"      Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/23\">",
"      Fresh JW, Reyes V, Clarke EJ, Uylangco CV. Philippine hemorrhagic fever: a clinical, laboratory, and necropsy study. J Lab Clin Med 1969; 73:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/24\">",
"      Schmidt AC. Response to dengue fever--the good, the bad, and the ugly? N Engl J Med 2010; 363:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/25\">",
"      Kurane I, Janus J, Ennis FA. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol 1992; 124:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/26\">",
"      Kurane I, Ennis FA. Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 1988; 69 ( Pt 2):445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/27\">",
"      Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/28\">",
"      Kurane I, Hebblewaite D, Brandt WE, Ennis FA. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol 1984; 52:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/29\">",
"      Mu&ntilde;oz-Jordan JL, S&aacute;nchez-Burgos GG, Laurent-Rolle M, Garc&iacute;a-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 2003; 100:14333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/30\">",
"      Jones M, Davidson A, Hibbert L, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 2005; 79:5414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/31\">",
"      Simmons CP, Popper S, Dolocek C, et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007; 195:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/32\">",
"      Schlesinger JJ, Brandriss MW, Walsh EE. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 1987; 68 ( Pt 3):853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/33\">",
"      He RT, Innis BL, Nisalak A, et al. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol 1995; 45:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/34\">",
"      Kaufman BM, Summers PL, Dubois DR, Eckels KH. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 1987; 36:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/35\">",
"      Kaufman BM, Summers PL, Dubois DR, et al. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 1989; 41:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/36\">",
"      Pierson TC, Diamond MS. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 2008; 10:e12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/37\">",
"      Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/38\">",
"      Goncalvez AP, Engle RE, St Claire M, et al. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A 2007; 104:9422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/39\">",
"      Balsitis SJ, Williams KL, Lachica R, et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010; 6:e1000790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/40\">",
"      Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010; 328:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/41\">",
"      Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 1999; 73:3623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/42\">",
"      Mathew A, Kurane I, Rothman AL, et al. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 1996; 98:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/43\">",
"      Kontny U, Kurane I, Ennis FA. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 1988; 62:3928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/44\">",
"      Halstead SB, Shotwell H, Casals J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 1973; 128:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/45\">",
"      Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/46\">",
"      Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000; 60:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/47\">",
"      Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/48\">",
"      Kuberski T, Rosen L, Reed D, Mataika J. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg 1977; 26:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/49\">",
"      Sudiro TM, Zivny J, Ishiko H, et al. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 2001; 63:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/50\">",
"      Green S, Pichyangkul S, Vaughn DW, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999; 180:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/51\">",
"      Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/52\">",
"      Zivna I, Green S, Vaughn DW, et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002; 168:5959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/53\">",
"      Simmons CP, Dong T, Chau NV, et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 2005; 79:5665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/54\">",
"      Dung NT, Duyen HT, Thuy NT, et al. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol 2010; 184:7281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/55\">",
"      Zivny J, DeFronzo M, Jarry W, et al. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol 1999; 163:2754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/56\">",
"      Mangada MM, Endy TP, Nisalak A, et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002; 185:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/57\">",
"      Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/58\">",
"      Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984; 120:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/59\">",
"      Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/60\">",
"      Rico-Hesse R, Harrison LM, Salas RA, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/61\">",
"      Watts DM, Porter KR, Putvatana P, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999; 354:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/62\">",
"      Pryor MJ, Carr JM, Hocking H, et al. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 2001; 65:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/63\">",
"      Cologna R, Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003; 77:3929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/64\">",
"      Guzm&aacute;n MG, Kour&iacute; G, Mart&iacute;nez E, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987; 21:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/65\">",
"      D&iacute;az A, Kour&iacute; G, Guzm&aacute;n MG, et al. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. Bull Pan Am Health Organ 1988; 22:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/66\">",
"      Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997; 56:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/67\">",
"      Kour&iacute; G, Guzm&aacute;n MG, Bravo J. Hemorrhagic dengue in Cuba: history of an epidemic. Bull Pan Am Health Organ 1986; 20:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/68\">",
"      Guzm&aacute;n MG, Kouri GP, Bravo J, et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990; 42:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/69\">",
"      Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/70\">",
"      Simmons CP, Chau TN, Thuy TT, et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 2007; 196:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/71\">",
"      Libraty DH, Acosta LP, Tallo V, et al. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med 2009; 6:e1000171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/72\">",
"      Thisyakorn U, Nimmannitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993; 16:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/73\">",
"      Halstead SB, Streit TG, Lafontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 2001; 65:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/74\">",
"      de la C Sierra B, Kour&iacute; G, Guzm&aacute;n MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 2007; 152:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/75\">",
"      Chiewsilp P, Scott RM, Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. Am J Trop Med Hyg 1981; 30:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/76\">",
"      Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002; 60:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/77\">",
"      Paradoa P&eacute;rez ML, Trujillo Y, Basanta P. Association of dengue hemorrhagic fever with the HLA system. Haematologia (Budap) 1987; 20:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/78\">",
"      Loke H, Bethell DB, Phuong CX, et al. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 2001; 184:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/79\">",
"      Fern&aacute;ndez-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004; 64:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/80\">",
"      Loke H, Bethell D, Phuong CX, et al. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002; 67:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/81\">",
"      Sakuntabhai A, Turbpaiboon C, Casad&eacute;mont I, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/82\">",
"      Kalayanarooj S, Gibbons RV, Vaughn D, et al. Blood group AB is associated with increased risk for severe dengue disease in secondary infections. J Infect Dis 2007; 195:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/83\">",
"      Sahaphong S, Riengrojpitak S, Bhamarapravati N, Chirachariyavej T. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1980; 11:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/84\">",
"      Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol 2007; 81:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/85\">",
"      Avirutnan P, Punyadee N, Noisakran S, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 2006; 193:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/86\">",
"      Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/87\">",
"      Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 1997; 71:4226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/88\">",
"      Bosch I, Xhaja K, Estevez L, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002; 76:5588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/89\">",
"      Talavera D, Castillo AM, Dominguez MC, et al. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 2004; 85:1801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/90\">",
"      Hober D, Poli L, Roblin B, et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 1993; 48:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/91\">",
"      Bethell DB, Flobbe K, Cao XT, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998; 177:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/92\">",
"      Juffrie M, van Der Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun 2000; 68:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/93\">",
"      Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991; 88:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/94\">",
"      Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/95\">",
"      Bokisch VA, Top FH Jr, Russell PK, et al. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 1973; 289:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/96\">",
"      Malasit P. Complement and dengue haemorrhagic fever/shock syndrome. Southeast Asian J Trop Med Public Health 1987; 18:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/97\">",
"      Hober D, Delannoy AS, Benyoucef S, et al. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol 1996; 40:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/98\">",
"      Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/99\">",
"      BIERMAN HR, NELSON ER. HEMATODEPRESSIVE VIRUS DISEASES OF THAILAND. Ann Intern Med 1965; 62:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/100\">",
"      Rothwell SW, Putnak R, La Russa VF. Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. Am J Trop Med Hyg 1996; 54:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/101\">",
"      Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 1989; 74:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/102\">",
"      Murgue B, Cassar O, Guigon M, Chungue E. Dengue virus inhibits human hematopoietic progenitor growth in vitro. J Infect Dis 1997; 175:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/103\">",
"      Mitrakul C, Poshyachinda M, Futrakul P, et al. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/104\">",
"      Cardier JE, Rivas B, Romano E, et al. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 2006; 13:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/105\">",
"      Sosothikul D, Seksarn P, Pongsewalak S, et al. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007; 97:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/106\">",
"      Srichaikul T, Nimmanitaya S, Artchararit N, et al. Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/107\">",
"      Chungue E, Poli L, Roche C, et al. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J Infect Dis 1994; 170:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/108\">",
"      Falconar AK. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 1997; 142:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/109\">",
"      Marianneau P, Cardona A, Edelman L, et al. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol 1997; 71:3244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/110\">",
"      Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/5/36953/abstract/111\">",
"      Ramos C, S&aacute;nchez G, Pando RH, et al. Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 1998; 4:465.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3029 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36953=[""].join("\n");
var outline_f36_5_36953=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2847719\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE DENGUE VIRAL REPLICATION CYCLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW OF THE COURSE OF INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Early events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Dissemination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Immune responses and viral clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Primary versus secondary infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FACTORS INFLUENCING DISEASE SEVERITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Viral factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prior dengue exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Nutritional status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PATHOPHYSIOLOGIC BASIS OF SPECIFIC DISEASE MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Capillary leak syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Blood and bone marrow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Liver",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2847719\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3029\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3029|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/15/28927\" title=\"figure 1\">",
"      Course acute dengue infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/55/26482\" title=\"figure 2\">",
"      Capillary leak in dengue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3029|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/1/19483\" title=\"table 1\">",
"      Risk factors for dengue HF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/34/18985?source=related_link\">",
"      Clinical presentation and diagnosis of dengue virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/27/16818?source=related_link\">",
"      Patient information: Dengue fever (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_5_36954="Physical exam skin front";
var content_f36_5_36954=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61227%7EPC%2F52494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61227%7EPC%2F52494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Common disorders encountered during the physical examination of skin, front view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 675px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Fitzpatrick, TB, Bernhard, JD, Copley, TG. In: Dermatology in General Medicine, Freedberg, IN, Eisin, AZ, Wolff, K, et al. (Eds), 5th ed, McGraw-Hill 1999. Copyright &copy; 1999 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Common disorders encountered during the physical examination of skin, back view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 670px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Fitzpatrick, TB, Bernhard, JD, Copley, TG. In: Dermatology in General Medicine, Freeberg, IN, Eisin, AZ, Wolff, K, et al. (Eds), 5th ed, McGraw-Hill 1999. Copyright &copy; 1999 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36954=[""].join("\n");
var outline_f36_5_36954=null;
var title_f36_5_36955="Scleritis and systemic diseases";
var content_f36_5_36955=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Systemic diseases associated with scleritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Connective tissue diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reactive arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relapsing polychondritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Systemic vasculitides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granulomatosis with polyangiitis (Wegener's)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Microscopic polyangitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Churg-Strauss syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyarteritis nodosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cogan's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Behcet's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urticarial vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syphilis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lyme disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes zoster",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aspergillis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36955=[""].join("\n");
var outline_f36_5_36955=null;
var title_f36_5_36956="Street names phencyclidine";
var content_f36_5_36956=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Street names for phencyclidine (PCP)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Pill or powder form",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Angel dust",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Boat",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Crystal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dust",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dusting",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Elephant tranquilizer",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hog",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Horse tranquilizer",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Little ones",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Live ones",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Love boat",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ozone",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            PCE",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Peace pill",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Porker",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Purple rain",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rocket fuel",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sherms",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            TCP",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tic tac",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Whack",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wickey",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Worm",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Zombie",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Zoot",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Combined with Marijuana",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Crystal super grass",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Embalming fluid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fry",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Green leaves",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Killer joints",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Killer weed",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            KJ",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Super weed",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wets",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36956=[""].join("\n");
var outline_f36_5_36956=null;
var title_f36_5_36957="CV response hypovolemia";
var content_f36_5_36957=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Model for cardiovascular response to hypovolemia from hemorrhage (based on normative data)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 292px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood pressure in hypovolemic children is maintained by increases in vascular resistance until hypovolemia exceeds 30 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Schwaitzberg, SD, Bergman, KS, Harris, BH, A Peditric trauma model of continuous hemorrhage. J Pediatr Surg 1988; 23:606.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36957=[""].join("\n");
var outline_f36_5_36957=null;
var title_f36_5_36958="Continuous aspiration system";
var content_f36_5_36958=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F68552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F68552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Device for continuous aspiration of subglottic secretions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 292px; height: 312px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Representation of a specially designed endotracheal tube that permits the drainage of subglottic secretions. Hi-Lo EVAC tube (Mallinckrodt).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Valles, J, Artigas, A, Rello, J, et al, Ann Intern Med 1995; 122:179.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36958=[""].join("\n");
var outline_f36_5_36958=null;
var title_f36_5_36959="Split pleura sign I CT";
var content_f36_5_36959=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Split pleura sign in empyema after coronary artery bypass grafting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows a crescentic collection of pleural liquid with enhancing visceral and parietal pleura (\"split pleura\" sign), which is characteristic of an inflammatory process.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_5_36959=[""].join("\n");
var outline_f36_5_36959=null;
